FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Deeter, A
   Dalman, M
   Haddad, J
   Duan, ZH
AF Deeter, Anthony
   Dalman, Mark
   Haddad, Joseph
   Duan, Zhong-Hui
TI Inferring gene and protein interactions using PubMed citations and
   consensus Bayesian networks
SO PLOS ONE
LA English
DT Article
ID CELL-CYCLE PROGRESSION; JAK-STAT PATHWAY; C-MYC; TYROSINE-PHOSPHATASE;
   PI3K/AKT PATHWAY; REGULATORY NETWORKS; SIGNALING PATHWAYS; APOPTOSIS;
   EXPRESSION; ATPASE
AB The PubMed database offers an extensive set of publication data that can be useful, yet inherently complex to use without automated computational techniques. Data repositories such as the Genomic Data Commons (GDC) and the Gene Expression Omnibus (GEO) offer experimental data storage and retrieval as well as curated gene expression profiles. Genetic interaction databases, including Reactome and Ingenuity Pathway Analysis, offer pathway and experiment data analysis using data curated from these publications and data repositories. We have created a method to generate and analyze consensus networks, inferring potential gene interactions, using large numbers of Bayesian networks generated by data mining publications in the PubMed database. Through the concept of network resolution, these consensus networks can be tailored to represent possible genetic interactions. We designed a set of experiments to confirm that our method is stable across variation in both sample and topological input sizes. Using gene product interactions from the KEGG pathway database and data mining PubMed publication abstracts, we verify that regardless of the network resolution or the inferred consensus network, our method is capable of inferring meaningful gene interactions through consensus Bayesian network generation with multiple, randomized topological orderings. Our method can not only confirm the existence of currently accepted interactions, but has the potential to hypothesize new ones as well. We show our method confirms the existence of known gene interactions such as JAKSTAT- PI3K-AKT-mTOR, infers novel gene interactions such as RAS-Bcl-2 and RAS-AKT, and found significant pathway-pathway interactions between the JAK-STAT signaling and Cardiac Muscle Contraction KEGG pathways.
C1 [Deeter, Anthony; Duan, Zhong-Hui] Univ Akron, Integrated Biosci, Akron, OH 44325 USA.
   [Deeter, Anthony; Haddad, Joseph; Duan, Zhong-Hui] Univ Akron, Dept Comp Sci, Akron, OH 44325 USA.
   [Dalman, Mark] Kent State Univ, Dept Biostat Environm Hlth Sci & Epidemiol, Coll Publ Hlth, Kent, OH 44242 USA.
   [Dalman, Mark] Kent State Univ, Dept Preclin Sci, Coll Podiatr Med, Kent, OH 44242 USA.
RP Deeter, A (reprint author), Univ Akron, Integrated Biosci, Akron, OH 44325 USA.; Deeter, A (reprint author), Univ Akron, Dept Comp Sci, Akron, OH 44325 USA.
EM aed27@zips.uakron.edu
CR AMATI B, 1993, EMBO J, V12, P5083, DOI 10.1002/j.1460-2075.1993.tb06202.x
   [Anonymous], 2016, GENOMIC DATA COMMONS
   [Anonymous], 2016, INGENUITY PATHWAY AN
   Bai Y, 2013, AM J PHYSIOL-HEART C, V304, pH427, DOI 10.1152/ajpheart.00462.2012
   Bialy L, 2005, ANGEW CHEM INT EDIT, V44, P3814, DOI 10.1002/anie.200461517
   BIELZA C, 2014, FRONT COMPUT NEUROSC, V8
   Braun F, 2013, CELL CYCLE, V12, P2937, DOI 10.4161/cc.25972
   Callagy GM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-153
   Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655
   Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824
   Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147
   Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Cooper G., 1991, P 7 C UNC ART INT, P86
   Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102
   Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010
   Cunnick JM, 2000, J BIOL CHEM, V275, P13842, DOI 10.1074/jbc.275.18.13842
   Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175
   Desouza M., 2012, BIOARCHITECTURE, V2, P75, DOI DOI 10.4161/BI0A.20975
   Ding J, 2006, BIOINFORMATICS, V22, P378, DOI 10.1093/bioinformatics/bti821
   Ding J, 2005, BIOINFORMATICS, V21, P694, DOI 10.1093/bioinformatics/bti087
   Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969
   Feng GS, 1999, EXP CELL RES, V253, P47, DOI 10.1006/excr.1999.4668
   Goetz T, 2005, NUCLEIC ACIDS RES, V33, pW774, DOI 10.1093/nar/gki429
   Haller RG, 1998, NEUROLOGY, V50, P37, DOI 10.1212/WNL.50.1.37
   HARRINGTON EA, 1994, EMBO J, V13, P3286, DOI 10.1002/j.1460-2075.1994.tb06630.x
   Hart TC, 2002, AM J HUM GENET, V70, P943, DOI 10.1086/339689
   Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704
   Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189
   Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902
   Hill SM, 2016, NAT METHODS, V13, P310, DOI [10.1038/nmeth.3773, 10.1038/NMETH.3773]
   Ho C, 2012, HEPATOLOGY, V55, P833, DOI 10.1002/hep.24736
   Hoffman B, 2002, ONCOGENE, V21, P3414, DOI 10.1038/sj/onc/1205400
   Holland BR, 2004, MOL BIOL EVOL, V21, P1459, DOI 10.1093/molbev/msh145
   Huson DH, 2004, IEEE ACM T COMPUT BI, V1, P151, DOI 10.1109/TCBB.2004.44
   Igaz P, 2001, INFLAMM RES, V50, P435, DOI 10.1007/PL00000267
   Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269
   Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070
   Kang J, 2012, FRONT ONCOL, V2, P3389
   Ke HN, 2010, CELL RES, V20, P458, DOI 10.1038/cr.2010.21
   Keppler-Noreuil KM, 2017, AM J MED GENET A, V173, P2359, DOI 10.1002/ajmg.a.38311
   Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958
   Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266
   Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012
   Kung AWC, 2006, CLIN ENDOCRINOL, V64, P158, DOI 10.1111/j.1365-2265.2006.02442.x
   Lancashire LJ, 2009, BRIEF BIOINFORM, V10, P315, DOI 10.1093/bib/bbp012
   Liongue Clifford, 2013, JAKSTAT, V2, pe22756, DOI 10.4161/jkst.22756
   Liu LJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1489, DOI 10.1152/ajpcell.00158.2007
   LUSCHER B, 1988, MOL CELL BIOL, V8, P2504
   Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039
   Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180
   Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623
   Murugan AK, 2012, ORAL ONCOL, V48, P383, DOI 10.1016/j.oraloncology.2011.12.006
   Oka T, 2001, AM J PATHOL, V159, P1495, DOI 10.1016/S0002-9440(10)62535-7
   Orloff MS, 2013, AM J HUM GENET, V92, P76, DOI 10.1016/j.ajhg.2012.10.021
   Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd
   Pearl J., 1988, PROBABILISTIC REASON
   Pena JM, 2011, J ARTIF INTELL RES, V42, P661
   Perez-Iratxeta C, 2003, NUCLEIC ACIDS RES, V31, P3866, DOI 10.1093/nar/gkg538
   Perez-Iratxeta C, 2001, TRENDS BIOCHEM SCI, V26, P573, DOI 10.1016/S0968-0004(01)01926-0
   Pestov NB, 2007, P NATL ACAD SCI USA, V104, P11215, DOI 10.1073/pnas.0704809104
   Petricoin EF, 2002, NAT GENET, V32, P474, DOI 10.1038/ng1029
   Plikus MV, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-424
   Poultney CS, 2012, METHOD CELL BIOL, V110, P19, DOI 10.1016/B978-0-12-388403-9.00002-3
   Prudent J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.286
   Rafalski VA, 2011, PROG NEUROBIOL, V93, P182, DOI 10.1016/j.pneurobio.2010.10.007
   Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963
   Reis-Filho JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2431
   Rohn JL, 1998, ONCOGENE, V17, P2811, DOI 10.1038/sj.onc.1202393
   Santarpia L, 2012, EXPERT OPIN THER TAR, V16, P103, DOI 10.1517/14728222.2011.645805
   Sarker D, 2009, CLIN CANCER RES, V15, P4799, DOI 10.1158/1078-0432.CCR-08-0125
   Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   Schultze SM, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002109
   SEGER R, 1995, FASEB J, V9, P726
   Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2
   Smit L, 2015, ONCOTARGET
   Sriram S., 2011, PREDICTING GENE RELA
   Stapley B J, 2000, Pac Symp Biocomput, P529
   Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109
   Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013
   Sugiura S, 1999, CARDIOVASC RES, V44, P266, DOI 10.1016/S0008-6363(99)00219-9
   Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772
   Tenenbaum D., 2016, KEGGREST CLIENT SIDE
   Velaithan R, 2011, BLOOD, V117, P6214, DOI 10.1182/blood-2010-08-301283
   Villarino AV, 2015, J IMMUNOL, V194, P21, DOI 10.4049/jimmunol.1401867
   Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/mrc839
   Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789
   Wang CM, 2013, CELL CYCLE, V12, P1999, DOI 10.4161/cc.25099
   Wang N, 2006, J BIOL CHEM, V281, P21878, DOI 10.1074/jbc.M605018200
   Werhli AV, 2007, STAT APPL GENET MOL, V6
   Wu QL, 2015, MOL MED REP, V12, P1429, DOI 10.3892/mmr.2015.3534
   Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x
   Yang ZR, 2004, BRIEF BIOINFORM, V5, P328, DOI 10.1093/bib/5.4.328
   Yoshimura Akihiko, 2009, Keio Journal of Medicine, V58, P73
   Zhang JD, 2009, BIOINFORMATICS, V25, P1470, DOI 10.1093/bioinformatics/btp167
   Zhou D, 2008, J BIOMED INFORM, V41, P393, DOI 10.1016/j.jbi.2007.11.008
NR 99
TC 4
Z9 4
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 19
PY 2017
VL 12
IS 10
AR 0186004
DI 10.1371/journal.pone.0186004
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FK0UN
UT WOS:000413195900033
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Liu, YM
   Zhao, N
   Li, CC
   Chang, Q
   Liu, XM
   Liao, YH
   Pan, RL
AF Liu, Yamin
   Zhao, Ning
   Li, Chenchen
   Chang, Qi
   Liu, Xinmin
   Liao, Yonghong
   Pan, Ruile
TI Longistyline C acts antidepressant in vivo and neuroprotection in vitro
   against glutamate-induced cytotoxicity by regulating NMDAR/NR2B-ERK
   pathway in PC12 cells
SO PLOS ONE
LA English
DT Article
ID ENDOPLASMIC-RETICULUM; SYNAPTIC PLASTICITY; PROTEIN-KINASES; NMDA
   RECEPTORS; DEPRESSION; EXCITOTOXICITY; DYSFUNCTION; DISORDERS; THERAPY;
   TARGETS
AB Depressive disorder is a common psychiatric disease which ranks among the leading cause of disability worldwide. The antidepressants presently used had low cure rate and caused a variety of side-effects. The screening of antidepressant drugs is usually used classic behavioural tests and neuroprotective strategy. Longistyline C, a natural stilbene isolated from the leaves of Cajanuscajan (L.) Millsp, was firstly investigated the antidepressant effect using animal behavioural tests, and studied the neuroprotection and its possible signaling pathways on glutamate-induced injury in PC12 cells. The results of animal test demonstrated that longistyline C had the antidepressant activity, which the effect is similar to the positive control. In current study, we investigated the effect of longistyline C on glutamate-induced injury in PC12 cells and explored its possible signaling pathways. The results demonstrated that pretreatment with longistyline C at the concentrations of 2-8 mu mol/L for 24 h had a significant reduction of the cytotoxicity induced by glutamate (15 mmol/L) in PC12 cells using MTT, lactate dehydrogenase (LDH) release assay and Annexin V-PI double staining. Subsequently, we found that pretreatment with longistyline C (8 mu mol/L) could drastically down-regulate the over-expression of NMDAR/NR2B and Ca2+/calmodulin-dependent protein kinase II (CaMKII), up-regulate the expressions of p-ERK and p-CREB and alleviate ER stress. In conclusison, longistyline C is most possibly through regulating NMDAR/NR2B-ERK1/2 related pathway and restoring endoplasmic reticulum function to exert neuroprotective effect against glutamate-induced injury in PC12 cells.
C1 [Liu, Yamin; Zhao, Ning; Li, Chenchen; Chang, Qi; Liu, Xinmin; Liao, Yonghong; Pan, Ruile] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing, Peoples R China.
RP Pan, RL (reprint author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing, Peoples R China.
EM rlpan@implad.ac.cn
FU CAMS innovation Fund for Medical Sciences (CIFMS) [2016-I2M-1-012]
FX This work was financially supported by CAMS innovation Fund for Medical
   Sciences (CIFMS) (2016-I2M-1-012). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR BATTELLI MG, 1995, DEV BRAIN RES, V86, P340, DOI 10.1016/0165-3806(95)00012-3
   Bhagwagar Z, 2007, INT C BIP DIS
   Bostwick JM, 2010, MAYO CLIN PROC, V85, P538, DOI 10.4065/mcp.2009.0565
   Choi AY, 2010, NEUROCHEM INT, V57, P143, DOI 10.1016/j.neuint.2010.05.006
   Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825
   Delgado PL, 2000, J CLIN PSYCHIAT, V61, P7
   Fatemi SH, 2005, SCHIZOPHR RES, V72, P109, DOI 10.1016/j.schres.2004.02.017
   Groenendyk J, 2005, ACTA BIOCHIM POL, V52, P381
   Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380
   Hindley A, 2002, J CELL SCI, V115, P1575
   Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936
   Krystal JH, 2002, MOL PSYCHIATR, V7, pS71, DOI 10.1038/sj.mp.4001021
   Lamkanfi M, 2004, CELL DEATH DIFFER, V11, P365, DOI 10.1038/sj.cdd.4401364
   Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003
   Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239
   Liu YM, 2015, CHIN HERB MED, V7, P238, DOI 10.1016/S1674-6384(15)60045-4
   [刘亚旻 Liu Yamin], 2014, [中草药, Chinese Traditional and Herbal Drugs], V45, P466
   Mantovani M, 2003, NEUROSCI LETT, V343, P1, DOI 10.1016/S0304-3940(03)00306-9
   Mao QQ, 2011, J ETHNOPHARMACOL, V133, P1121, DOI 10.1016/j.jep.2010.11.043
   Markan S, 2009, MOL CELL BIOCHEM, V324, P131, DOI 10.1007/s11010-008-9991-2
   Martel MA, 2009, NEUROSCIENCE, V158, P334, DOI 10.1016/j.neuroscience.2008.01.080
   Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032
   Micale V, 2006, EUR NEUROPSYCHOPHARM, V16, P538, DOI 10.1016/j.euroneuro.2006.01.005
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
   Murrough JW, 2012, CLIN PHARMACOL THER, V91, P303, DOI 10.1038/clpt.2011.244
   Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0
   Olney J W, 1990, Can Dis Wkly Rep, V16 Suppl 1E, P47
   Sanacora G, 2002, AM J PSYCHIAT, V159, P663, DOI 10.1176/appi.ajp.159.4.663
   Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011
   Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056
   SEGER R, 1995, FASEB J, V9, P726
   SODERLING TR, 1995, ADV SEC MESS PHOSPH, V30, P175
   Stanika RI, 2009, P NATL ACAD SCI USA, V106, P9854, DOI 10.1073/pnas.0903546106
   Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001
   Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346
   Vizi ES, 2013, BRAIN RES BULL, V93, P32, DOI 10.1016/j.brainresbull.2012.10.005
   Westbrook Gary L., 1994, Current Opinion in Neurobiology, V4, P337, DOI 10.1016/0959-4388(94)90094-9
   Wu LJ, 2009, NEUROTHERAPEUTICS, V6, P693, DOI 10.1016/j.nurt.2009.07.008
   Xia ZG, 1996, J NEUROSCI, V16, P5425
   Xuejun L G M Z H, BASIC CLIN PHARM TOX, V104, P236
   Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982
NR 41
TC 5
Z9 5
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 5
PY 2017
VL 12
IS 9
AR e0183702
DI 10.1371/journal.pone.0183702
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FF8QL
UT WOS:000409282800021
PM 28873095
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Martinez-Rivera, FJ
   Perez-Laspiur, J
   Santiago-Gascot, ME
   Aleman-Reyes, AG
   Garcia-Santiago, E
   Rodriguez-Perez, Y
   Cabo-Guadalupe, C
   Otero-Pagan, I
   Ayala-Pagan, RN
   Martinez, M
   Cantres-Rosario, YM
   Melendez, LM
   Barreto-Estrada, JL
AF Martinez-Rivera, Freddyson J.
   Perez-Laspiur, Juliana
   Santiago-Gascot, Maria E.
   Aleman-Reyes, Abner G.
   Garcia-Santiago, Emanuel
   Rodriguez-Perez, Yolanda
   Cabo-Guadalupe, Cristhian
   Otero-Pagan, Inelia
   Ayala-Pagan, Roxsana N.
   Martinez, Magdiel
   Cantres-Rosario, Yisel M.
   Melendez, Loyda M.
   Barreto-Estrada, Jennifer L.
TI Differential protein expression profile in the hypothalamic GT1-7 cell
   line after exposure to anabolic androgenic steroids
SO PLOS ONE
LA English
DT Article
ID GNRH GENE-EXPRESSION; HUMAN CYTOCHROME-P450 ENZYMES; BREAST-CANCER
   CELLS; HORMONE NEURONS; RECEPTOR EXPRESSION; CEREBROSPINAL-FLUID;
   TESTOSTERONE LEVELS; HOUSEKEEPING GENES; PROTEOMIC ANALYSIS;
   STATISTICAL-MODEL
AB The abuse of anabolic androgenic steroids (AAS) has been considered a major public health problem during decades. Supraphysiological doses of AAS may lead to a variety of neuroendocrine problems. Precisely, the hypothalamic-pituitary-gonadal (HPG) axis is one of the body systems that is mainly influenced by steroidal hormones. Fluctuations of the hormonal milieu result in alterations of reproductive function, which are made through changes in hypothalamic neurons expressing gonadotropin-releasing hormone (GnRH). In fact, previous studies have shown that AAS modulate the activity of these neurons through steroid-sensitive afferents. To increase knowledge about the cellular mechanisms induced by AAS in GnRH neurons, we performed proteomic analyses of the murine hypothalamic GT1-7 cell line after exposure to 17a-methyltestosterone (17 alpha-meT; 1 mu M). These cells represent a good model for studying regulatory processes because they exhibit the typical characteristics of GnRH neurons, and respond to compounds that modulate GnRH in vivo. Two-dimensional difference in gel electrophoresis (2D-DIGE) and mass spectrometry analyses identified a total of 17 different proteins that were significantly affected by supraphysiological levels of AAS. Furthermore, pathway analyses showed that modulated proteins were mainly associated to glucose metabolism, drug detoxification, stress response and cell cycle. Validation of many of these proteins, such as GSTM1, ERH, GAPDH, PEBP1 and PDIA6, were confirmed by western blotting. We further demonstrated that AAS exposure decreased expression of estrogen receptors and GnRH, while two important signaling pathway proteins p-ERK, and p-p38, were modulated. Our results suggest that steroids have the capacity to directly affect the neuroendocrine system by modulating key cellular processes for the control of reproductive function.
C1 [Martinez-Rivera, Freddyson J.; Santiago-Gascot, Maria E.; Otero-Pagan, Inelia; Barreto-Estrada, Jennifer L.] Univ Puerto Rico, Dept Anat & Neurobiol, Med Sci Campus, San Juan, PR 00936 USA.
   [Perez-Laspiur, Juliana; Rodriguez-Perez, Yolanda; Melendez, Loyda M.] Univ Puerto Rico, Translat Prote Ctr RCMI, Med Sci Campus, San Juan, PR 00936 USA.
   [Aleman-Reyes, Abner G.; Ayala-Pagan, Roxsana N.] Univ Puerto Rico, Dept Biol, Rio Piedras, PR USA.
   [Garcia-Santiago, Emanuel; Cabo-Guadalupe, Cristhian] Univ Este, Dept Biotechnol, Carolina, PR USA.
   [Martinez, Magdiel] Univ Puerto Rico, Dept Physiol & Biophys, Med Sci Campus, San Juan, PR 00936 USA.
   [Cantres-Rosario, Yisel M.; Melendez, Loyda M.] Univ Puerto Rico, Dept Microbiol & Med Zool, Med Sci Campus, San Juan, PR 00936 USA.
RP Barreto-Estrada, JL (reprint author), Univ Puerto Rico, Dept Anat & Neurobiol, Med Sci Campus, San Juan, PR 00936 USA.
EM jennifer.barreto1@upr.edu
FU RCMI Translational Proteomics Center NIMHD [8G12MD007600]; RTRN
   [U54MD008149]; NIH-NCRR [2P20RR016470]; NIGMS [8P20GM103475]; MBRS-RISE
   [R25GM061838, R25GM066250]
FX This work was supported by grants, RCMI Translational Proteomics Center
   NIMHD (8G12MD007600), RTRN Small Grants Program (U54MD008149) to JLBE;
   NIH-NCRR (2P20RR016470) and NIGMS (8P20GM103475) to JLBE and MESG;
   MBRS-RISE (R25GM061838) to FJMR, and MBRS-RISE (R25GM066250) to EGS and
   CCG. Authors want to thank, Dr. Scott Shaffer, Director of Proteomics
   and Mass Spectrometry Facility at University of Massachusetts Medical
   School and Dr. Richard Noel, Director of Molecular and Genomics Core
   NIH-RCMI Program (NIMHD MD007579) at the Ponce Health Sciences
   University. We also thank Namyr Martinez for his technical assistance,
   and Angelica B. Rolon-Barreto for editorial revision.; This work was
   funded by RTRN Small Grants Program (U54MD008149)
   http://grants.rtm.net/index.php/SMALLGRANT20162017, to JLBE; NIH-NCRR
   (2P20RR016470) http://www.nems.nih.gov/teams/Pages/NCRR.aspx, to JLBE;
   NIGMS (8P20GM103475) https://www.nigms.nih.gov/Pages/default.aspx to
   JLBE; MBRS-RISE (R25GM061838) http://mbrsrise.rcm.upr.edu. to FJMR;
   MBRS-RISE (R25GM066250)
   http://www.sugam.edu/une/propuestas/rise/rise_index.html. to EGS and
   CCG; RCMI Translational Proteomics Center NIMHD (8G12MD007600),
   htp://rcmi.rcm.upr.edu/ resreso/guidelines_rcmi. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Angele MK, 2003, AM J PHYSIOL-ENDOC M, V285, pE189, DOI 10.1152/ajpendo.00035.2003
   Belsham DD, 1998, ENDOCRINOLOGY, V139, P1108, DOI 10.1210/en.139.3.1108
   Bravo-Cordero JJ, 2013, NAT REV MOL CELL BIO, V14, P405, DOI 10.1038/nrm3609
   Brayman MJ, 2012, MOL ENDOCRINOL, V26, P2, DOI 10.1210/me.2011-1015
   BROOKS DE, 1976, BIOCHEM J, V156, P527, DOI 10.1042/bj1560527
   Caraci F, 2011, J NEUROSCI RES, V89, P592, DOI 10.1002/jnr.22578
   Castoria G, 2014, ROLE NONGENOMIC ANDR, V5, pe1548
   Castoria G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017218
   Chen Jie, 2009, Cancer Genomics & Proteomics, V6, P331
   Cheng J, 2007, ENDOCRINOLOGY, V148, P2066, DOI 10.1210/en.2006-1465
   COHEN JC, 1987, J CLIN ENDOCR METAB, V64, P960, DOI 10.1210/jcem-64-5-960
   Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137
   Coles BF, 2003, BIOFACTORS, V17, P115, DOI 10.1002/biof.5520170112
   Cui H, 2003, MOL CELL ENDOCRINOL, V203, P13, DOI 10.1016/S0303-7207(03)00121-7
   Cunningham RL, 2009, ENDOCRINOLOGY, V150, P5539, DOI 10.1210/en.2009-0640
   Daly RC, 2001, ARCH GEN PSYCHIAT, V58, P172, DOI 10.1001/archpsyc.58.2.172
   de Gooyer ME, 2003, STEROIDS, V68, P235, DOI 10.1015/S0039-128X(02)00184-8
   Dodge T, 2011, DRUG ALCOHOL DEPENDE
   Escara-Wilke J, 2012, CANCER METAST REV, V31, P615, DOI 10.1007/s10555-012-9365-9
   Estrada M, 2006, J BIOL CHEM, V281, P25492, DOI 10.1074/jbc.M603193200
   Fix C, 2004, P NATL ACAD SCI USA, V101, P10919, DOI 10.1073/pnas.0404278101
   Frankenfeld SP, 2014, J ENDOCRINOL, V220, P143, DOI 10.1530/JOE-13-0259
   Fu Q-F, 2015, ALPHA ENOLASE PROMOT, P1
   Fujimura A, 2012, BIOCHEM BIOPH RES CO, V423, P588, DOI 10.1016/j.bbrc.2012.06.018
   Gao JC, 2015, COMP BIOCHEM PHYS D, V15, P20, DOI 10.1016/j.cbd.2015.05.001
   Garrido P, 2014, METABOLISM, V63, P1178, DOI 10.1016/j.metabol.2014.06.003
   Go RE, 2015, J STEROID BIOCHEM, V147, P24, DOI 10.1016/j.jsbmb.2014.11.003
   Gore AC, 1997, FRONT NEUROENDOCRIN, V18, P209, DOI 10.1006/frne.1996.0149
   Gu S, 2011, PAPADOPOULOU N MOL M, V17, P1
   HALES TG, 1992, MOL PHARMACOL, V42, P197
   Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012
   Hazard D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-101
   Hitosugi T, 2012, CANCER CELL, V22, P585, DOI 10.1016/j.ccr.2012.09.020
   Imperlini E, 2010, PROTEOMICS, V10, P3165, DOI 10.1002/pmic.201000079
   Jiang M, 2009, MOL ENDOCRINOL, V23, P1927, DOI 10.1210/me.2009-0103
   Jin JM, 2014, GENE, V551, P15, DOI 10.1016/j.gene.2014.08.048
   Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h
   Li HS, 2010, EXPERT OPIN DRUG MET, V6, P409, DOI 10.1517/17425251003598886
   Liao RS, 2013, ANDROGEN RECEPTOR ME
   Liu T, 2015, GENE, V555, P108, DOI 10.1016/j.gene.2014.10.051
   Liu X, 2015, INT J ENDOCRINOL, DOI 10.1155/2015/949085
   Malorni L, 2006, PROTEOMICS, V6, P5973, DOI 10.1002/pmic.200600333
   Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224
   Martinez-Rivera FJ, 2015, BEHAV PROCESS, V113, P81, DOI 10.1016/j.beproc.2015.01.008
   Mayer CM, 2009, FRONT NEUROENDOCRIN, V30, P405, DOI 10.1016/j.yfrne.2009.03.005
   McNamara LE, 2010, J R SOC INTERFACE, V7, pS107, DOI 10.1098/rsif.2009.0177.focus
   Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147
   MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E
   Moenter SM, 2003, FRONT NEUROENDOCRIN, V24, P79, DOI 10.1016/S0091-3022(03)00013-X
   Mulchahey JJ, 2001, PSYCHONEUROENDOCRINO, V26, P273, DOI 10.1016/S0306-4530(00)00052-4
   Navarro CE, 2003, MOL ENDOCRINOL, V17, P1792, DOI 10.1210/me.2003-0040
   Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261
   Nguyen TVV, 2005, J NEUROCHEM, V94, P1639, DOI 10.1111/j.1471-4159.2005.03318.x
   Nishimura M, 2006, BIOCHEM BIOPH RES CO, V346, P1033, DOI 10.1016/j.bbrc.2006.06.012
   Onaran I, 2007, ARCH ANDROLOGY, V53, P13, DOI 10.1080/01485010600889134
   Ozanne DM, 2000, MOL ENDOCRINOL, V14, P1618, DOI 10.1210/me.14.10.1618
   Payne JR, 2004, HEART, V90, P473, DOI 10.1136/hrt.2003.025783
   Penatti CAA, 2011, NEUROPHARMACOLOGY, V61, P653, DOI 10.1016/j.neuropharm.2011.05.008
   Penatti CAA, 2010, J NEUROSCI, V30, P6497, DOI 10.1523/JNEUROSCI.5383-09.2010
   Penatti CAA, 2009, J NEUROSCI, V29, P12484, DOI 10.1523/JNEUROSCI.3108-09.2009
   Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0
   Poletti A, 2001, J NEUROENDOCRINOL, V13, P353, DOI 10.1046/j.1365-2826.2001.00635.x
   Rendic S, 1999, J CHROMATOGR B, V735, P73, DOI 10.1016/S0378-4347(99)00400-4
   Riedmaier I, 2009, J CHROMATOGR A, V1216, P8192, DOI 10.1016/j.chroma.2009.01.094
   Roy D, 1999, ENDOCRINOLOGY, V140, P5045, DOI 10.1210/en.140.11.5045
   Schroder AL, 2009, ENDOCRINE, V35, P211, DOI 10.1007/s12020-009-9154-6
   SCHWANZELFUKUDA M, 1992, ENDOCR REV, V13, P623, DOI 10.1210/er.13.4.623
   SEGER R, 1995, FASEB J, V9, P726
   Shakil T, 2002, MOL ENDOCRINOL, V16, P2592, DOI 10.1210/me.2002-0011
   Skynner HA, 2006, BRAIN RES, V1102, P12, DOI 10.1016/j.brainres.2006.04.112
   Stanton PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041718
   Stefansson J, 2016, PSYCHONEUROENDOCRINO, V74, P1, DOI 10.1016/j.psyneuen.2016.08.009
   Stella R, 2015, PROTEOMICS, V15, P2332, DOI 10.1002/pmic.201400468
   STRAUSS RH, 1985, JAMA-J AM MED ASSOC, V254, P3337, DOI 10.1001/jama.254.23.3337
   Suehara Y, 2009, PROTEOM CLIN APPL, V3, P584, DOI 10.1002/prca.200800168
   TORANZO D, 1989, MOL ENDOCRINOL, V3, P1748, DOI 10.1210/mend-3-11-1748
   Tufo G, 2014, CELL DEATH DIFFER, V21, P685, DOI 10.1038/cdd.2013.193
   van Amsterdam J, 2010, REGUL TOXICOL PHARM, V57, P117, DOI 10.1016/j.yrtph.2010.02.001
   Wada-Kiyama Y, 2013, BIOCHEM BIOPH RES CO, V434, P287, DOI 10.1016/j.bbrc.2013.02.117
   WELDER AA, 1995, J PHARMACOL TOX MET, V33, P187, DOI 10.1016/1056-8719(94)00073-D
   Weng MT, 2013, PROTEIN CELL, V4, P807, DOI 10.1007/s13238-013-3056-3
   WETSEL WC, 1995, CELL MOL NEUROBIOL, V15, P43, DOI 10.1007/BF02069558
   Wiebe JP, 2001, ENDOCRINE, V16, P7, DOI 10.1385/ENDO:16:1:07
   WIERMAN ME, 1995, CELL MOL NEUROBIOL, V15, P79, DOI 10.1007/BF02069559
   Winters S J, 1990, NIDA Res Monogr, V102, P113
   Wood RI, 2004, PHYSIOL BEHAV, V83, P279, DOI 10.1016/j.physbeh.2004.08.012
   Yamada M., 2009, J PROTEOM BIOINFORM, V2, P001
   YESALIS CE, 1995, SPORTS MED, V19, P326, DOI 10.2165/00007256-199519050-00003
   Yuen GS, 2011, BRAIN RES, V1379, P44, DOI 10.1016/j.brainres.2010.07.067
   Zarubin T, 2005, CELL RES
   Zhang BG, 2013, EUR J CANCER, V49, P3900, DOI 10.1016/j.ejca.2013.07.146
   Zhang HL, 2012, CELL PHYSIOL BIOCHEM, V30, P1340, DOI 10.1159/000343323
   Zhang YY, 2009, EXPERT OPIN DRUG MET, V5, P621, DOI 10.1517/17425250902967648
   Zhao KK, 2013, EUR J OBSTET GYN R B, V171, P301, DOI 10.1016/j.ejogrb.2013.09.026
NR 94
TC 0
Z9 0
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 18
PY 2017
VL 12
IS 7
AR e0180409
DI 10.1371/journal.pone.0180409
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FB3RW
UT WOS:000406061400012
PM 28719635
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Nam, HY
   Raghavendran, HRB
   Pingguan-Murphy, B
   Abbas, AA
   Merican, AM
   Kamarul, T
AF Nam, Hui Yin
   Raghavendran, Hanumantha Rao Balaji
   Pingguan-Murphy, Belinda
   Abbas, Azlina A.
   Merican, Azhar M.
   Kamarul, Tunku
TI Fate of tenogenic differentiation potential of human bone marrow stromal
   cells by uniaxial stretching affected by stretch-activated calcium
   channel agonist gadolinium
SO PLOS ONE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; ION CHANNELS; SIGNALING PATHWAYS;
   MECHANICAL-STRESS; TENDON REPAIR; STRAIN; CHONDROCYTES; OSTEOBLASTS;
   APOPTOSIS; DEATH
AB The role for mechanical stimulation in the control of cell fate has been previously proposed, suggesting that there may be a role of mechanical conditioning in directing mesenchymal stromal cells (MSCs) towards specific lineage for tissue engineering applications. Although previous studies have reported that calcium signalling is involved in regulating many cellular processes in many cell types, its role in managing cellular responses to tensile loading (mechanotransduction) of MSCs has not been fully elucidated. In order to establish this, we disrupted calcium signalling by blocking stretch-activated calcium channel (SACC) in human MSCs (hMSCs) in vitro. Passaged-2 hMSCs were exposed to cyclic tensile loading (1 Hz + 8% for 6, 24, 48, and 72 hours) in the presence of the SACC blocker, gadolinium. Analyses include image observations of immunochemistry and immunofluorescence staining from extracellular matrix (ECM) production, and measuring related tenogenic and apoptosis gene marker expression. Uniaxial tensile loading increased the expression of tenogenic markers and ECM production. However, exposure to strain in the presence of 20 mu M gadolinium reduced the induction of almost all tenogenic markers and ECM staining, suggesting that SACC acts as a mechanosensor in strain-induced hMSC tenogenic differentiation process. Although cell death was observed in prolonged stretching, it did not appear to be apoptosis mediated. In conclusion, the knowledge gained in this study by elucidating the role of calcium in MSC mechanotransduction processes, and that in prolonged stretching results in non-apoptosis mediated cell death may be potential useful for regenerative medicine applications.
C1 [Nam, Hui Yin; Raghavendran, Hanumantha Rao Balaji; Abbas, Azlina A.; Merican, Azhar M.; Kamarul, Tunku] Univ Malaya, Fac Med, Dept Orthopaed Surg NOCERAL, Tissue Engn Grp, Kuala Lumpur, Malaysia.
   [Pingguan-Murphy, Belinda] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia.
RP Nam, HY; Kamarul, T (reprint author), Univ Malaya, Fac Med, Dept Orthopaed Surg NOCERAL, Tissue Engn Grp, Kuala Lumpur, Malaysia.
EM huiyin26@yahoo.com; tkzrea@um.edu.my
RI Pingguan-Murphy, Belinda/B-8332-2010; Merican, Azhar M/S-2982-2019;
   Lahuddin, Haslinda/S-1588-2017; Abidin, Tunku Kamarul Zaman Tunku
   Zainol/B-9633-2011
OI Pingguan-Murphy, Belinda/0000-0001-5567-1141; Merican, Azhar
   M/0000-0001-6442-8776; Abidin, Tunku Kamarul Zaman Tunku
   Zainol/0000-0002-6028-1313
FU High Impact Research Ministry of Education, HIR-MoE
   [UM.C/625/1/HIR/MOHE/CHAN/03, A000003-50001]; University of Malaya
FX This work was supported by High Impact Research Ministry of Education,
   HIR-MoE Grant (Reference number - UM.C/625/1/HIR/MOHE/CHAN/03, account
   number - A000003-50001). We also thank the University of Malaya for a
   PhD thesis scholarship for the first author. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.; This work was supported by High Impact
   Research-Ministry of Education, HIR-MoE Grant (Reference number
   UM.C/625/1/HIR/MOHE/CHAN/03, account number - A000003-50001). We also
   thank the University of Malaya for a PhD thesis scholarship for the
   first author.
CR Banes AJ, 1999, CLIN ORTHOP RELAT R, pS356
   Banes AJ, 2001, CURR OPIN ORTHOP, V12, P389
   Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035
   Blatt NB, 2001, BIOORGAN MED CHEM, V9, P1371, DOI 10.1016/S0968-0896(01)00041-4
   Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211
   Boudreault F, 2002, AM J PHYSIOL-CELL PH, V282, pC219, DOI 10.1152/ajpcell.00317.2001
   Bullough R, 2008, DISABIL REHABIL, V30, P1746, DOI 10.1080/09638280701788258
   Cain K, 2003, DRUG METAB REV, V35, P337, DOI 10.1081/DMR-120026497
   Caldwell RA, 1998, AM J PHYSIOL-CELL PH, V275, pC619
   Chuen FS, 2004, J HISTOCHEM CYTOCHEM, V52, P1151, DOI 10.1369/jhc.3A6232.2004
   Cigognini D, 2013, DRUG DISCOV TODAY, V18, P1099, DOI 10.1016/j.drudis.2013.06.007
   Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028
   Coirault C, 1999, EUR RESPIR J, V14, P1297, DOI 10.1183/09031936.99.14612979
   Costa P, 2012, INT J BIOCHEM CELL B, V44, P2233, DOI 10.1016/j.biocel.2012.09.003
   Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7
   Docheva D, 2015, ADV DRUG DELIVER REV, V84, P222, DOI 10.1016/j.addr.2014.11.015
   Dook JE, 1997, MED SCI SPORT EXER, V29, P291, DOI 10.1097/00005768-199703000-00002
   Ge DX, 2009, BIOCHEM BIOPH RES CO, V381, P317, DOI 10.1016/j.bbrc.2009.01.173
   Hamill OP, 2001, PHYSIOL REV, V81, P685
   Hamill OP, 1996, PHARMACOL REV, V48, P231
   Hung CT, 1996, J BIOMECH, V29, P1411, DOI 10.1016/0021-9290(96)84536-2
   Huo B, 2010, PHILOS T R SOC A, V368, P617, DOI 10.1098/rsta.2009.0221
   Jang JY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/860652
   Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540
   Kawano S, 2002, CELL CALCIUM, V32, P165, DOI 10.1016/S0143-4160(02)00124-0
   Kearney EM, 2010, ANN BIOMED ENG, V38, P1767, DOI 10.1007/s10439-010-9979-4
   Kearney EM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2979870
   Khatib L, 2004, FASEB J, V18, P1903, DOI 10.1096/fj.04-1814fje
   Killian ML, 2012, J SHOULDER ELB SURG, V21, P228, DOI 10.1016/j.jse.2011.11.002
   Kim TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109378
   Lebart MC, 2006, FEBS J, V273, P3415, DOI 10.1111/j.1742-4658.2006.05350.x
   Liu YK, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025004
   Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007
   Massoud EIE, 2013, WORLD J ORTHOP, V4, P229, DOI 10.5312/wjo.v4.i4.229
   Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760
   Mayr M, 2002, FASEB J, V16, P1423, DOI 10.1096/fj.02-0042fje.
   McKayed KK, 2012, STEM CELLS CANC STEM, P199
   McMahon LA, 2008, ANN BIOMED ENG, V36, P185, DOI 10.1007/s10439-007-9416-5
   Miyauchi A, 2000, J BIOL CHEM, V275, P3335, DOI 10.1074/jbc.275.5.3335
   Mobasheri A, 2002, CELL BIOL INT, V26, P1, DOI 10.1006/cbir.2001.0826
   Nam HY, 2015, BIOMECH MODEL MECHAN, V14, P649, DOI 10.1007/s10237-014-0628-y
   Nam HY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4309
   Nowycky MC, 2002, J CELL SCI, V115, P3715, DOI 10.1242/jcs.00078
   Park JS, 2004, BIOTECHNOL BIOENG, V88, P359, DOI 10.1002/bit.20250
   Park JY, 2002, BIOCHEM BIOPH RES CO, V290, P1176, DOI 10.1006/bbrc.2001.6323
   Pingguan-Murphy B, 2005, ARCH BIOCHEM BIOPHYS, V444, P45, DOI 10.1016/j.abb.2005.09.015
   Riddle RC, 2006, AM J PHYSIOL-CELL PH, V290, pC776, DOI 10.1152/ajpcell.00082.2005
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   RUKNUDIN A, 1993, AM J PHYSIOL, V264, pH960
   Salameh A, 2013, BBA-BIOMEMBRANES, V1828, P147, DOI 10.1016/j.bbamem.2011.12.030
   Scott A, 2007, ARTHRITIS RHEUM-US, V56, P871, DOI 10.1002/art.22446
   SEGER R, 1995, FASEB J, V9, P726
   Sun XH, 2012, BONE, V51, P860, DOI 10.1016/j.bone.2012.08.116
   Sun XH, 2012, BONE, V50, P581, DOI 10.1016/j.bone.2011.12.015
   Tan JL, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.3
   Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076
   Tonelli FMP, 2012, ADV EXP MED BIOL, V740, P891, DOI 10.1007/978-94-007-2888-2_40
   Upadhyay R. K, 2015, J REGEN MED TISSUE E, V4, P1
   Wall M. E., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P70
   Wang ECY, 2003, AM J PHYSIOL-RENAL, V285, pF651, DOI 10.1152/ajprenal.00403.2002
   Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011
   Wang JHC, 2000, CONNECT TISSUE RES, V41, P29, DOI 10.3109/03008200009005639
   Wedhas N, 2005, FASEB J, V19, P1986, DOI 10.1096/fj.05-4198com
   Wright MO, 1997, J ORTHOPAED RES, V15, P742, DOI 10.1002/jor.1100150517
   YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333
   Yano S, 2004, J INVEST DERMATOL, V122, P783, DOI 10.1111/j.0022-202X.2004.22328.x
   Yao L, 2006, TISSUE ENG, V12, P1843, DOI 10.1089/ten.2006.12.1843
NR 67
TC 4
Z9 4
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 27
PY 2017
VL 12
IS 6
AR e0178117
DI 10.1371/journal.pone.0178117
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EZ2LT
UT WOS:000404541500012
PM 28654695
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Svenningsen, K
   Veno, MT
   Henningsen, K
   Mallien, AS
   Jensen, L
   Christensen, T
   Kjems, J
   Vollmayr, B
   Wiborg, O
AF Svenningsen, Katrine
   Veno, Morten T.
   Henningsen, Kim
   Mallien, Anne S.
   Jensen, Line
   Christensen, Trine
   Kjems, Jorgen
   Vollmayr, Barbara
   Wiborg, Ove
TI MicroRNA Profiling in the Medial and Lateral Habenula of Rats Exposed to
   the Learned Helplessness Paradigm: Candidate Biomarkers for
   Susceptibility and Resilience to Inescapable Shock
SO PLOS ONE
LA English
DT Article
ID MAJOR DEPRESSIVE DISORDER; REGION-SPECIFIC CHANGES; STRESS RESILIENCE;
   GENE-EXPRESSION; ANTIDEPRESSANT TREATMENT; MOOD DISORDERS; MODEL; BRAIN;
   RESISTANCE; BEHAVIOR
AB Depression is a highly heterogeneous disorder presumably caused by a combination of several factors ultimately causing the pathological condition. The genetic liability model of depression is likely to be of polygenic heterogeneity. miRNAs can regulate multiple genes simultaneously and therefore are candidates that align with this model. The habenula has been linked to depression in both clinical and animal studies, shifting interest towards this region as a neural substrate in depression. The goal of the present study was to search for alterations in miRNA expression levels in the medial and lateral habenula of rats exposed to the learned helplessness (LH) rat model of depression. Ten miRNAs showed significant alterations associating with their response to the LH paradigm. Of these, six and four miR-NAs were significantly regulated in the MHb and LHb, respectively. In the MHb we identified miR-490, miR-291a-3p, MiR-467a, miR-216a, miR-18b, and miR-302a. In the LHb miR-543, miR-367, miR-467c, and miR-760-5p were significantly regulated. A target gene analysis showed that several of the target genes are involved in MAPK signaling, neutrophin signaling, and ErbB signaling, indicating that neurotransmission is affected in the habenula as a consequence of exposure to the LH paradigm.
C1 [Svenningsen, Katrine; Henningsen, Kim; Jensen, Line; Christensen, Trine; Wiborg, Ove] Aarhus Univ, Dept Clin Med, Translat Neuropsychiat Unit, Risskov, Denmark.
   [Veno, Morten T.; Kjems, Jorgen] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.
   [Veno, Morten T.; Kjems, Jorgen] Aarhus Univ, Interdisciplinary Nanosci Ctr, Aarhus, Denmark.
   [Mallien, Anne S.; Vollmayr, Barbara] Heidelberg Univ, Dept Psychiat & Psychotherapy, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany.
   [Svenningsen, Katrine] Hosp Southern Jutland, Mol Diagnost & Clin Hlth Res Unit, Aabenraa, Denmark.
RP Wiborg, O (reprint author), Aarhus Univ, Dept Clin Med, Translat Neuropsychiat Unit, Risskov, Denmark.
EM ove.wiborg@clin.au.dk
RI Kjems, Jorgen/I-3490-2016
OI Kjems, Jorgen/0000-0003-4128-9317
FU Lundbeck Foundation [R77-A7085]
FX The study was funded by the Lundbeck Foundation (R77-A7085). The funder
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Alonso M, 2004, LEARN MEMORY, V11, P172, DOI 10.1101/lm.67804
   Andres KH, 1999, J COMP NEUROL, V407, P130, DOI 10.1002/(SICI)1096-9861(19990428)407:1<130::AID-CNE10>3.0.CO;2-8
   Bergstrom A, 2007, J MOL NEUROSCI, V33, P201, DOI 10.1007/s12031-007-0065-9
   Bergstrom A, 2008, BRAIN RES, V1196, P41, DOI 10.1016/j.brainres.2007.12.025
   Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846
   Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90
   Bisgaard CF, 2007, J MOL NEUROSCI, V32, P132, DOI 10.1007/s12031-007-0025-4
   Bisgaard CF, 2012, J PSYCHOPHARMACOL, V26, P1569, DOI 10.1177/0269881112460110
   Bousman CA, 2014, AM J MED GENET B, V165, P62, DOI 10.1002/ajmg.b.32206
   Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008
   Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406
   Buttenschon HN, 2015, J AFFECT DISORDERS, V183, P287, DOI 10.1016/j.jad.2015.05.027
   Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163
   Christensen T, 2011, NEUROSCIENCE, V196, P66, DOI 10.1016/j.neuroscience.2011.08.024
   Christensen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080666
   Czeh B, 2016, PROG NEURO-PSYCHOPH, V64, P293, DOI 10.1016/j.pnpbp.2015.04.004
   Dobrowsky RT, 2000, J NEUROSCI RES, V61, P237, DOI 10.1002/1097-4547(20000801)61:3<237::AID-JNR1>3.0.CO;2-M
   Duric V, 2010, NAT MED, V16, P1328, DOI 10.1038/nm.2219
   Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002
   English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103
   Felger JC, 2013, NEUROSCIENCE, V246, P199, DOI 10.1016/j.neuroscience.2013.04.060
   Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115
   Gaska M, 2012, PSYCHOPHARMACOLOGY, V223, P281, DOI 10.1007/s00213-012-2714-0
   GROENEWEGEN HJ, 1986, J COMP NEUROL, V249, P65, DOI 10.1002/cne.902490107
   Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075
   Hassel B, 2010, EPILEPSIA, V51, P1714, DOI 10.1111/j.1528-1167.2010.02545.x
   Henningsen K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016428
   Hoyer C, 2012, NEUROPSYCHOBIOLOGY, V65, P147, DOI 10.1159/000335243
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018
   Ladanyi A, 2006, CYTOM PART A, V69A, P947, DOI 10.1002/cyto.a.20322
   Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004
   Lee BH, 2010, PSYCHIAT INVEST, V7, P231, DOI 10.4306/pi.2010.7.4.231
   Lopez JP, 2014, NAT MED, V20, P764, DOI 10.1038/nm.3582
   Mann JJ, 1999, NEUROPSYCHOPHARMACOL, V21, pS99, DOI 10.1038/sj.npp.1395364
   O'Connor RM, 2012, MOL PSYCHIATR, V17, P359, DOI 10.1038/mp.2011.162
   Obata T, 2000, CRIT CARE MED, V28, pN67, DOI 10.1097/00003246-200004001-00008
   Organization WH, 2012, DEPRESSION FACT SHEE
   OVERMIER JB, 1967, J COMP PHYSIOL PSYCH, V63, P28, DOI 10.1037/h0024166
   Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011
   Richter SH, 2014, BEHAV BRAIN FUNCT, V10, DOI 10.1186/1744-9081-10-41
   Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346
   Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027
   Savitz JB, 2013, MOL PSYCHIATR, V18, P523, DOI 10.1038/mp.2013.43
   Savitz JB, 2011, BIOL PSYCHIAT, V69, P336, DOI 10.1016/j.biopsych.2010.09.027
   SEGER R, 1995, FASEB J, V9, P726
   Smalheiser NR, 2011, INT J NEUROPSYCHOPH, V14, P1315, DOI 10.1017/S1461145710001628
   Terao A, 2003, NEUROSCIENCE, V120, P1115, DOI 10.1016/S0306-4522(03)00395-6
   Tian WM, 2012, PSYCHIAT GENET, V22, P161, DOI 10.1097/YPG.0b013e3283539550
   Vollmayr B, 2001, BRAIN RES PROTOC, V8, P1, DOI 10.1016/S1385-299X(01)00067-8
   Vollmayr B, 2013, CELL TISSUE RES, V354, P171, DOI 10.1007/s00441-013-1654-2
   Wiborg O, 1999, PHARMACOL TOXICOL, V84, P88, DOI 10.1111/j.1600-0773.1999.tb00879.x
   Winter C, 2011, BEHAV BRAIN RES, V216, P463, DOI 10.1016/j.bbr.2010.07.034
   Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104
   Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073
NR 55
TC 2
Z9 2
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 5
PY 2016
VL 11
IS 8
AR e0160318
DI 10.1371/journal.pone.0160318
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT3GR
UT WOS:000381369500030
PM 27494716
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Shuaib, A
   Hartwell, A
   Kiss-Toth, E
   Holcombe, M
AF Shuaib, Aban
   Hartwell, Adam
   Kiss-Toth, Endre
   Holcombe, Mike
TI Multi-Compartmentalisation in the MAPK Signalling Pathway Contributes to
   the Emergence of Oscillatory Behaviour and to Ultrasensitivity
SO PLOS ONE
LA English
DT Article
ID ACTIVATED PROTEIN-KINASE; EPIDERMAL-GROWTH-FACTOR; CELL-CYCLE ARREST;
   NEGATIVE-FEEDBACK; GENE-EXPRESSION; NUCLEAR TRANSLOCATION; TRANSDUCTION
   PATHWAYS; COMPLEX-FORMATION; SYSTEMS BIOLOGY; RAS
AB Signal transduction through the Mitogen Activated Protein Kinase (MAPK) pathways is evolutionarily highly conserved. Many cells use these pathways to interpret changes to their environment and respond accordingly. The pathways are central to triggering diverse cellular responses such as survival, apoptosis, differentiation and proliferation. Though the interactions between the different MAPK pathways are complex, nevertheless, they maintain a high level of fidelity and specificity to the original signal. There are numerous theories explaining how fidelity and specificity arise within this complex context; spatio-temporal regulation of the pathways and feedback loops are thought to be very important. This paper presents an agent based computational model addressing multi-compartmentalisation and how this influences the dynamics of MAPK cascade activation. The model suggests that multi-compartmentalisation coupled with periodic MAPK kinase (MAPKK) activation may be critical factors for the emergence of oscillation and ultrasensitivity in the system. Finally, the model also establishes a link between the spatial arrangements of the cascade components and temporal activation mechanisms, and how both contribute to fidelity and specificity of MAPK mediated signalling.
C1 [Shuaib, Aban; Kiss-Toth, Endre] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England.
   [Shuaib, Aban; Holcombe, Mike] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England.
   [Shuaib, Aban] Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England.
   [Hartwell, Adam] Univ Sheffield, Dept Automat Control & Syst Engn, Sheffield, S Yorkshire, England.
   [Holcombe, Mike] Univ Sheffield, Adv Comp Res Ctr, Sheffield Bioincubator, Sheffield, S Yorkshire, England.
RP Holcombe, M (reprint author), Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England.; Holcombe, M (reprint author), Univ Sheffield, Adv Comp Res Ctr, Sheffield Bioincubator, Sheffield, S Yorkshire, England.
EM m.holcombe@sheffield.ac.uk
RI Kiss-Toth, Endre/A-8596-2014
OI Kiss-Toth, Endre/0000-0003-4406-4017; Shuaib, Aban/0000-0002-6137-8205
FU Biotechnology and Biological Sciences Research Council BBSRC Doctoral
   Training Grant [BB/F016840/1]
FX Funded by Biotechnology and Biological Sciences Research Council BBSRC
   Doctoral Training Grant BB/F016840/1 (www.bbsrc.ac.uk).
CR Adra SF, 2008, TECHNICAL REPORT
   Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200
   Angermann BR, 2012, NAT METHODS, V9, P283, DOI [10.1038/NMETH.1861, 10.1038/nmeth.1861]
   Baldassare JJ, 1999, J IMMUNOL, V162, P5367
   Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873
   Bhalla US, 2004, BIOPHYS J, V87, P733, DOI 10.1529/biophysj.104.040469
   BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J
   Bray D, 1997, P NATL ACAD SCI USA, V94, P13493, DOI 10.1073/pnas.94.25.13493
   Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664
   Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010
   Chickarmane V, 2007, J THEOR BIOL, V244, P68, DOI 10.1016/j.jtbi.2006.05.013
   Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783
   Choi TG, 2011, BBA-MOL CELL RES, V1813, P1412, DOI 10.1016/j.bbamcr.2011.04.001
   Coakley S., 2006, SIMULATION SERIES, V38, P33
   Colpoys WE, 2005, CELL SIGNAL, V17, P891, DOI 10.1016/j.cellsig.2004.11.014
   DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8
   Eblen ST, 2004, MOL CELL BIOL, V24, P2308, DOI 10.1128/MCB.24.6.2308-2317.2004
   Ferrell JE, 2009, FEBS LETT, V583, P3999, DOI 10.1016/j.febslet.2009.10.068
   Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895
   Gaumont-Leclerc MF, 2004, J BIOL CHEM, V279, P46802, DOI 10.1074/jbc.M403893200
   Hanada M, 1998, FEBS LETT, V437, P172, DOI 10.1016/S0014-5793(98)01229-0
   Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231
   Hao Bai, 2014, PLOS COMPUT IN PRESS
   Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020
   Harris VK, 2000, J BIOL CHEM, V275, P10802, DOI 10.1074/jbc.275.15.10802
   Hilioti Z, 2008, CURR BIOL, V18, P1700, DOI 10.1016/j.cub.2008.09.027
   Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078
   Inder K, 2008, MOL BIOL CELL, V19, P4776, DOI 10.1091/mbc.E08-04-0407
   Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682
   Kageyama R, 2012, WIRES DEV BIOL, V1, P629, DOI 10.1002/wdev.46
   Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7
   Kholodenko BN, 2000, BIOCHEM J, V350, P901, DOI 10.1042/0264-6021:3500901
   Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x
   Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039
   Klann MT, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-71
   Kolch W, 2005, FEBS LETT, V579, P1891, DOI 10.1016/j.febslet.2005.02.002
   Le Dreau G, 2012, DEV NEUROBIOL, V72, P1471, DOI 10.1002/dneu.22015
   Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237
   Legewie S, 2007, BIOPHYS J, V93, P2279, DOI 10.1529/biophysj.107.109132
   Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818
   Lim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007244
   Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621
   Liu P, 2011, BIOPHYS J, V101, P2572, DOI 10.1016/j.bpj.2011.10.025
   Mallavarapu A, 2009, J R SOC INTERFACE, V6, P257, DOI 10.1098/rsif.2008.0205
   MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8
   McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001
   Morley SJ, 1997, FEBS LETT, V418, P327, DOI 10.1016/S0014-5793(97)01405-1
   Mugler A, 2012, BIOPHYS J, V102, P1069, DOI 10.1016/j.bpj.2012.02.005
   Munoz-Garcia J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000330
   Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101
   Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004
   Nakayama K, 2008, CURR BIOL, V18, pR332, DOI 10.1016/j.cub.2008.03.013
   NGUYEN TT, 1993, J BIOL CHEM, V268, P9803
   Niwa Y, 2011, GENE DEV, V25, P1115, DOI [10.1101/gad.2035311, 10.1101/gad.2035311.]
   Ortega F, 2006, FEBS J, V273, P3915, DOI 10.1111/j.1742-4658.2006.05394.x
   Plowman SJ, 2008, MOL CELL BIOL, V28, P4377, DOI 10.1128/MCB.00050-08
   Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184
   Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7
   Sabouri-Ghomi M, 2008, J THEOR BIOL, V250, P209, DOI 10.1016/j.jtbi.2007.09.001
   Sarma Uddipan, 2012, BMC Res Notes, V5, P287, DOI 10.1186/1756-0500-5-287
   SEGER R, 1995, FASEB J, V9, P726
   Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588
   Shalom-Feuerstein R, 2008, CANCER RES, V68, P6608, DOI 10.1158/0008-5472.CAN-08-1117
   Shankaran H, 2011, MOL CARCINOGEN, V50, P424, DOI 10.1002/mc.20724
   Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90
   Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319
   Smith ER, 2004, J CELL BIOL, V164, P689, DOI 10.1083/jcb.200312028
   Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744
   Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7
   Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025
   Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615
   Tian XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011926
   Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951
   Vetterkind S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030409
   Wang X, 2006, BIOPHYS J, V90, P1961, DOI 10.1529/biophysj.105.073874
   Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598
   Zhao Q, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/055004
   Zhou Q, 2012, BRIT J PHARMACOL, V166, P1756, DOI 10.1111/j.1476-5381.2012.01875.x
NR 78
TC 2
Z9 4
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 31
PY 2016
VL 11
IS 5
AR e0156139
DI 10.1371/journal.pone.0156139
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DN5XX
UT WOS:000377146100017
PM 27243235
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Rojewska, E
   Popiolek-Barczyk, K
   Kolosowska, N
   Piotrowska, A
   Zychowska, M
   Makuch, W
   Przewlocka, B
   Mika, J
AF Rojewska, Ewelina
   Popiolek-Barczyk, Katarzyna
   Kolosowska, Natalia
   Piotrowska, Anna
   Zychowska, Magdalena
   Makuch, Wioletta
   Przewlocka, Barbara
   Mika, Joanna
TI PD98059 Influences Immune Factors and Enhances Opioid Analgesia in Model
   of Neuropathy
SO PLOS ONE
LA English
DT Article
ID ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; SPINAL NERVE LIGATION;
   NITRIC-OXIDE SYNTHASE; MORPHINE ANTINOCICEPTIVE TOLERANCE; MECHANICAL
   ALLODYNIA; P38 MAPK; PAIN HYPERSENSITIVITY; CENTRAL SENSITIZATION;
   INFLAMMATORY PAIN
AB Neuropathic pain treatment remains challenging due to ineffective therapy and resistance to opioid analgesia. Mitogen-activated protein kinase kinase (MAPKK) have been identified as the crucial regulators of pro- and antinociceptive factors. We used PD98059, an inhibitor of the MAPKK family members MEK1/2. The aim of study was to examine the influence of single and/or repeated PD98059 on nociception and opioid effectiveness in neuropathy. Moreover, we examined how PD98059 influences selected members of cellular pathways and cytokines. The PD98059 (2.5 mcg) was intrathecally preemptively administered before chronic constriction injury (CCI), and then once daily for 7 days. Additionally, at day 7 after CCI the PD98059-treated rats received a single injection of opioids. Using Western blot and qRT-PCR techniques in PD98059-treated rats we analyzed the mRNA and/or protein level of p38, ERK1/2, JNK, NF-kappaB, IL-1beta, IL-6, iNOS and IL-10 in the lumbar spinal cord. Our results indicate that PD98059 has an analgesic effects and potentiates morphine and/or buprenorphine analgesia. Parallel we observed that PD98059 inhibit upregulation of the CCI-elevated p38, ERK1/2, JNK and NF-kappaB protein levels. Moreover, PD98059 also prevented increase of pro- (IL-1beta, IL-6, and iNOS) but enhances anti-nociceptive (IL-10) factors. Summing up, PD98059 diminished pain and increased the effectiveness of opioids in neuropathy. The inhibition of MEKs might inactivate a variety of cell signaling pathways that are implicated in nociception.
C1 [Rojewska, Ewelina; Popiolek-Barczyk, Katarzyna; Kolosowska, Natalia; Piotrowska, Anna; Zychowska, Magdalena; Makuch, Wioletta; Przewlocka, Barbara; Mika, Joanna] Polish Acad Sci, Inst Pharmacol, Dept Pain Pharmacol, Krakow, Poland.
RP Mika, J (reprint author), Polish Acad Sci, Inst Pharmacol, Dept Pain Pharmacol, Krakow, Poland.
EM joamika@if-pan.krakow.pl
OI Makuch, Wioletta/0000-0002-1579-3643; Popiolek-Barczyk,
   Katarzyna/0000-0003-4366-6577; Mika, Joanna/0000-0003-1986-7205
FU National Science Centre, Poland [OPUSNCN 2011/03/B/NZ4/00042]; KNOW;
   Ministry of Science and Higher Education, Republic of Poland
FX This work was supported by the National Science Centre, Poland, grant
   OPUSNCN 2011/03/B/NZ4/00042 grant and statutory funds. Katarzyna
   Popiolek-Barczyk and Magdalena Zychowska are Ph. D. students and have a
   scholarships from the KNOW, sponsored by the Ministry of Science and
   Higher Education, Republic of Poland.
CR Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866
   ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489
   BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095
   BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6
   Bethea JR, 1998, J NEUROSCI, V18, P3251
   Chang YW, 2010, J PAIN, V11, P1146, DOI 10.1016/j.jpain.2010.02.010
   Chen YL, 2006, J BIOL CHEM, V281, P3067, DOI 10.1074/jbc.M506721200
   Cheng XP, 2003, NEUROSCIENCE, V119, P701, DOI 10.1016/S0306-4522(03)00035-6
   Clemons AP, 2002, PANCREAS, V25, P251, DOI 10.1097/00006676-200210000-00007
   Correa F, 2005, BRIT J PHARMACOL, V145, P441, DOI 10.1038/sj.bjp.0706215
   Cui Y, 2008, BRAIN BEHAV IMMUN, V22, P114, DOI 10.1016/j.bbi.2007.07.014
   Daulhac L, 2006, MOL PHARMACOL, V70, P1246, DOI 10.1124/mol.106.025478
   DeLeo JA, 1996, J INTERF CYTOK RES, V16, P695, DOI 10.1089/jir.1996.16.695
   DeLeo JA, 2004, NEUROSCIENTIST, V10, P40, DOI 10.1177/1073858403259950
   Di Paola R, 2009, INT J IMMUNOPATH PH, V22, P937, DOI 10.1177/039463200902200409
   Dominguez E, 2008, J NEUROCHEM, V107, P50, DOI 10.1111/j.1471-4159.2008.05566.x
   DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686
   Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623
   FIORE RS, 1993, J NEUROCHEM, V61, P1626, DOI 10.1111/j.1471-4159.1993.tb09796.x
   Foey AD, 1998, J IMMUNOL, V160, P920
   Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009
   Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040
   Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002
   Ji RR, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-33
   Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011
   Jin SX, 2003, J NEUROSCI, V23, P4017
   Karim F, 2001, J NEUROSCI, V21, P3771, DOI 10.1523/JNEUROSCI.21-11-03771.2001
   Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279
   Kawasaki Y, 2006, J PHARMACOL EXP THER, V316, P601, DOI 10.1124/jpet.105.093583
   Komatsu T, 2007, NEUROPHARMACOLOGY, V52, P1237, DOI 10.1016/j.neuropharm.2007.01.003
   Kraus J, 2003, MOL PHARMACOL, V64, P876, DOI 10.1124/mol.64.4.876
   Law PY, 2004, NEUROPHARMACOLOGY, V47, P300, DOI 10.1016/j.neuropharm.2004.07.013
   Ledeboer A, 2007, BRAIN BEHAV IMMUN, V21, P686, DOI 10.1016/j.bbi.2006.10.012
   Lee HL, 2004, NEUROREPORT, V15, P2807
   Lee MK, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-57
   Levy D, 2001, J NEUROPATH EXP NEUR, V60, P411, DOI 10.1093/jnen/60.5.411
   Ma VY, 1998, BRAIN RES, V797, P243, DOI 10.1016/S0006-8993(98)00380-1
   Ma WY, 2002, PAIN, V99, P175, DOI 10.1016/S0304-3959(02)00097-0
   Meng Z, 2013, ACTA PHARMACOL SIN, V34, P901, DOI 10.1038/aps.2013.24
   Mika J, 2008, PHARMACOL REP, V60, P297
   Mika J, 2007, EUR J PHARMACOL, V560, P142, DOI 10.1016/j.ejphar.2007.01.013
   Mika J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104420
   Mika J, 2009, BRAIN BEHAV IMMUN, V23, P75, DOI 10.1016/j.bbi.2008.07.005
   Milligan ED, 2003, J NEUROSCI, V23, P1026
   Milligan ED, 2006, PAIN, V126, P294, DOI 10.1016/j.pain.2006.07.009
   Miyoshi K, 2008, J NEUROSCI, V28, P12775, DOI 10.1523/JNEUROSCI.3512-08.2008
   MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165
   Obata K, 2004, J NEUROSCI, V24, P10211, DOI 10.1523/JNEUROSCI.3388-04.2004
   Pollock G, 2005, EXP BRAIN RES, V165, P470, DOI 10.1007/s00221-005-2318-6
   Popiolek-Barczyk K, 2015, NEURAL PLAST
   Popiolek-Barczyk K, 2014, PHARMACOL REP, V66, P845, DOI 10.1016/j.pharep.2014.05.001
   Raghavendra V, 2002, J NEUROSCI, V22, P9980
   Rojewska E, 2014, J NEUROIMMUNOL, V277, P57, DOI 10.1016/j.jneuroim.2014.09.020
   Rojewska E, 2014, NEUROPHARMACOLOGY, V86, P301, DOI 10.1016/j.neuropharm.2014.08.001
   Sawada M, 1999, J NEUROCHEM, V72, P1466, DOI 10.1046/j.1471-4159.1999.721466.x
   Schmidt H, 2000, J NEUROCHEM, V74, P414, DOI 10.1046/j.1471-4159.2000.0740414.x
   SEGER R, 1995, FASEB J, V9, P726
   Song P, 2001, NEUROSCI RES, V39, P281, DOI 10.1016/S0168-0102(00)00226-1
   Sung CS, 2005, J NEUROCHEM, V94, P742, DOI 10.1111/j.1471-4159.2005.03226.x
   Svensson CI, 2003, J NEUROCHEM, V86, P1534, DOI 10.1046/j.1471-4159.2003.01969.x
   Tanabe K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-68
   Tanabe K, 2009, BRAIN RES, V1274, P11, DOI 10.1016/j.brainres.2009.03.063
   Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308
   van den Heuvel I, 2015, EUR J PAIN, V19, P225, DOI 10.1002/ejp.540
   Wang ZY, 2010, PEPTIDES, V31, P2179, DOI 10.1016/j.peptides.2010.08.020
   Wen YR, 2007, ANESTHESIOLOGY, V107, P312, DOI 10.1097/01.anes.0000270759.11086.e7
   Widmann C, 1999, PHYSIOL REV, V79, P143
   Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765
   Xu Z, 2006, LIFE SCI, V79, P1895, DOI 10.1016/j.lfs.2006.06.023
   YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9
   Zang Y, 2011, CHINESE J PHYSIOL, V54, P241, DOI 10.4077/CJP.2011.AMM075
   Zhang Q, 2013, BRAIN RES BULL, V99, P132, DOI 10.1016/j.brainresbull.2013.10.008
   Zhou CH, 2014, ANESTH ANALG, V118, P1090, DOI 10.1213/ANE.0000000000000174
   Zhu JY, 2015, INFLAMMATION, V38, P637, DOI 10.1007/s10753-014-9971-5
   Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022
   Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006
   ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4
NR 77
TC 20
Z9 20
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 1
PY 2015
VL 10
IS 10
AR e0138583
DI 10.1371/journal.pone.0138583
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CS6GT
UT WOS:000362177100015
PM 26426693
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Sanderson, M
   Sadie-Van Gijsen, H
   Hough, S
   Ferris, WF
AF Sanderson, Micheline
   Sadie-Van Gijsen, Hanel
   Hough, Stephen
   Ferris, William F.
TI The Role of MKP-1 in the Anti-Proliferative Effects of Glucocorticoids
   in Primary Rat Pre-Osteoblasts
SO PLOS ONE
LA English
DT Article
ID PROTEIN-KINASE PHOSPHATASE-1; SIGNAL-REGULATED KINASE; INDUCED
   OSTEOPOROSIS; MAPK PHOSPHATASE-1; SPECIFICITY PHOSPHATASE-1;
   CELL-DIFFERENTIATION; GENE-EXPRESSION; ADIPOSE-TISSUE; IN-VITRO;
   PROLIFERATION
AB Glucocorticoid (GC)-induced osteoporosis has been attributed to a GC-induced suppression of pre-osteoblast proliferation. Our previous work identified a critical role for mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1) in mediating the anti-proliferative effects of GCs in immortalized pre-osteoblasts, but we subsequently found that MKP-1 null mice were not protected against the pathological effects of GCs on bone. In order to reconcile this discrepancy, we have assessed the effects of GCs on proliferation, activation of the MAPK ERK1/2 and MKP-1 expression in primary adipose-derived stromal cells (ADSCs) and ADSC-derived pre-osteoblasts (ADSC-OBs). ADSCs were isolated by means of collagenase digestion from adipose tissue biopsies harvested from adult male Wistar rats. ADSC-OBs were prepared by treating ADSCs with osteoblast differentiation media for 7 days. The effects of increasing concentrations of the GC dexamethasone on basal and mitogen-stimulated cell proliferation were quantified by tritiated thymidine incorporation. ERK1/2 activity was measured by Western blotting, while MKP-1 expression was quantified on both RNA and protein levels, using semi-quantitative real-time PCR and Western blotting, respectively. GCs were strongly anti-proliferative in both naive ADSCs and ADSC-OBs, but had very little effect on mitogen-induced ERK1/2 activation and did not upregulate MKP-1 protein expression. These findings suggest that the anti-proliferative effects of GCs in primary ADSCs and ADSC-OBs in vitro do not require the inhibition of ERK1/2 activation by MKP-1, which is consistent with our in vivo findings in MKP-1 null mice.
C1 [Sanderson, Micheline; Sadie-Van Gijsen, Hanel; Hough, Stephen; Ferris, William F.] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Med, Div Endocrinol, Parow, South Africa.
RP Ferris, WF (reprint author), Univ Stellenbosch, Fac Med & Hlth Sci, Dept Med, Div Endocrinol, Tygerberg Campus, Parow, South Africa.
EM wferris@sun.ac.za
OI Ferris, William/0000-0002-4515-5239; Sadie-Van Gijsen,
   Hanel/0000-0002-1745-563X
FU South African Medical Research Council (SAMRC); National Research
   Foundation of South Africa (NRF)
FX This work was funded by the South African Medical Research Council
   (SAMRC) (www.mrc.ac.za) to WFF (no grant number issued), and National
   Research Foundation of South Africa (NRF) (www.nrf.ac.za) to MS. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336
   Beloti Márcio Mateus, 2005, Braz. Dent. J., V16, P156, DOI 10.1590/S0103-64402005000200013
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Camps M, 2000, FASEB J, V14, P6
   Canalis E, 2007, OSTEOPOROSIS INT, V18, P1319, DOI 10.1007/s00198-007-0394-0
   Canalis E, 1996, J CLIN ENDOCR METAB, V81, P3441, DOI 10.1210/jcem.81.10.8855781
   Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000
   Conradie MM, 2011, CALCIFIED TISSUE INT, V89, P221, DOI 10.1007/s00223-011-9509-x
   Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266
   Dorfman K, 1996, ONCOGENE, V13, P925
   Engelbrecht Y, 2003, ENDOCRINOLOGY, V144, P412, DOI 10.1210/en.2002-220769
   Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623
   Furst R, 2007, FASEB J, V21, P74, DOI 10.1096/fj.06-6752com
   Gijsen HSV, 2012, MOL CELL ENDOCRINOL, V348, P55, DOI 10.1016/j.mce.2011.07.030
   HAHN TJ, 1979, J CLIN INVEST, V64, P655, DOI 10.1172/JCI109506
   Horsch K, 2007, MOL ENDOCRINOL, V21, P2929, DOI 10.1210/me.2007-0153
   Huang JI, 2002, PLAST RECONSTR SURG, V109, P1033, DOI 10.1097/00006534-200203000-00037
   Hulley PA, 1998, ENDOCRINOLOGY, V139, P2423, DOI 10.1210/en.139.5.2423
   Ishida Y, 1998, J BONE MINER RES, V13, P1822, DOI 10.1359/jbmr.1998.13.12.1822
   Kim CH, 1999, J ENDOCRINOL, V162, P371, DOI 10.1677/joe.0.1620371
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002
   Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115
   MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8
   Nishikawa K, 2010, J CLIN INVEST, V120, P3455, DOI 10.1172/JCI42528
   Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412
   Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234
   Pereira RC, 2002, BONE, V30, P685, DOI 10.1016/S8756-3282(02)00687-7
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   POCKWINSE SM, 1995, EXP CELL RES, V216, P244, DOI 10.1006/excr.1995.1031
   Price DM, 2004, FEBS LETT, V577, P220, DOI 10.1016/j.febslet.2004.09.083
   Sadie-Van Gijsen H, 2010, MOL CELL ENDOCRINOL, V328, P22, DOI 10.1016/j.mce.2010.06.009
   Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899
   SEGER R, 1995, FASEB J, V9, P726
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993
   van Wijngaarden P, 2007, MOL VIS, V13, P1508
   Walsh S, 2001, RHEUMATOLOGY, V40, P74, DOI 10.1093/rheumatology/40.1.74
   Yin L, 2006, CHINESE MED J-PEKING, V119, P581, DOI 10.1097/00029330-200604010-00012
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 40
TC 3
Z9 3
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 11
PY 2015
VL 10
IS 8
AR e0135358
DI 10.1371/journal.pone.0135358
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO7PP
UT WOS:000359353300075
PM 26263165
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Zhou, YN
   Wu, YQ
   Jiang, XQ
   Zhang, XL
   Xia, LG
   Lin, KL
   Xu, YJ
AF Zhou, Yuning
   Wu, Yuqiong
   Jiang, Xinquan
   Zhang, Xiuli
   Xia, Lunguo
   Lin, Kaili
   Xu, Yuanjin
TI The Effect of Quercetin on the Osteogenesic Differentiation and
   Angiogenic Factor Expression of Bone Marrow-Derived Mesenchymal Stem
   Cells
SO PLOS ONE
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; MAPK SIGNALING
   PATHWAYS; STROMAL CELLS; IN-VITRO; OSTEOBLAST DIFFERENTIATION;
   MORPHOGENETIC PROTEIN-2; PROGENITOR CELLS; BLOOD-VESSELS; P38
AB Bone marrow-derived mesenchymal stem cells (BMSCs) are widely used in regenerative medicine in light of their ability to differentiate along the chondrogenic and osteogenic lineages. As a type of traditional Chinese medicine, quercetin has been preliminarily reported to promote osteogenic differentiation in osteoblasts. In the present study, the effects of quercetin on the proliferation, viability, cellular morphology, osteogenic differentiation and angiogenic factor secretion of rat BMSCs (rBMSCs) were examined by MTT assay, fluorescence activated cell sorter (FACS) analysis, real-time quantitative PCR (RT-PCR) analysis, alkaline phosphatase (ALP) activity and calcium deposition assays, and Enzyme-linked immunosorbent assay (ELISA). Moreover, whether mitogen-activated protein kinase (MAPK) signaling pathways were involved in these processes was also explored. The results showed that quercetin significantly enhanced the cell proliferation, osteogenic differentiation and angiogenic factor secretion of rBMSCs in a dose-dependent manner, with a concentration of 2 mu M achieving the greatest stimulatory effect. Moreover, the activation of the extracellular signal-regulated protein kinases (ERK) and p38 pathways was observed in quercetin-treated rBMSCs. Furthermore, these induction effects could be repressed by either the ERK inhibitor PD98059 or the p38 inhibitor SB202190, respectively. These data indicated that quercetin could promote the proliferation, osteogenic differentiation and angiogenic factor secretion of rBMSCs in vitro, partially through the ERK and p38 signaling pathways.
C1 [Zhou, Yuning; Xu, Yuanjin] Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Shanghai Peoples Hosp 9, Dept Oral Surg,Sch Med, Shanghai 200030, Peoples R China.
   [Zhou, Yuning; Xu, Yuanjin] Shanghai Res Inst Stomatol, Shanghai, Peoples R China.
   [Wu, Yuqiong; Jiang, Xinquan] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Prosthodont, Sch Med, Shanghai 200030, Peoples R China.
   [Wu, Yuqiong; Jiang, Xinquan; Zhang, Xiuli] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Shanghai Res Inst Stomatol, Oral Bioengn Lab,Sch Med, Shanghai 200030, Peoples R China.
   [Xia, Lunguo] Shanghai Jiao Tong Univ, Dept Oral & Craniomaxillofacial Sci, Ctr Craniofacial Orthodont, Sch Med,Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China.
   [Lin, Kaili] Chinese Acad Sci, Shanghai Inst Ceram, Biomat & Tissue Engn Res Ctr, Shanghai 200050, Peoples R China.
   [Lin, Kaili] Tongji Univ, Lab Oral Biomed Sci & Translat Med, Sch Stomatol, Shanghai 200092, Peoples R China.
RP Xia, LG (reprint author), Shanghai Jiao Tong Univ, Dept Oral & Craniomaxillofacial Sci, Ctr Craniofacial Orthodont, Sch Med,Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China.
EM xialunguo@hotmail.com; lklecnu@aliyun.com; xuyuanjin@hotmail.com
FU National Natural Science Foundation of China [81171458, 81470713,
   81400554]; Specialized Research Fund for the Doctoral Program of Higher
   Education [20110073110076]; Science and Technology Committee of Shanghai
   Municipality [14140904100, 14YF1402400, 12nm0501600]; Medicine and
   Engineering Cross Project of Shanghai Jiao Tong University [YG2012SM29]
FX This work was funded by National Natural Science Foundation of China
   (81171458, 81470713 and 81400554), Specialized Research Fund for the
   Doctoral Program of Higher Education (20110073110076), Science and
   Technology Committee of Shanghai Municipality (14140904100, 14YF1402400
   and 12nm0501600), Medicine and Engineering Cross Project of Shanghai
   Jiao Tong University (YG2012SM29).
CR Abiramasundari G, 2012, J ETHNOPHARMACOL, V141, P474, DOI 10.1016/j.jep.2012.03.015
   AMBROSE ANTHONY M., 1949, JOUR NUTRITION, V38, P305
   Anand K, 2011, ASIAN PAC J CANCER P, V12, P2829
   Bai Y, 2013, BIOTECHNOL LETT, V35, P301, DOI 10.1007/s10529-012-1084-3
   Bara JJ, 2014, TISSUE ENG PT A, V20, P147, DOI [10.1089/ten.tea.2013.0196, 10.1089/ten.TEA.2013.0196]
   Bavaria MN, 2014, APOPTOSIS, V19, P467, DOI 10.1007/s10495-013-0944-1
   BIKFALVI A, 1991, J CELL PHYSIOL, V149, P50, DOI 10.1002/jcp.1041490108
   BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303
   Cancedda Ranieri, 2003, Novartis Found Symp, V249, P133
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Chen ML, 2011, INT J MOL MED, V27, P545, DOI 10.3892/ijmm.2011.619
   Clark D, 2015, J BIOMED MATER RES A, V103, P639, DOI 10.1002/jbm.a.35215
   DVORAK HF, 1991, J EXP MED, V174, P1275, DOI 10.1084/jem.174.5.1275
   Feric NT, 2014, BIOMATER SCI-UK, V2, P1384, DOI 10.1039/c4bm00073k
   Ferrara N, 1996, Curr Opin Nephrol Hypertens, V5, P35, DOI 10.1097/00041552-199601000-00008
   Fukuhara S, 2010, HISTOL HISTOPATHOL, V25, P387, DOI 10.14670/HH-25.387
   Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046
   Glowacki J, 1998, CLIN ORTHOP RELAT R, pS82, DOI 10.1097/00003086-199810001-00010
   Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060
   Hanada K, 1997, J BONE MINER RES, V12, P1606, DOI 10.1359/jbmr.1997.12.10.1606
   Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.3.CO;2-7
   Ho AWY, 2008, IMMUNOBIOLOGY, V213, P533, DOI 10.1016/j.imbio.2008.01.003
   Hoch AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035579
   Hu N, 2013, J CELL SCI, V126, P532, DOI 10.1242/jcs.114231
   Hu YY, 2003, ENDOCRINOLOGY, V144, P2068, DOI 10.1210/en.2002-220863
   Hung SC, 2007, STEM CELLS, V25, P2363, DOI 10.1634/stemcells.2006-0686
   Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200
   Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645
   Jansen RG, 2009, J ORAL PATHOL MED, V38, P630, DOI 10.1111/j.1600-0714.2009.00763.x
   Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021
   JOHNSON GL, 1994, CURR OPIN CELL BIOL, V6, P230, DOI 10.1016/0955-0674(94)90141-4
   Kim KI, 2014, BIOMATERIALS, V35, P4792, DOI 10.1016/j.biomaterials.2014.02.048
   Kim YJ, 2006, BIOCHEM PHARMACOL, V72, P1268, DOI 10.1016/j.bcp.2006.08.021
   Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC
   Ko J, 2007, EXP MOL MED, V39, P129, DOI 10.1038/emm.2007.15
   Krane SM, 2005, J EXP MED, V201, P841, DOI 10.1084/jem.20050354
   Kuhnau J, 1976, World Rev Nutr Diet, V24, P117
   Li ZH, 2014, INT J CLIN EXP MED, V7, P540
   Lin KL, 2013, BIOMATERIALS, V34, P10028, DOI 10.1016/j.biomaterials.2013.09.056
   Lin ZW, 2014, EXP THER MED, V7, P625, DOI 10.3892/etm.2013.1464
   Liu MM, 2017, J TISSUE ENG REGEN M, V11, P276, DOI 10.1002/term.1911
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Marrony S, 2003, BONE, V33, P426, DOI 10.1016/S8756-3282(03)00195-9
   Matsuoka F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055082
   Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1
   Miles SL, 2014, NUTR REV, V72, P720, DOI 10.1111/nure.12152
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Neumann T, 2003, MICROVASC RES, V66, P59, DOI 10.1016/S0026-2862(03)00040-2
   Oh SJ, 2010, FOOD CHEM TOXICOL, V48, P3227, DOI 10.1016/j.fct.2010.08.028
   Peluso I, 2015, CRIT REV FOOD SCI, V55, P383, DOI 10.1080/10408398.2012.656770
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prouillet C, 2004, BIOCHEM PHARMACOL, V67, P1307, DOI 10.1016/j.bcp.2003.11.009
   Satue M, 2013, BIOCHEM PHARMACOL, V86, P1476, DOI 10.1016/j.bcp.2013.09.009
   Schmid J, 1997, CLIN ORAL IMPLAN RES, V8, P244, DOI 10.1034/j.1600-0501.1997.080311.x
   SEGER R, 1995, FASEB J, V9, P726
   Suehiro F, 2011, STEM CELLS DEV, V20, P1540, DOI 10.1089/scd.2010.0279
   Suzuki A, 2006, J BONE MINER RES, V21, P674, DOI 10.1359/JBMR.020603
   Tamama K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795385
   Taylor SC, 2013, MOL BIOTECHNOL, V55, P217, DOI 10.1007/s12033-013-9672-6
   Utesch D, 2008, MUTAT RES-GEN TOX EN, V654, P38, DOI 10.1016/j.mrgentox.2008.04.008
   Wanachewin O, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-71
   Wang DS, 1997, ENDOCRINOLOGY, V138, P2953, DOI 10.1210/en.138.7.2953
   Wang XT, 2006, PLAST RECONSTR SURG, V117, P129, DOI 10.1097/01.prs.0000185609.07293.3e
   Wenger A, 2005, CELLS TISSUES ORGANS, V181, P80, DOI 10.1159/000091097
   Winet H, 1996, BONE, V19, pS39, DOI 10.1016/S8756-3282(96)00133-0
   Wu BY, 2000, J NEUROSCI RES, V62, P730, DOI 10.1002/1097-4547(20001201)62:5<730::AID-JNR13>3.3.CO;2-B
   Wu YQ, 2015, CELL PROLIFERAT, V48, P375, DOI 10.1111/cpr.12185
   Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453
   ZEMANKOVA-KUNZOVA H, 1949, Lek List, V4, P401
   Zeng Q, 2007, BONE, V40, P374, DOI 10.1016/j.bone.2006.09.022
   Zhai YK, 2014, INT J ENDOCRINOL, DOI 10.1155/2014/921954
   Zhang LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099946
   Zhang ZT, 2010, APOPTOSIS, V15, P105, DOI 10.1007/s10495-009-0425-8
   Zhao YF, 2014, BIOMED RES INT, DOI 10.1155/2014/637415
   Zhou C, 2014, CELL PROLIFERAT, V47, P124, DOI 10.1111/cpr.12097
NR 76
TC 39
Z9 41
U1 1
U2 21
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 8
PY 2015
VL 10
IS 6
AR e0129605
DI 10.1371/journal.pone.0129605
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CK1GM
UT WOS:000355955300152
PM 26053266
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Zhao, ZQ
   Wang, LJ
   Sun, XW
   Zhang, JJ
   Zhao, YJ
   Na, RS
   Zhang, JH
AF Zhao, Zhong Quan
   Wang, Li Juan
   Sun, Xiao Wei
   Zhang, Jiao Jiao
   Zhao, Yong Ju
   Na, Ri Su
   Zhang, Jia Hua
TI Transcriptome Analysis of the Capra hircus Ovary
SO PLOS ONE
LA English
DT Article
ID OOCYTE MATURATION; RNA-SEQ; CUMULUS CELLS; BLACK GOAT; IN-VITRO; MOUSE;
   GENE; IDENTIFICATION; EMBRYOS; CYCLE
AB Background
   Capra hircus is an important economic livestock animal, and therefore, it is necessary to discover transcriptome information about their reproductive performance. In this study, we performed de novo transcriptome sequencing to produce the first transcriptome dataset for the goat ovary using high-throughput sequencing technologies. The result will contribute to research on goat reproductive performance.
   Method and Results
   RNA-seq analysis generated more than 38.8 million clean paired end (PE) reads, which were assembled into 80,069 unigenes (mean size = 619 bp). Based on sequence similarity searches, 64,824 (60.6%) genes were identified, among which 29,444 and 11,271 unigenes were assigned to Gene Ontology (GO) categories and Clusters of Orthologous Groups (COG), respectively. Searches in the Kyoto Encyclopedia of Genes and Genomes pathway database (KEGG) showed that 27,766 (63.4%) unigenes were mapped to 258 KEGG pathways. Furthermore, we investigated the transcriptome differences of goat ovaries at two different ages using a tag-based digital gene expression system. We obtained a sequencing depth of over 5.6 million and 5.8 million tags for the two ages and identified a large number of genes associated with reproductive hormones, ovulatory cycle and follicle. Moreover, many antisense transcripts and novel transcripts were found; clusters with similar differential expression patterns, enriched GO terms and metabolic pathways were revealed for the first time with regard to the differentially expressed genes.
   Conclusions
   The transcriptome provides invaluable new data for a functional genomic resource and future biological research in Capra hircus, and it is essential for the in-depth study of candidate genes in breeding programs.
C1 [Zhao, Zhong Quan; Wang, Li Juan; Sun, Xiao Wei; Zhao, Yong Ju; Na, Ri Su; Zhang, Jia Hua] Southwest Univ, Chongqing Engn Res Ctr Herbivores Resource Protec, Chongqing, Peoples R China.
   [Zhang, Jiao Jiao] Jeju Natl Univ, Genet Engn & Stem Cell Biol Lab, Dept Anim Biotechnol, Fac Biotechnol, Jeju, South Korea.
RP Zhang, JH (reprint author), Southwest Univ, Chongqing Engn Res Ctr Herbivores Resource Protec, Chongqing, Peoples R China.
EM jhzhang007@aliyun.com
RI Zhang, Jiao Jiao/V-8705-2018
OI Zhang, Jiao Jiao/0000-0002-2699-6729
FU Chongqing Municipal Natural Science Foundation [cstc2012jjA80016];
   Fundamental Research Funds for the Central Universities [XDJK 2013B024]
FX The study was founded by Chongqing Municipal Natural Science Foundation
   project cstc2012jjA80016 and the Fundamental Research Funds for the
   Central Universities (XDJK 2013B024).
CR Ahn YK, 2014, GENE, V533, P494, DOI 10.1016/j.gene.2013.09.095
   Alkan N, 2013, MOL PLANT MICROBE IN, V26, P1345, DOI 10.1094/MPMI-03-13-0080-R
   Alldinger S, 2006, DEUT TIERARZTL WOCH, V113, P151
   Aprea J, 2013, EMBO J, V32, P3145, DOI 10.1038/emboj.2013.245
   Bent ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077834
   Boyer A, 2010, TRENDS ENDOCRIN MET, V21, P25, DOI 10.1016/j.tem.2009.08.005
   Brunet S, 2005, REPRODUCTION, V130, P801, DOI 10.1530/rep.1.00364
   Lanes CFC, 2013, MAR BIOTECHNOL, V15, P677, DOI 10.1007/s10126-013-9527-y
   Chavan SS, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S14-S4
   Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3
   Chitwood JL, 2014, REPROD FERT DEVELOP, V26, P179
   Chow RWY, 2010, ENDOCRINOLOGY, V151, P2411, DOI 10.1210/en.2009-1456
   EPPIG JJ, 1991, BIOESSAYS, V13, P569, DOI 10.1002/bies.950131105
   Faustino LR, 2013, SMALL RUMINANT RES, V114, P112, DOI 10.1016/j.smallrumres.2013.05.002
   Fisch KM, 2013, ARTHRITIS RHEUM-US, V65, pS807
   Fournier A, 2013, J AGR FOOD CHEM, V61, P7156, DOI 10.1021/jf401048j
   Ganguly A, 2013, RES VET SCI, V95, P374, DOI 10.1016/j.rvsc.2013.03.013
   Garcia A, 2013, HISTOL HISTOPATHOL, V28, P1369, DOI 10.14670/HH-28.1369
   Gilchrist RB, 2004, ANIM REPROD SCI, V82-3, P431, DOI 10.1016/j.anireprosci.2004.05.017
   Hammond GL, 2011, BIOL REPROD, V85, P431, DOI 10.1095/biolreprod.111.092593
   Han XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076890
   Harding LB, 2013, AQUAT TOXICOL, V142, P146, DOI 10.1016/j.aquatox.2013.07.020
   HARROUK W, 1995, MOL REPROD DEV, V41, P29, DOI 10.1002/mrd.1080410106
   Harwood BN, 2008, DEV DYNAM, V237, P1099, DOI 10.1002/dvdy.21491
   He QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081357
   Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009
   Huang YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-691
   Igwebuike UM, 2013, VET ARHIV, V83, P313
   Jorth P, 2013, J BACTERIOL, V195, P4991, DOI 10.1128/JB.00875-13
   Lin XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079258
   Ma H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-152
   Mamo S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-151
   Metcalfe NB, 2013, TRENDS ECOL EVOL, V28, P347, DOI 10.1016/j.tree.2013.01.015
   Pashaj A, 2013, PHYSIOL GENOMICS, V45, P1136, DOI 10.1152/physiolgenomics.00138.2013
   Peng JY, 2013, GENE, V524, P105, DOI 10.1016/j.gene.2013.04.054
   Raman D, 2011, EXP CELL RES, V317, P575, DOI 10.1016/j.yexcr.2011.01.005
   Ranjan R, 2013, BIOCHEM GENET, V51, P944, DOI 10.1007/s10528-013-9619-4
   Regassa A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-57
   SEGER R, 1995, FASEB J, V9, P726
   Sharma RK, 2013, SCANNING, V35, P344, DOI 10.1002/sca.21073
   Souza-Fabjan JMG, 2013, REPROD BIOL, V13, P325, DOI 10.1016/j.repbio.2013.09.005
   Sun QY, 2006, REPRODUCTION, V131, P193, DOI 10.1530/rep.1.00847
   Tong CB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-689
   Vas J, 2013, APPL ANIM BEHAV SCI, V147, P117, DOI 10.1016/j.applanim.2013.04.009
   Wang HX, 2009, MOL HUM REPROD, V15, P11, DOI 10.1093/molehr/gan070
   Wang LB, 2011, MOL BIOL REP, V38, P1621, DOI 10.1007/s11033-010-0272-2
   Wang PQ, 2011, GENET MOL RES, V10, P731, DOI 10.4238/vol10-2gmr1091
   Xu T, 2013, GENE, V520, P30, DOI 10.1016/j.gene.2013.01.068
   Xue SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076718
   Zhang Chao, 2011, Yichuan, V33, P607, DOI 10.3724/SP.J.1005.2011.00607
   Zhao ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080146
   Zhu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076282
   Zi XD, 2013, GEN COMP ENDOCR, V187, P1, DOI 10.1016/j.ygcen.2013.03.023
NR 53
TC 11
Z9 11
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 30
PY 2015
VL 10
IS 3
AR e0121586
DI 10.1371/journal.pone.0121586
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CE9AD
UT WOS:000352134700116
PM 25822507
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Tarzemany, R
   Jiang, GQ
   Larjava, H
   Hakkinen, L
AF Tarzemany, Rana
   Jiang, Guoqiao
   Larjava, Hannu
   Haekkinen, Lari
TI Expression and Function of Connexin 43 in Human Gingival Wound Healing
   and Fibroblasts
SO PLOS ONE
LA English
DT Article
ID MEDIATED INTERCELLULAR COMMUNICATION; HEMICHANNEL-INDEPENDENT ACTIONS;
   GAP JUNCTIONAL COMMUNICATION; TGF-BETA; IN-VIVO; EPITHELIAL-CELLS;
   MIMETIC PEPTIDE; SCAR REDUCTION; ORAL-MUCOSA; SKIN
AB Connexins (Cxs) are a family of transmembrane proteins that form hemichannels and gap junctions (GJs) on the cell membranes, and transfer small signaling molecules between the cytoplasm and extracellular space and between connecting cells, respectively. Among Cxs, suppressing Cx43 expression or function promotes skin wound closure and granulation tissue formation, and may alleviate scarring, but the mechanisms are not well understood. Oral mucosal gingiva is characterized by faster wound closure and scarless wound healing outcome as compared to skin wounds. Therefore, we hypothesized that Cx43 function is down regulated during human gingival wound healing, which in fibroblasts promotes expression of genes conducive for fast and scarless wound healing. Cultured gingival fibroblasts expressed Cx43 as their major connexin. Immunostaining of unwounded human gingiva showed that Cx43 was abundantly present in the epithelium, and in connective tissue formed large Cx43 plaques in fibroblasts. At the early stages of wound healing, Cx43 was strongly down regulated in wound epithelial cells and fibroblasts, returning to the level of normal tissue by day 60 post-wounding. Blocking of Cx43 function by Cx43 mimetic peptide Gap27 suppressed GJ-mediated dye transfer, promoted migration, and caused significant changes in the expression of wound healing-associated genes in gingival fibroblasts. In particular, out of 54 genes analyzed, several MMPs and TGF-beta 1, involved in regulation of inflammation and extracellular matrix (ECM) turnover, and VEGF-A, involved in angiogenesis, were significantly upregulated while pro-fibrotic ECM molecules, including Collagen type I, and cell contractility-related molecules were significantly down regulated. These responses involved MAPK, GSK3 alpha/beta and TGF-beta signaling pathways, and AP1 and SP1 transcription factors. Thus, suppressed function of Cx43 in fibroblasts promotes their migration, and regulates expression of wound healing-associated genes via AP1, SP1, MAPK, GSK3 alpha/beta and TGF-beta signaling pathways, and may promote fast and scarless wound healing in human gingiva.
C1 [Tarzemany, Rana; Jiang, Guoqiao; Larjava, Hannu; Haekkinen, Lari] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada.
RP Hakkinen, L (reprint author), Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada.
EM lhakkine@dentistry.ubc.ca
RI Hakkinen, Lari/B-2228-2016
FU Canadian Institutes of Health Research; University of British Columbia
   CIHR Skin Research Training Centre (SRTC) Award; CIHR IMHA Institute
   Community Support Travel Award
FX Supported by Canadian Institutes of Health Research (LH), University of
   British Columbia CIHR Skin Research Training Centre (SRTC) Award (RT),
   and CIHR IMHA Institute Community Support Travel Award (RT).
CR Akita S, 2013, ADV WOUND CARE, V2, P44, DOI 10.1089/wound.2011.0324
   Asazuma-Nakamura Y, 2009, EXP CELL RES, V315, P1190, DOI 10.1016/j.yexcr.2008.12.021
   Becker DL, 2012, BBA-BIOMEMBRANES, V1818, P2068, DOI 10.1016/j.bbamem.2011.11.017
   Brandner JM, 2004, J INVEST DERMATOL, V122, P1310, DOI 10.1111/j.0022-202X.2004.22529.x
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Caillou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022567
   Chaytor AT, 1997, J PHYSIOL-LONDON, V503, P99, DOI 10.1111/j.1469-7793.1997.099bi.x
   Cheon SS, 2006, FASEB J, V20, P692, DOI 10.1096/fj.05-4759com
   Churko JM, 2013, PHYSIOLOGY, V28, P190, DOI 10.1152/physiol.00058.2012
   Churko JM, 2011, HUM MUTAT, V32, P456, DOI 10.1002/humu.21472
   Coutinho P, 2005, BRIT J PLAST SURG, V58, P658, DOI 10.1016/j.bjps.2004.12.022
   Coutinho P, 2003, CELL BIOL INT, V27, P525, DOI 10.1016/S1065-6995(03)00077-5
   Dai P, 2007, MOL BIOL CELL, V18, P2264, DOI 10.1091/mbc.E06-12-1064
   Davis NG, 2013, WOUND REPAIR REGEN, V21, P571, DOI 10.1111/wrr.12054
   Degen KE, 2012, BIRTH DEFECTS RES C, V96, P258, DOI 10.1002/bdrc.21019
   Desplantez T, 2012, PHARMACOL RES, V65, P546, DOI 10.1016/j.phrs.2012.02.002
   Dufour A, 2013, TRENDS PHARMACOL SCI, V34, P233, DOI 10.1016/j.tips.2013.02.004
   Ehrlich HP, 2013, ADV WOUND CARE, V2, P113, DOI 10.1089/wound.2012.0414
   Ehrlich HP, 2000, J CELL PHYSIOL, V184, P86, DOI 10.1002/(SICI)1097-4652(200007)184:1<86::AID-JCP9>3.0.CO;2-5
   Eslami A, 2009, J HISTOCHEM CYTOCHEM, V57, P543, DOI 10.1369/jhc.2009.952572
   Evans WH, 2012, J MEMBRANE BIOL, V245, P437, DOI 10.1007/s00232-012-9488-5
   Fournier BPJ, 2013, STEM CELLS DEV, V22, P3157, DOI 10.1089/scd.2013.0015
   Fujita T, 2008, J PERIODONTAL RES, V43, P96, DOI 10.1111/j.1600-0765.2007.01000.x
   GABBIANI G, 1978, J CELL BIOL, V76, P561, DOI 10.1083/jcb.76.3.561
   Garcia-Dorado D, 2002, CARDIOVASC RES, V55, P456, DOI 10.1016/S0008-6363(02)00441-8
   Ghatnekar GS, 2009, REGEN MED, V4, P205, DOI 10.2217/17460751.4.2.205
   Ghersi G, 2002, J BIOL CHEM, V277, P29231, DOI 10.1074/jbc.M202770200
   Glim JE, 2013, WOUND REPAIR REGEN, V21, P648, DOI 10.1111/wrr.12072
   GOLIGER JA, 1995, MOL BIOL CELL, V6, P1491
   Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072
   Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576
   Gopalakrishnan A, 2006, ARCH PHARM RES, V29, P633, DOI 10.1007/BF02968247
   Gourdie RG, 2006, ANN NY ACAD SCI, V1080, P49, DOI 10.1196/annals.1380.005
   Hakkinen L, 2014, CYTOTHERAPY, V16, P1171, DOI 10.1016/j.jcyt.2014.04.004
   Hakkinen L, 2000, PERIODONTOL 2000, V24, P127, DOI 10.1034/j.1600-0757.2000.2240107.x
   HAKKINEN L, 1994, BBA-MOL CELL RES, V1224, P33, DOI 10.1016/0167-4889(94)90110-4
   Hakkinen L, 2014, STEM CELL B IN PRESS
   Hakkinen Lari, 2012, ORAL WOUND HEALING C, P125
   Harks EGA, 2001, J PHARMACOL EXP THER, V298, P1033
   Hatakeyama S, 2006, J PERIODONTAL RES, V41, P322, DOI 10.1111/j.1600-0765.2006.00875.x
   Hawat G, 2012, J MOL CELL CARDIOL, V53, P559, DOI 10.1016/j.yjmcc.2012.07.008
   Hawat G, 2010, PFLUG ARCH EUR J PHY, V460, P583, DOI 10.1007/s00424-010-0849-6
   Hebert C, 2013, J CELL BIOCHEM, V114, P2542, DOI 10.1002/jcb.24603
   Hematti P, 2012, CYTOTHERAPY, V14, P516, DOI 10.3109/14653249.2012.677822
   Herve JC, 2012, BBA-BIOMEMBRANES, V1818, P1844, DOI 10.1016/j.bbamem.2011.12.009
   Honardoust D, 2008, WOUND REPAIR REGEN, V16, P814, DOI 10.1111/j.1524-475X.2008.00435.x
   Honardoust HA, 2006, HISTOPATHOLOGY, V49, P634, DOI 10.1111/j.1365-2559.2006.02559.x
   Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mcb.E05-08-0737
   Ishikawa S, 2012, AM J PHYSIOL-HEART C, V302, pH2536, DOI 10.1152/ajpheart.00940.2011
   Jiang JX, 2005, BBA-BIOMEMBRANES, V1711, P208, DOI 10.1016/j.bbamem.2004.10.001
   Kandyba EE, 2008, J INVEST DERMATOL, V128, P1039, DOI 10.1038/sj.jid.5701125
   King SJ, 2011, METHODS MOL BIOL, V769, P53, DOI 10.1007/978-1-61779-207-6_5
   Ko K, 2000, AM J PHYSIOL-CELL PH, V279, P147
   Komatsu I, 2010, J HAND SURG-AM, V35A, P1580, DOI 10.1016/j.jhsa.2010.07.009
   Kretz M, 2004, EUR J CELL BIOL, V83, P647, DOI 10.1078/0171-9335-00422
   Kretz M, 2003, J CELL SCI, V116, P3443, DOI 10.1242/jcs.00638
   Lal R, 1995, AM J PHYSIOL, V268, P968
   Langevin HM, 2004, HISTOCHEM CELL BIOL, V122, P7, DOI 10.1007/s00418-004-0667-z
   Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899
   Mah W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090715
   Mak K, 2009, J DERMATOL SCI, V56, P168, DOI 10.1016/j.jdermsci.2009.09.005
   McCubrey JA, 2014, LEUKEMIA, V28, P15, DOI 10.1038/leu.2013.184
   Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb901
   Mori R, 2006, J CELL SCI, V119, P5193, DOI 10.1242/jcs.03320
   Moyer KE, 2002, EXP MOL PATHOL, V72, P10, DOI 10.1006/exmp.2001.2406
   NAGASE H, 1991, BIOMED BIOCHIM ACTA, V50, P749
   Nakano Y, 2008, INVEST OPHTH VIS SCI, V49, P93, DOI 10.1167/iovs.07-0255
   Negoro H, 2013, FEBS LETT, V587, P98, DOI 10.1016/j.febslet.2012.11.021
   Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051
   Niger C, 2011, BONE, V49, P683, DOI 10.1016/j.bone.2011.07.027
   Ongstad EL, 2013, ADV WOUND CARE, V2, P55, DOI 10.1089/wound.2011.0341
   Penn JW, 2012, INT J BURNS TRAUMA, V2, P18
   Pollok S, 2011, J CELL MOL MED, V15, P861, DOI 10.1111/j.1582-4934.2010.01057.x
   Principi Mariabeatrice, 2013, World J Gastrointest Pathophysiol, V4, P100, DOI 10.4291/wjgp.v4.i4.100
   Profyris C, 2012, J AM ACAD DERMATOL, V66, P1, DOI 10.1016/j.jaad.2011.05.055
   Qiu C, 2003, CURR BIOL, V13, P1697, DOI 10.1016/j.cub.2003.09.007
   Rhett JM, 2008, TRENDS BIOTECHNOL, V26, P173, DOI 10.1016/j.tibtech.2007.12.007
   Richards TS, 2004, J CELL BIOL, V167, P555, DOI 10.1083/jcb.200404142
   Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001
   Salameh A, 2008, J PHARMACOL EXP THER, V326, P315, DOI 10.1124/jpet.108.136663
   SALOMON D, 1988, J CLIN INVEST, V82, P248, DOI 10.1172/JCI113578
   Schalper KA, 2012, MOL BIOSYST, V8, P685, DOI 10.1039/c1mb05294b
   SEGER R, 1995, FASEB J, V9, P726
   Solan JL, 2014, FEBS LETT, V588, P1423, DOI 10.1016/j.febslet.2014.01.049
   Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319
   Sosinsky GE, 2007, BIOCHEM J, V408, P375, DOI 10.1042/BJ20070550
   Stains JP, 2014, CALCIFIED TISSUE INT, V94, P55, DOI 10.1007/s00223-013-9742-6
   Steffensen B, 2001, CRIT REV ORAL BIOL M, V12, P373, DOI 10.1177/10454411010120050201
   SULLIVAN R, 1993, GENE, V130, P191, DOI 10.1016/0378-1119(93)90419-4
   Vinken M, 2012, BBA-BIOMEMBRANES, V1818, P2002, DOI 10.1016/j.bbamem.2011.06.011
   Wang CM, 2007, DIABETES, V56, P2809, DOI 10.2337/db07-0613
   Wang N, 2013, NEUROPHARMACOLOGY, V75, P506, DOI 10.1016/j.neuropharm.2013.08.021
   Wong JW, 2009, WOUND REPAIR REGEN, V17, P717, DOI 10.1111/j.1524-475X.2009.00531.x
   Wong VW, 2012, SEMIN CELL DEV BIOL, V23, P981, DOI 10.1016/j.semcdb.2012.09.010
   Wright CS, 2012, J CELL PHYSIOL, V227, P77, DOI 10.1002/jcp.22705
   Wright CS, 2009, WOUND REPAIR REGEN, V17, P240, DOI 10.1111/j.1524-475X.2009.00471.x
   Yamaoka Y, 2002, TISSUE CELL, V34, P375, DOI 10.1016/S0040-8166(02)00038-1
   Ye P, 2000, J PATHOL, V192, P58
   Zhou JZ, 2014, FEBS LETT, V588, P1186, DOI 10.1016/j.febslet.2014.01.001
NR 99
TC 25
Z9 27
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 13
PY 2015
VL 10
IS 1
AR e0115524
DI 10.1371/journal.pone.0115524
PG 31
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AZ4OG
UT WOS:000348201300003
PM 25584940
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Zhang, J
   Carnduff, L
   Norman, G
   Josey, T
   Wang, YS
   Sawyer, TW
   Martyniuk, CJ
   Langlois, VS
AF Zhang, Jing
   Carnduff, Lisa
   Norman, Grant
   Josey, Tyson
   Wang, Yushan
   Sawyer, Thomas W.
   Martyniuk, Christopher J.
   Langlois, Valerie S.
TI Transcriptional Profiling in Rat Hair Follicles following Simulated
   Blast Insult: A New Diagnostic Tool for Traumatic Brain Injury
SO PLOS ONE
LA English
DT Article
ID PROTEIN-COUPLED RECEPTORS; GENE-EXPRESSION; INFLAMMATORY RESPONSE;
   CEREBROSPINAL-FLUID; ENRICHMENT ANALYSIS; CEREBRAL-ISCHEMIA; GENOMIC
   PROFILE; HEAD-INJURY; APOPTOSIS; CALCIUM
AB With wide adoption of explosive-dependent weaponry during military activities, Blast-induced neurotrauma (BINT)-induced traumatic brain injury (TBI) has become a significant medical issue. Therefore, a robust and accessible biomarker system is in demand for effective and efficient TBI diagnosis. Such systems will also be beneficial to studies of TBI pathology. Here we propose the mammalian hair follicles as a potential candidate. An Advanced Blast Simulator (ABS) was developed to generate shock waves simulating traumatic conditions on brains of rat model. Microarray analysis was performed in hair follicles to identify the gene expression profiles that are associated with shock waves. Gene set enrichment analysis (GSEA) and sub-network enrichment analysis (SNEA) were used to identify cell processes and molecular signaling cascades affected by simulated bomb blasts. Enrichment analyses indicated that genes with altered expression levels were involved in central nervous system (CNS)/peripheral nervous system (PNS) responses as well as signal transduction including Ca2+, K+-transportation-dependent signaling, Toll-Like Receptor (TLR) signaling and Mitogen Activated Protein Kinase (MAPK) signaling cascades. Many of the pathways identified as affected by shock waves in the hair follicles have been previously reported to be TBI responsive in other organs such as brain and blood. The results suggest that the hair follicle has some common TBI responsive molecular signatures to other tissues. Moreover, various TBI-associated diseases were identified as preferentially affected using a gene network approach, indicating that the hair follicle may be capable of reflecting comprehensive responses to TBI conditions. Accordingly, the present study demonstrates that the hair follicle is a potentially viable system for rapid and non-invasive TBI diagnosis.
C1 [Zhang, Jing; Carnduff, Lisa; Norman, Grant; Langlois, Valerie S.] Royal Mil Coll Canada, Dept Chem & Chem Engn, Kingston, ON, Canada.
   [Josey, Tyson; Wang, Yushan; Sawyer, Thomas W.] Def Res & Dev Canada Suffield, Medicine Hat, AB, Canada.
   [Martyniuk, Christopher J.] Univ New Brunswick, Fredericton, NB, Canada.
   [Martyniuk, Christopher J.] Canadian River Inst, Fredericton, NB, Canada.
RP Langlois, VS (reprint author), Royal Mil Coll Canada, Dept Chem & Chem Engn, Kingston, ON, Canada.
EM valerie.langlois@rmc.ca
RI Zhang, Jing/F-4468-2017
OI Zhang, Jing/0000-0002-6076-7321
FU Defence Research and Development Canada (DRDC) Technology Investment
   Fund (TIF)
FX This research was supported by the Defence Research and Development
   Canada (DRDC) Technology Investment Fund (TIF),
   http://www.drdc-rddc.gc.ca. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054657
   Akins PT, 1996, STROKE, V27, P1682, DOI 10.1161/01.STR.27.9.1682
   Arck PC, 2003, AM J PATHOL, V162, P803, DOI 10.1016/S0002-9440(10)63877-1
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Bergad PL, 2000, AM J PHYSIOL-CELL PH, V279, pC1906
   Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31
   Botchkarev VA, 2003, J EXP ZOOL PART B, V298B, P164, DOI 10.1002/jez.b.00033
   Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04
   Brea D, 2011, J CEREBR BLOOD F MET, V31, P1424, DOI 10.1038/jcbfm.2010.231
   Cao R, 2006, NEUROSCI LETT, V401, P136, DOI 10.1016/j.neulet.2006.03.005
   Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203
   Chen Y, 2013, J NEUROPSYCH CLIN N, V25, P103, DOI 10.1176/appi.neuropsych.12030058
   Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313
   Chishti YZ, 2013, GEN COMP ENDOCR, V192, P115, DOI 10.1016/j.ygcen.2013.04.033
   Choi HI, 2011, BRIT J DERMATOL, V165, P1183, DOI 10.1111/j.1365-2133.2011.10625.x
   Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1
   De Preter K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn114
   Defense and Veterans Brain Injury Center (DVBIC), 2013, DOD WORLDW NUMB TBI
   Defense Manpower Data Center (DMDC), 2008, GLOB WAR TERR CAUS R
   Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9
   DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6
   Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5
   DRAGUNOW M, 1995, BRAIN RES REV, V21, P1, DOI 10.1016/0165-0173(95)00003-L
   Elsayed NM, 1996, EXP LUNG RES, V22, P179, DOI 10.3109/01902149609050846
   Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0
   Foley LM, 2013, J CEREBR BLOOD F MET, V33, P129, DOI 10.1038/jcbfm.2012.145
   Garrett MR, 2003, MAMM GENOME, V14, P268, DOI 10.1007/s00335-002-2245-9
   Gilibert S, 2009, J HYPERTENS, V27, P1186, DOI 10.1097/HJH.0b013e328329e4c0
   Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407
   He M, 2013, CHIN J TRAUMATOL, V16, P136, DOI 10.3760/cma.j.issn.1008-1275.2013.03.002
   Heim MH, 1999, J RECEPT SIGNAL TR R, V19, P75, DOI 10.3109/10799899909036638
   Hnasko TS, 2012, ANNU REV PHYSIOL, V74, P225, DOI 10.1146/annurev-physiol-020911-153315
   Horvath C.M, 2004, SCI STKE, V2004, ptr8, DOI DOI 10.1126/STKE.2602004TR8
   Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42
   Kim SJ, 2006, ANN CLIN LAB SCI, V36, P115
   Langlois VS, 2013, MECH DEVELOP, V130, P304, DOI 10.1016/j.mod.2012.12.002
   Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010
   Leist M, 1998, EXP CELL RES, V239, P183, DOI 10.1006/excr.1997.4026
   Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169
   Lozada A, 2005, NEUROPATH APPL NEURO, V31, P150, DOI 10.1111/j.1365-2990.2004.00622.x
   Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489
   Maejima D, 2011, MICROCIRCULATION, V18, P474, DOI 10.1111/j.1549-8719.2011.00108.x
   Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6
   McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287
   McMahon CG, 2008, CRIT CARE MED, V36, P216, DOI 10.1097/01.CCM.0000295425.41831.85
   Mishra A, 2010, INT J CANCER, V126, P819, DOI 10.1002/ijc.24807
   Moreno C, 2011, AM J PHYSIOL-HEART C, V300, pH1530, DOI 10.1152/ajpheart.01026.2010
   Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008
   Mott FW, 1916, LANCET, V1, P331
   Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5
   Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x
   Olson N Eric, 2006, NeuroRx, V3, P373
   Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032
   Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706
   Pelletier S, 2003, MOL CELL BIOL, V23, P1316, DOI 10.1128/MCB.23.4.1316-1333.2003
   Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927
   Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963
   Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9
   Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800
   Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031
   Ritzel D, 2011, MIL VET HLTH RES FOR
   Sabroe I, 2008, J PATHOL, V214, P126, DOI 10.1002/path.2264
   SEGER R, 1995, FASEB J, V9, P726
   Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd
   Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052
   Sivachenko AY, 2007, J BIOINF COMPUT BIOL, V5, P429, DOI 10.1142/S0219720007002795
   STENN KS, 1994, J INVEST DERMATOL, V103, P107, DOI 10.1111/1523-1747.ep12391844
   Stenn KS, 2001, PHYSIOL REV, V81, P449
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789
   Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x
   Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609
   Truettner JS, 2007, J NEUROTRAUM, V24, P599, DOI 10.1089/neu.2006.0186
   Vassart G, 2011, NAT REV ENDOCRINOL, V7, P362, DOI 10.1038/nrendo.2011.20
   Wang SJ, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat046
   Wang YF, 2012, J NEUROSCI, V32, P713, DOI 10.1523/JNEUROSCI.3872-11.2012
   Weber JT, 2004, CURR NEUROVASC RES, V1, P151, DOI 10.2174/1567202043480134
   White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282
   Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/Neurocrit.Care2005;3:177-182
   Yamada T, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.03.029
   Yeh DD, 2012, WORLD J SURG, V36, P966, DOI 10.1007/s00268-012-1500-9
   Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7
   Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9
NR 83
TC 4
Z9 4
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 19
PY 2014
VL 9
IS 8
AR e104518
DI 10.1371/journal.pone.0104518
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AN6XM
UT WOS:000340742100039
PM 25136963
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Lamarca, A
   Gella, A
   Martianez, T
   Segura, M
   Figueiro-Silva, J
   Grijota-Martinez, C
   Trullas, R
   Casals, N
AF Lamarca, Aloa
   Gella, Alejandro
   Martianez, Tania
   Segura, Monica
   Figueiro-Silva, Joana
   Grijota-Martinez, Carmen
   Trullas, Ramon
   Casals, Nuria
TI Uridine 5 '-Triphosphate Promotes In Vitro Schwannoma Cell Migration
   through Matrix Metalloproteinase-2 Activation
SO PLOS ONE
LA English
DT Article
ID RAT SCIATIC-NERVE; PERIPHERAL-NERVE; P2Y RECEPTORS; PROTEIN-KINASES;
   GROWTH-FACTOR; UP-REGULATION; SIGNALING MOLECULE; BASEMENT-MEMBRANE; MAP
   KINASES; INJURY
AB In response to peripheral nerve injury, Schwann cells adopt a migratory phenotype and modify the extracellular matrix to make it permissive for cell migration and axonal re-growth. Uridine 5'-triphosphate (UTP) and other nucleotides are released during nerve injury and activate purinergic receptors expressed on the Schwann cell surface, but little is known about the involvement of purine signalling in wound healing. We studied the effect of UTP on Schwannoma cell migration and wound closure and the intracellular signaling pathways involved. We found that UTP treatment induced Schwannoma cell migration through activation of P2Y(2) receptors and through the increase of extracellular matrix metalloproteinase-2 (MMP-2) activation and expression. Knockdown P2Y(2) receptor or MMP-2 expression greatly reduced wound closure and MMP-2 activation induced by UTP. MMP-2 activation evoked by injury or UTP was also mediated by phosphorylation of all 3 major mitogen-activated protein kinases (MAPKs): JNK, ERK1/2, and p38. Inhibition of these MAPK pathways decreased both MMP-2 activation and cell migration. Interestingly, MAPK phosphorylation evoked by UTP exhibited a biphasic pattern, with an early transient phosphorylation 5 min after treatment, and a late and sustained phosphorylation that appeared at 6 h and lasted up to 24 h. Inhibition of MMP-2 activity selectively blocked the late, but not the transient, phase of MAPK activation. These results suggest that MMP-2 activation and late MAPK phosphorylation are part of a positive feedback mechanism to maintain the migratory phenotype for wound healing. In conclusion, our findings show that treatment with UTP stimulates in vitro Schwannoma cell migration and wound repair through a MMP-2-dependent mechanism via P2Y(2) receptors and MAPK pathway activation.
C1 [Lamarca, Aloa; Gella, Alejandro; Martianez, Tania; Segura, Monica; Grijota-Martinez, Carmen; Casals, Nuria] Univ Int Catalunya, Fac Med, Dept Basic Sci, Sant Cugat Del Valles, Spain.
   [Figueiro-Silva, Joana; Trullas, Ramon] CSIC, Inst Invest Biomed Pi & Sunyer, Neurobiol Unit, Inst Invest Biomed Barcelona, Barcelona, Spain.
   [Casals, Nuria] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain.
RP Gella, A (reprint author), Univ Int Catalunya, Fac Med, Dept Basic Sci, Sant Cugat Del Valles, Spain.
EM alexgella@gmail.com
RI LAMARCA DAMS, ALOA/Q-4765-2017; Gella, Alejandro/H-3845-2019; Casals,
   Nuria/L-3378-2014; Trullas, Ramon/D-2197-2016; Grijota-Martinez,
   Carmen/P-5093-2017
OI LAMARCA DAMS, ALOA/0000-0001-8324-3195; Gella,
   Alejandro/0000-0002-3983-1392; Casals, Nuria/0000-0002-6719-4300;
   Trullas, Ramon/0000-0001-7951-9881; Grijota-Martinez,
   Carmen/0000-0003-2656-9062
FU Ferrer S.A. (Barcelona, Spain); Ministerio de Economia y Competitividad
   of Spain [SAF2011-23550]
FX This research was supported by an unrestricted research grant from
   Ferrer S.A. (Barcelona, Spain) and by grant SAF2011-23550 from
   Ministerio de Economia y Competitividad of Spain. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001
   Ando K, 2010, J PHARMACOL EXP THER, V334, P809, DOI 10.1124/jpet.110.167528
   Arai K, 2003, GLIA, V43, P254, DOI 10.1002/glia.10255
   Ben Yebdri F, 2009, EUR J IMMUNOL, V39, P2885, DOI 10.1002/eji.200939347
   Birchmeier C, 2008, GLIA, V56, P1491, DOI 10.1002/glia.20753
   Boucher I, 2007, EXP EYE RES, V85, P130, DOI 10.1016/j.exer.2007.03.009
   Boucher I, 2010, AM J PHYSIOL-CELL PH, V299, pC411, DOI 10.1152/ajpcell.00100.2009
   Braun OO, 2010, J MOL CELL CARDIOL, V49, P362, DOI 10.1016/j.yjmcc.2010.05.001
   BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9
   Brunet A, 1996, SCIENCE, V272, P1652, DOI 10.1126/science.272.5268.1652
   Carroll SL, 1997, J NEUROSCI, V17, P1642
   Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4
   Chattopadhyay S, 2009, GLIA, V57, P1316, DOI 10.1002/glia.20851
   Cheng C, 2002, NEUROSCIENCE, V115, P321, DOI 10.1016/S0306-4522(02)00291-9
   DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414
   Demestre M, 2004, NEUROSCIENCE, V124, P767, DOI 10.1016/j.neuroscience.2003.12.037
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296
   Ferguson TA, 2000, MOL CELL NEUROSCI, V16, P157, DOI 10.1006/mcne.2000.0859
   Ferreira R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062345
   Fields RD, 2000, TRENDS NEUROSCI, V23, P625, DOI 10.1016/S0166-2236(00)01674-X
   Gerevich Zoltan, 2004, Purinergic Signal, V1, P3, DOI 10.1007/s11302-004-4740-9
   Griffin JW, 2010, EXP NEUROL, V223, P60, DOI 10.1016/j.expneurol.2009.12.033
   Gurjar MV, 2001, AM J PHYSIOL-HEART C, V281, pH2568
   He Y, 2010, NAT NEUROSCI, V13, P1472, DOI 10.1038/nn.2686
   HEUMANN R, 1987, P NATL ACAD SCI USA, V84, P8735, DOI 10.1073/pnas.84.23.8735
   Hossain S, 2012, GLIA, V60, P1130, DOI 10.1002/glia.22340
   Hsu JYC, 2006, J NEUROSCI, V26, P9841, DOI 10.1523/JNEUROSCI.1993-06.2006
   Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481
   Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761
   Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682
   Kaempchen K, 2003, HUM MOL GENET, V12, P1211, DOI 10.1093/hmg/ddg146
   KENNEDY C, 1985, BLOOD VESSELS, V22, P145
   Kherif S, 1998, NEUROPATH APPL NEURO, V24, P309
   Kim MS, 2003, CANCER RES, V63, P5454
   Klepeis VE, 2004, J CELL BIOCHEM, V93, P1115, DOI 10.1002/jcb.20258
   KREIDER BQ, 1981, BRAIN RES, V207, P433, DOI 10.1016/0006-8993(81)90375-9
   Krekoski CA, 2002, J NEUROSCI, V22, P10408
   LaFleur M, 1996, J EXP MED, V184, P2311
   Lakka SS, 2000, CLIN EXP METASTAS, V18, P245, DOI 10.1023/A:1006724826083
   Lazarowski ER, 1999, BRIT J PHARMACOL, V127, P1272, DOI 10.1038/sj.bjp.0702654
   Lehmann HC, 2009, GLIA, V57, P479, DOI 10.1002/glia.20774
   Leppert D, 1999, NEUROLOGY, V53, P62, DOI 10.1212/WNL.53.1.62
   Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098
   Li WH, 2013, BRIT J CANCER, V109, P1666, DOI 10.1038/bjc.2013.484
   Lien SC, 2006, CELL SIGNAL, V18, P1270, DOI 10.1016/j.cellsig.2005.10.013
   Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008
   Martianez T, 2013, PURINERG SIGNAL, V9, P259, DOI 10.1007/s11302-012-9348-x
   Martianez T, 2012, PROTEOMICS, V12, P145, DOI 10.1002/pmic.201100187
   Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822
   Newbern JM, 2011, NEURON, V69, P91, DOI 10.1016/j.neuron.2010.12.003
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   Pillois X, 2002, CIRC RES, V90, P678, DOI 10.1161/01.RES.0000013700.98464.8E
   Pintor J, 2004, OPHTHAL PHYSL OPT, V24, P186, DOI 10.1111/j.1475-1313.2004.00182.x
   Platt CI, 2003, J NEUROSCI RES, V74, P417, DOI 10.1002/jnr.10783
   Ralevic V, 1998, PHARMACOL REV, V50, P413
   Rodriguez-Zayas AE, 2010, INT J DEV NEUROSCI, V28, P413, DOI 10.1016/j.ijdevneu.2010.07.001
   Santiago-Perez LI, 2001, J CELL PHYSIOL, V187, P196, DOI 10.1002/jcp.1063
   SEGER R, 1995, FASEB J, V9, P726
   Sheu JY, 2000, EXP NEUROL, V166, P392, DOI 10.1006/exnr.2000.7508
   Shubayev VI, 2000, BRAIN RES, V855, P83, DOI 10.1016/S0006-8993(99)02321-5
   Van Kolen Kristof, 2006, Purinergic Signal, V2, P451, DOI 10.1007/s11302-006-9008-0
   Vazquez-Cuevas FG, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-88
   von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014
   von Kugelgen I, 2000, N-S ARCH PHARMACOL, V362, P310, DOI 10.1007/s002100000310
   Wanner IB, 2002, J NEUROSCI, V22, P4066, DOI 10.1523/JNEUROSCI.22-10-04066.2002
   Weinger Ilene, 2005, Purinergic Signal, V1, P281, DOI 10.1007/s11302-005-8132-6
   Weisman GA, 2012, PURINERG SIGNAL, V8, P559, DOI 10.1007/s11302-012-9307-6
   Wildman SS, 2003, BRIT J PHARMACOL, V140, P1177, DOI 10.1038/sj.bjp.0705544
   Woodhoo A, 2009, NAT NEUROSCI, V12, P839, DOI 10.1038/nn.2323
   Yamauchi J, 2003, P NATL ACAD SCI USA, V100, P14421, DOI 10.1073/pnas.2336152100
   Yang DP, 2012, J NEUROSCI, V32, P7158, DOI 10.1523/JNEUROSCI.5812-11.2012
   Yang LL, 2004, J CELL BIOCHEM, V91, P938, DOI 10.1002/jcb.10774
   Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366
   Zhang HQ, 2011, NEUROTHERAPEUTICS, V8, P206, DOI 10.1007/s13311-011-0038-0
   Zine A., 2004, Current Drug Targets - CNS and Neurological Disorders, V3, P325, DOI 10.2174/1568007043337166
NR 76
TC 13
Z9 14
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 6
PY 2014
VL 9
IS 6
AR e98998
DI 10.1371/journal.pone.0098998
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AP1YS
UT WOS:000341869000086
PM 24905332
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Yang, F
   Nam, S
   Brown, CE
   Zhao, R
   Starr, R
   Horne, DA
   Malkas, LH
   Jove, R
   Hickey, RJ
AF Yang, Fan
   Nam, Sangkil
   Brown, Christine E.
   Zhao, Robin
   Starr, Renate
   Horne, David A.
   Malkas, Linda H.
   Jove, Richard
   Hickey, Robert J.
TI A Novel Berbamine Derivative Inhibits Cell Viability and Induces
   Apoptosis in Cancer Stem-Like Cells of Human Glioblastoma, via
   Up-Regulation of miRNA-4284 and JNK/AP-1 Signaling
SO PLOS ONE
LA English
DT Article
ID ACTIVATED PROTEIN-KINASES; MELANOMA-CELLS; GROWTH; GLIOMA; JNK;
   MICRORNAS; INVASION
AB Glioblastoma (GBM) is the most common primary brain tumor, accounting for approximately 40% of all central nervous system malignancies. Despite standard treatment consisting of surgical resection, radiotherapy and/or chemotherapy, the prognosis for GBM is poor; with a median survival of 14.6 months. The cancer stem cell or cancer-initiating cell model has provided a new paradigm for understanding development and recurrence of GBM following treatment. Berbamine (BBM) is a natural compound derived from the Berberis amurensis plant, and along with its derivatives, has been shown to exhibit antitumor activity in several cancers. Here, we reported that a novel synthetic Berbamine derivative, BBMD3, inhibits cell viability and induces apoptosis of cancer stem-like cells (CSCs) in a time-and dose-dependent manner when the CSCs from four GBM patients (PBT003, PBT008, PBT022, and PBT030) were cultured. These CSCs grew in neurospheres and expressed CD133 and nestin as markers. Treatment with BBMD3 destroyed the neurosphere morphology, and led to the induction of apoptosis in the CSCs. Induction of apoptosis in these CSCs is dependent upon activation of caspase-3 and cleavage of poly (ADP-ribose) polymerase (PARP). MicroRNA-4284 (miR-4284) was shown to be over-expressed about 4-fold in the CSCs following BBMD3 treatment. Furthermore, transfection of synthetic anti-sense oligonucleotide against human miR-4284 partially blocked the anticancer effects of BBMD3 on the GBM derived CSCs. BBMD3 also increased phosphorylation of the c-Jun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK), resulting in an increase expression of phosphorylated c-Jun and total c-Fos; the major components of transcriptional factor AP-1. The JNK-c-Jun/AP-1 signaling pathway plays an important role in the induction of apoptosis in response to UV irradiation and some drug treatments. Targeting glioblastoma stem-like cells with BBMD3 is therefore novel, and may have promise as an effective therapeutic strategy for treating GBM patients.
C1 [Yang, Fan; Hickey, Robert J.] City Hope Natl Med Ctr, Ctr Comprehens Canc, Beckman Res Inst, Translat Biomarker Discovery Core, Duarte, CA 91010 USA.
   [Nam, Sangkil; Brown, Christine E.; Zhao, Robin; Starr, Renate; Horne, David A.; Malkas, Linda H.; Hickey, Robert J.] City Hope Natl Med Ctr, Ctr Comprehens Canc, Beckman Res Inst, Duarte, CA USA.
   [Jove, Richard] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA.
RP Hickey, RJ (reprint author), City Hope Natl Med Ctr, Ctr Comprehens Canc, Beckman Res Inst, Translat Biomarker Discovery Core, Duarte, CA 91010 USA.
EM rohickey@coh.org
OI Brown, Christine/0000-0003-4915-8207
FU National Institutes of Health/National Cancer Institute [CA-1155674];
   Beckman Research Institute; National Cancer Institute of the National
   Institutes of Health [P30CA33572]
FX Funding for the study was provided by a grant from the National
   Institutes of Health/National Cancer Institute #CA-1155674 to RJ and
   start-up funding to RH from the Beckman Research Institute. Research
   reported in this publication included work performed in the
   Translational Biomarker Discovery Core, which is supported in part by
   the National Cancer Institute of the National Institutes of Health under
   award number P30CA33572. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079
   Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236
   Brown CE, 2009, CANCER RES, V69, P8886, DOI 10.1158/0008-5472.CAN-09-2687
   Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848
   Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1
   Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301
   Dimov I, 2011, THESCIENTIFICWORLDJO, V11, P930, DOI 10.1100/tsw.2011.42
   Du HP, ONCOL REP, V23, P709
   Duan HY, 2010, CYTOTECHNOLOGY, V62, P341, DOI 10.1007/s10616-009-9240-x
   Fatoo A, 2011, J NEURO-ONCOL, V103, P397, DOI 10.1007/s11060-010-0406-3
   FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761
   Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364
   Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629
   HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135
   Huang Z, 2010, PROTEIN CELL, V1, P638, DOI 10.1007/s13238-010-0078-y
   Liang Y, 2009, ACTA PHARMACOL SIN, V30, P1659, DOI 10.1038/aps.2009.167
   Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262
   Mizoguchi M., 2012, J ONCOL, V2012, DOI DOI 10.1155/2012/732874.EPUB
   Mizoguchi M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00019
   Nakada M, 2007, CELL MOL LIFE SCI, V64, P458, DOI 10.1007/s00018-007-6342-5
   Nam S, 2012, MOL ONCOL, V6, P484, DOI 10.1016/j.molonc.2012.05.002
   Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533
   Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004
   Sathornsumetee S, 2007, CANCER-AM CANCER SOC, V110, P13, DOI 10.1002/cncr.22741
   SEGER R, 1995, FASEB J, V9, P726
   Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008
   Shieh JM, 2010, BRIT J PHARMACOL, V160, P1171, DOI 10.1111/j.1476-5381.2010.00746.x
   Thorsen SB, 2012, CANCER J, V18, P275, DOI 10.1097/PPO.0b013e318258b5d6
   Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870
   Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556
   Wang GY, 2009, J ASIAN NAT PROD RES, V11, P219, DOI 10.1080/10286020802675076
   Wang S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-81
   Wei G, 2010, J CELL PHYSIOL, V224, P112, DOI 10.1002/jcp.22099
   Yang F, 2013, CANC BIOL THER, V14
NR 35
TC 8
Z9 10
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 14
PY 2014
VL 9
IS 4
AR e94443
DI 10.1371/journal.pone.0094443
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI6GP
UT WOS:000336970400037
PM 24732116
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Huo, XL
   Min, JJ
   Pan, CY
   Zhao, CC
   Pan, LL
   Gui, FF
   Jin, L
   Wang, XT
AF Huo, Xin-long
   Min, Jing-jing
   Pan, Cai-yu
   Zhao, Cui-cui
   Pan, Lu-lu
   Gui, Fei-fei
   Jin, Lu
   Wang, Xiao-tong
TI Efficacy of Lovastatin on Learning and Memory Deficits Caused by Chronic
   Intermittent Hypoxia-Hypercapnia: Through Regulation of NR2B-Containing
   NMDA Receptor-ERK Pathway
SO PLOS ONE
LA English
DT Article
ID SYNAPTIC PLASTICITY; GLUTAMATE NEUROTOXICITY; COGNITIVE FUNCTION;
   CORTICAL-NEURONS; PROTEIN-KINASES; LIPID RAFTS; CELL-DEATH; CHOLESTEROL;
   TRAFFICKING; RAS
AB Background: Chronic intermittent hypoxia- hypercapnia (CIHH) exposure leads to learnning and memory deficits in rats. Overactivation of N-methyl-D-aspartate receptors(NMDARs) can lead to the death of neurons through a process termed excitotoxicity, which is involved in CIHH-induced cognitive deficits. Excessively activated NR2B (GluN2B)-containing NMDARs was reported as the main cause of excitotoxicity. The ERK1/2 (extracellular signal-regulated kinase 1/2) signaling cascade acts as a key component in NMDARs-dependent neuronal plasticity and survival. Ca2+/calmodulin-dependent protein kinase II (CaMKII), synapse-associated protein 102 ( SAP102) and Ras GTPase-activating protein (SynGAP) have been shown to be involved in the regulation of NMDAR-ERK signalling cascade. Recent studies revealed statins (the HMG-CoA reductase inhibitor) have effect on the expression of NMDARs. The present study intends to explore the potential effect of lovastatin on CIHH-induced cognitive deficits and the NR2B-ERK signaling pathway. Methods and Findings: Eighty male Sprague Dawley rats were randomly divided into five groups. Except for those in the control group, the rats were exposed to chronic intermittent hypoxia-hypercapnia (CIHH) ( 9,11% O-2, 5.5,6.5% CO2) for 4 weeks. After lovastatin administration, the rats performed better in the Morris water maze test. Electron microscopy showed alleviated hippocampal neuronal synaptic damage. Further observation suggested that either lovastatin or ifenprodil (a selective NR2B antagonist) administration similarly downregulated NR2B subunit expression leading to a suppression of CaMKII/SAP102/SynGAP signaling cascade, which in turn enhanced the phosphorylation of ERK1/2. The phosphorylated ERK1/2 induced signaling cascade involving cAMP-response element-binding protein (CREB) phosphorylation and brainderived neurotrophic factor (BDNF) activation, which is responsible for neuroprotection. Conclusions: These findings suggest that the ameliorative cognitive deficits caused by lovastatin are due to the downregulation of excessive NR2B expression accompanied by increased expression of ERK signaling cascade. The effect of NR2B in upregulating pERK1/2 maybe due, at least in part, to inactivation of CaMKII/SAP102/SynGAP signaling cascade.
C1 [Huo, Xin-long; Min, Jing-jing; Pan, Cai-yu; Zhao, Cui-cui; Pan, Lu-lu; Gui, Fei-fei; Jin, Lu; Wang, Xiao-tong] Wenzhou Med Univ, Affiliated Hosp 2, Ctr Neurol & Rehabil, Wenzhou, Peoples R China.
RP Wang, XT (reprint author), Wenzhou Med Univ, Affiliated Hosp 2, Ctr Neurol & Rehabil, Wenzhou, Peoples R China.
EM doctorhxl@163.com
FU Medical Science Research Foundation of Zhejiang Province [Y205233];
   Wenzhou City Science and Technology Bureau [Y2005A001]
FX This research was supported by the Medical Science Research Foundation
   of Zhejiang Province grant (NO: Y205233) and by Wenzhou City Science and
   Technology Bureau grant (NO: Y2005A001). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aamodt S M, 1999, Adv Neurol, V79, P133
   BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0
   Chalovich EM, 2006, J BIOL CHEM, V281, P17870, DOI 10.1074/jbc.M602632200
   Chen BS, 2011, J NEUROSCI, V31, P89, DOI 10.1523/JNEUROSCI.1034-10.2011
   CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6
   CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131
   Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003
   Eisner MD, 2008, AM J MED, V121, P789, DOI 10.1016/j.amjmed.2008.04.030
   Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005
   Etnier J, 1999, CHEST, V116, P953, DOI 10.1378/chest.116.4.953
   Follesa P, 1996, J NEUROSCI, V16, P2172
   Frank C, 2008, EXP NEUROL, V212, P407, DOI 10.1016/j.expneurol.2008.04.019
   Gambrill AC, 2011, J NEUROPHYSIOLX, V14, P2425
   Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835
   Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380
   Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911
   Harvey BH, 2012, PHARMACOL BIOCHEM BE, V100, P775, DOI 10.1016/j.pbb.2011.06.014
   He X, 2006, J NEUROPATH EXP NEUR, V65, P652, DOI 10.1097/01.jnen.0000225906.82428.69
   Hering H, 2003, J NEUROSCI, V23, P3262
   Hetman M, 2006, CURR TOP MED CHEMX, V40, P775
   Himi T, 2003, J NEUROSCI RES, V71, P679, DOI 10.1002/jnr.10510
   Hindley A, 2002, J CELL SCI, V115, P1575
   Hota SK, 2007, NEUROCHEM INT, V51, P384, DOI 10.1016/j.neuint.2007.04.003
   Incalzi RA, 2003, J NEUROL, V250, P325, DOI 10.1007/s00415-003-1005-4
   Jin KL, 2002, J NEUROCHEM, V80, P119, DOI 10.1046/j.0022-3042.2001.00678.x
   Jonsson N, 2001, STROKE, V32, P1112, DOI 10.1161/01.STR.32.5.1112
   Kannan M, 2010, NEUROBIOL AGING, V31, P1543, DOI 10.1016/j.neurobiolaging.2008.09.004
   Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9
   Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031
   Kocsis B, 2012, BIOL PSYCHIAT, V71, P987, DOI 10.1016/j.biopsych.2011.10.002
   Koudinov AR, 2001, FASEB J, V15, P1858, DOI 10.1096/fj.00-0815fje
   Kozora E, 2000, CHEST, V117, p249S, DOI 10.1378/chest.117.5_suppl_1.249S
   Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7
   Krysiak R, 2003, DRUGS, V63, P1821, DOI 10.2165/00003495-200363170-00005
   Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027
   Liesker JJW, 2004, RESP MED, V98, P351, DOI 10.1016/j.rmed.2003.11.004
   Maiti P, 2008, J CHEM NEUROANAT, V36, P227, DOI 10.1016/j.jchemneu.2008.07.003
   Makino K, 1997, ONCOGENE, V14, P2425, DOI 10.1038/sj.onc.1201087
   Marti-Fabregas J, 2004, STROKE, V35, P1117, DOI 10.1161/01.STR.0000125863.93921.3f
   MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4
   MORRISETT RA, 1990, EUR J PHARMACOL, V176, P103, DOI 10.1016/0014-2999(90)90138-V
   Nakazawa T, 2007, J NEUROCHEM, V100, P1018, DOI 10.1111/j.1471-4159.2006.04274.x
   Oh JS, 2004, J BIOL CHEM, V279, P17980, DOI 10.1074/jbc.M314109200
   OLNEY JW, 1971, EXP BRAIN RES, V14, P61
   Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200
   Ponce J, 2008, STROKE, V39, P1269, DOI 10.1161/STROKEAHA.107.498923
   Gonzalez-Moro JMR, 2009, INT J CLIN PRACT, V63, P742, DOI 10.1111/j.1742-1241.2009.02040.x
   Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011
   SEGER R, 1995, FASEB J, V9, P726
   Stanika RI, 2009, P NATL ACAD SCI USA, V106, P9854, DOI 10.1073/pnas.0903546106
   Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001
   Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346
   Vizi ES, 2013, BRAIN RES BULL, V93, P32, DOI 10.1016/j.brainresbull.2012.10.005
   Wang Chen Xu, 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P143, DOI 10.2174/1568007053544183
   Wang XT, 2007, J WENZHOU MED COLL, V5, P003
   Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803
   Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067
   Wroge CM, 2012, J NEUROSCI, V32, P6732, DOI 10.1523/JNEUROSCI.6371-11.2012
   Yang Q, 2010, NEUROCHEM RES, V35, P1353, DOI 10.1007/s11064-010-0191-6
   Yang XY, 2011, CHINESE PHYS B, V20, DOI 10.1088/1674-1056/20/3/034208
   YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9
   Zheng GQ, 2008, MED HYPOTHESES, V71, P111, DOI 10.1016/j.mehy.2008.01.025
   Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8
NR 63
TC 15
Z9 18
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 9
PY 2014
VL 9
IS 4
AR e94278
DI 10.1371/journal.pone.0094278
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AE9PC
UT WOS:000334339000101
PM 24718106
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Jeong, W
   Kim, J
   Bazer, FW
   Song, G
AF Jeong, Wooyoung
   Kim, Jinyoung
   Bazer, Fuller W.
   Song, Gwonhwa
TI Proliferation-Stimulating Effect of Colony Stimulating Factor 2 on
   Porcine Trophectoderm Cells Is Mediated by Activation of
   Phosphatidylinositol 3-Kinase and Extracellular Signal-Regulated Kinase
   1/2 Mitogen-Activated Protein Kinase
SO PLOS ONE
LA English
DT Article
ID FACTOR GM-CSF; UTERINE EPITHELIAL-CELLS; FACTOR GENE-EXPRESSION;
   INTERFERON-TAU; GROWTH-FACTOR; EMBRYO DEVELOPMENT; IN-VITRO; BOVINE
   LYMPHOCYTES; ENDOMETRIAL GLANDS; EARLY-PREGNANCY
AB Colony-stimulating factor 2 (CSF2), also known as granulocyte macrophage colony-stimulating factor, facilitates mammalian embryonic development and implantation. However, biological functions and regulatory mechanisms of action of porcine endometrial CSF2 in peri-implantation events have not been elucidated. The aim of present study was to determine changes in cellular activities induced by CSFs and to access CSF2-induced intracellular signaling in porcine primary trophectoderm (pTr) cells. Differences in expression of CSF2 mRNA in endometrium from cyclic and pregnant gilts were evaluated. Endometrial CSF2 mRNA expression increases during the peri-implantation period, Days 10 to 14 of pregnancy, as compared to the estrous cycle. pTr cells obtained in Day 12 of pregnancy were cultured in the presence or absence of CSF2 (20 ng/ml) and LY294002 (20 mu M), U0126 (20 mu M), rapamycin (20 nM), and SB203580 (20 mu M). CSF2 in pTr cell culture medium at 20 ng/ml significantly induced phosphorylation of AKT1, ERK1/2, MTOR, p70RSK and RPS6 protein, but not STAT3 protein. Also, the PI3K specific inhibitor (LY294002) abolished CSF2-induced increases in p-ERK1/2 and p-MTOR proteins, as well as CSF2-induced phosphorylation of AKT1. Changes in proliferation and migration of pTr cells in response to CSF2 were examined in dose- and time-response experiments. CSF2 significantly stimulated pTr cell proliferation and, U0126, rapamycin and LY294002 blocked this CSF2-induced proliferation of pTr cells. Collectively, during the peri-implantation phase of pregnancy in pigs, endometrial CSF2 stimulates proliferation of trophectoderm cells by activation of the PI3K-and ERK1/2 MAPK-dependent MTOR signal transduction cascades.
C1 [Jeong, Wooyoung; Song, Gwonhwa] Korea Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul, South Korea.
   [Kim, Jinyoung] Dankook Univ, Dept Anim Resources Sci, Cheonan, South Korea.
   [Bazer, Fuller W.] Texas A&M Univ, Ctr Anim Biotechnol & Genom, College Stn, TX USA.
   [Bazer, Fuller W.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA.
RP Song, G (reprint author), Korea Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul, South Korea.
EM ghsong@korea.ac.kr
RI gwonhwa, song/H-3208-2015; Song, Gwonhwa/H-3647-2015
FU Next-Generation BioGreen 21 Program [PJ008142]; Rural Development
   Administration; Basic Science Research Program through National Research
   Foundation of Korea, Republic of Korea [NRF-26 2013R1A1A3012164];
   National Research Initiative Competitive Grant from United States
   Department of Agriculture National Institute of Food and Agriculture,
   United States of America [2006-35203-17283]
FX This research was funded by the grant from the Next-Generation BioGreen
   21 Program (No. PJ008142), Rural Development Administration and by the
   Basic Science Research Program (No. NRF-26 2013R1A1A3012164) through the
   National Research Foundation of Korea, Republic of Korea, and also by
   the National Research Initiative Competitive Grant No. 2006-35203-17283
   from the United States Department of Agriculture National Institute of
   Food and Agriculture, United States of America. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR BALDWIN GC, 1992, DEV BIOL, V151, P352, DOI 10.1016/0012-1606(92)90175-G
   BALDWIN GC, 1991, BLOOD, V78, P609
   Bazer FW, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-23
   Bazer Fuller W, 2011, Front Biosci (Schol Ed), V3, P745, DOI 10.2741/s184
   BAZER FW, 1975, J ANIM SCI, V41, P1376
   Behr B, 2005, J ASSIST REPROD GEN, V22, P25, DOI 10.1007/s10815-005-0817-9
   Burghardt RC, 1997, J REPROD FERTIL, P151
   Burton GJ, 2007, PLACENTA, V28, pS64, DOI 10.1016/j.placenta.2007.01.007
   Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767
   CLARK DA, 1994, CELL IMMUNOL, V154, P143, DOI 10.1006/cimm.1994.1064
   CRAINIE M, 1990, BIOL REPROD, V43, P999, DOI 10.1095/biolreprod43.6.999
   DANTZER V, 1985, ANAT EMBRYOL, V172, P281, DOI 10.1007/BF00318976
   de Moraes AAS, 1999, J REPROD IMMUNOL, V42, P135, DOI 10.1016/S0165-0378(98)00075-8
   deMoraes AAS, 1997, BIOL REPROD, V57, P1060, DOI 10.1095/biolreprod57.5.1060
   Diaz-Cueto L, 2001, ARCH MED RES, V32, P619, DOI 10.1016/S0188-4409(01)00326-5
   Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683
   Emond V, 2000, BIOL REPROD, V62, P1728, DOI 10.1095/biolreprod62.6.1728
   Emond V, 2004, BIOL REPROD, V70, P54, DOI 10.1095/biolreprod.103.018689
   Emond V, 1998, BIOL REPROD, V58, P143, DOI 10.1095/biolreprod58.1.143
   Fernandez-Serra M, 2004, DEV BIOL, V268, P384, DOI 10.1016/j.ydbio.2003.12.029
   Fitzgerald JS, 2005, INT J BIOCHEM CELL B, V37, P2284, DOI 10.1016/j.biocel.2005.02.025
   Fitzgerald JS, 2005, CHEM IMMUNOL ALLERGY, V88, P181
   Fortin M, 1997, AM J REPROD IMMUNOL, V38, P129
   GASSON JC, 1991, BLOOD, V77, P1131
   GEISERT RD, 1982, BIOL REPROD, V27, P925, DOI 10.1095/biolreprod27.4.925
   GEISERT RD, 1982, BIOL REPROD, V27, P941, DOI 10.1095/biolreprod27.4.941
   Geisert RD, 1997, J REPROD FERTIL, P133
   Giacomini G, 1995, HUM REPROD, V10, P3259, DOI 10.1093/oxfordjournals.humrep.a135899
   Gingras A C, 2004, Curr Top Microbiol Immunol, V279, P169
   Gray CA, 2001, BIOL REPROD, V64, P1608, DOI 10.1095/biolreprod64.6.1608
   Gray CA, 2001, BIOL REPROD, V65, P1311, DOI 10.1095/biolreprod65.5.1311
   GUILLOMOT M, 1995, J REPROD FERTIL, P39
   Hardy K, 2002, J ENDOCRINOL, V172, P221, DOI 10.1677/joe.0.1720221
   HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655
   IMAKAWA K, 1993, ENDOCRINOLOGY, V132, P1869, DOI 10.1210/en.132.4.1869
   Jaeger LA, 2005, ENDOCRINOLOGY, V146, P3933, DOI 10.1210/en.2005-0090
   Ka H, 2001, ENDOCRINOLOGY, V142, P2303, DOI 10.1210/en.142.6.2303
   Kanzaki H, 1991, Growth Factors, V5, P69, DOI 10.3109/08977199109000272
   Karagenc L, 2005, REPROD BIOMED ONLINE, V10, P511, DOI 10.1016/S1472-6483(10)60829-2
   KEYS JL, 1990, AM J ANAT, V188, P221, DOI 10.1002/aja.1001880302
   Kim J, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105080
   Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481
   LEISER R, 1994, EXP CLIN ENDOCRINOL, V102, P122, DOI 10.1055/s-0029-1211275
   Lim HJ, 2002, VITAM HORM, V64, P43, DOI 10.1016/S0083-6729(02)64002-6
   Martinez-Moczygemba M, 2003, J ALLERGY CLIN IMMUN, V112, P653, DOI 10.1067/mai.2003.1796
   Michael DD, 2006, AM J REPROD IMMUNOL, V56, P63, DOI 10.1111/j.1600-0897.2006.00390.x
   MIYAJIMA A, 1993, BLOOD, V82, P1960
   O'Leary S, 2004, REPRODUCTION, V128, P237, DOI 10.1530/rep.1.00160
   PERRY JS, 1981, J REPROD FERTIL, V62, P321
   Peterson RT, 1998, CURR BIOL, V8, pR248, DOI 10.1016/S0960-9822(98)70152-6
   Pollard JW, 1997, MOL REPROD DEV, V46, P54
   RAPOPORT AP, 1992, BLOOD REV, V6, P43, DOI 10.1016/0268-960X(92)90007-D
   ROBERTSON SA, 1994, CRIT REV IMMUNOL, V14, P239, DOI 10.1615/CritRevImmunol.v14.i3-4.30
   Robertson SA, 1996, BIOL REPROD, V54, P183, DOI 10.1095/biolreprod54.1.183
   Robertson SA, 1999, BIOL REPROD, V60, P251, DOI 10.1095/biolreprod60.2.251
   ROBERTSON SA, 1992, BIOL REPROD, V46, P1069, DOI 10.1095/biolreprod46.6.1069
   Robertson SA, 2001, BIOL REPROD, V64, P1206, DOI 10.1095/biolreprod64.4.1206
   Robertson SA, 2007, CYTOKINE GROWTH F R, V18, P287, DOI 10.1016/j.cytogfr.2007.04.008
   Schafer-Somi S, 2003, ANIM REPROD SCI, V75, P73, DOI 10.1016/S0378-4320(02)00222-1
   SEGER R, 1995, FASEB J, V9, P726
   Sjoblom C, 2005, ENDOCRINOLOGY, V146, P2142, DOI 10.1210/en.2004-1260
   Sjoblom C, 2002, BIOL REPROD, V67, P1817, DOI 10.1095/biolreprod.101.001503
   Sjoblom C, 1999, HUM REPROD, V14, P3069, DOI 10.1093/humrep/14.12.3069
   Song G, 2011, REPRODUCTION, V141, P127, DOI 10.1530/REP-10-0348
   Spandorfer SD, 1998, AM J REPROD IMMUNOL, V40, P377
   Spencer T E, 2004, J Anim Sci, V82 E-Suppl, pE4
   Spencer TE, 2007, REPROD FERT DEVELOP, V19, P65, DOI 10.1071/RD06102
   Stroband H W, 1990, J Reprod Fertil Suppl, V40, P261
   Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801
   Tortorella C, 2006, J GERONTOL A-BIOL, V61, P1111, DOI 10.1093/gerona/61.11.1111
   Tremellen KP, 1998, BIOL REPROD, V58, P1217, DOI 10.1095/biolreprod58.5.1217
   Wang YC, 2004, DEV DYNAM, V231, P72, DOI 10.1002/dvdy.20144
   Zhao Y, 1999, AM J REPROD IMMUNOL, V42, P303
   ZHAO Y, 1994, J CLIN ENDOCR METAB, V79, P662, DOI 10.1210/jc.79.2.662
NR 74
TC 12
Z9 13
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 10
PY 2014
VL 9
IS 2
AR e88731
DI 10.1371/journal.pone.0088731
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AA7CL
UT WOS:000331254600109
PM 24520418
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Zhang, YP
   Zheng, Y
   Li, DS
   Fan, YL
AF Zhang, Yuping
   Zheng, Yuan
   Li, Dunsong
   Fan, Yilin
TI Transcriptomics and Identification of the Chemoreceptor Superfamily of
   the Pupal Parasitoid of the Oriental Fruit Fly, Spalangia endius Walker
   (Hymenoptera: Pteromalidae)
SO PLOS ONE
LA English
DT Article
ID BACTROCERA-DORSALIS; RNA-SEQ; DROSOPHILA-MELANOGASTER; STABLE FLY;
   WD-REPEAT; GENE; PROTEIN; RESISTANCE; EXPRESSION; DIPTERA
AB Background: The oriental fruit fly, Bactrocera dorsalis Hendel, causes serious losses to fruit production and is one of the most economically important pests in many countries, including China, Spalangia endius Walker is a pupal parasitoid of various dipteran hosts, and may be considered a potentially important ectoparasitic pupal parasitoid of B. dorsalis. However, lack of genetic information on this organism is an obstacle to understanding the mechanisms behind its interaction with this host. Analysis of the S. endius transcriptome is essential to extend the resources of genetic information on this species and, to support studies on S. endius on the host B. dorsalis.
   Methodology/Principal Findings: We performed de novo assembly RNA-seq of S. endius. We obtained nearly 10 Gbp of data using a HiSeq platform, and 36319 high-quality transcripts using Trinity software. A total of 22443 (61.79%) unigenes were aligned to homologous sequences in the jewel wasp and honeybee (Apis florae) protein set from public databases. A total of 10037 protein domains were identified in 7892 S. endius transcripts using HMMER3 software. We identified expression of six gustatory receptor and 21 odorant receptor genes in the sample, with only one gene having a high expression level in each family. The other genes had a low expression level, including two genes regulated by splicing. This result may be due to the wasps being kept under laboratory conditions. Additionally, a total of 3727 SSR markers were predicted, which could facilitate the identification of polymorphisms and functional genes within wasp populations.
   Conclusion/Significance: This transcriptome greatly improves our genetic understanding of S. endius and provides a large number of gene sequences for further study.
C1 [Zhang, Yuping; Zheng, Yuan; Li, Dunsong; Fan, Yilin] Guangdong Acad Agr Sci, Inst Plant Protect, Guangzhou, Guangdong, Peoples R China.
   [Zhang, Yuping; Zheng, Yuan; Li, Dunsong; Fan, Yilin] Guangdong Prov Key Lab High Technol Plant Protect, Guangzhou, Guangdong, Peoples R China.
   [Zhang, Yuping; Zheng, Yuan; Li, Dunsong; Fan, Yilin] Guangdong Acad Agr Sci, Guangzhou, Guangdong, Peoples R China.
RP Li, DS (reprint author), Guangdong Acad Agr Sci, Inst Plant Protect, Guangzhou, Guangdong, Peoples R China.
EM dsli@gdppri.cn
FU National natural science foundation of China [31101492]
FX This study was funded by the National natural science foundation of
   China (31101492). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ahier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005651
   Bai XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016336
   Blow NS, 2005, PLOS PATHOG, V1, P92, DOI 10.1371/journal.ppat.0010008
   Chen B, 2005, GENE, V347, P115, DOI 10.1016/j.gene.2004.12.026
   Chiu TL, 2008, P NATL ACAD SCI USA, V105, P8855, DOI 10.1073/pnas.0709249105
   Clancy DW, 1950, P HAWAII ENTOMOL SOC, V14, P25
   Clausen CP, 1965, USDA TECH B, V1322, P102
   Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4
   Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830
   Consoli FL, 2004, COMP BIOCHEM PHYS A, V138, P229, DOI 10.1016/j.cbpb.2004.04.002
   Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311
   Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252
   Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028
   Glass Roger I., 1992, P129
   Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   GUT LJ, 1994, ENTOMOPHAGA, V39, P41, DOI 10.1007/BF02373493
   HOGSETTE JA, 1994, ENVIRON ENTOMOL, V23, P778, DOI 10.1093/ee/23.3.778
   Hsu J. C, 2002, Plant Protection Bulletin (Taichung), V44, P303
   Hsu JC, 2004, J ECON ENTOMOL, V97, P1682, DOI 10.1603/0022-0493-97.5.1682
   Hsu JC, 2006, INSECT BIOCHEM MOLEC, V36, P396, DOI 10.1016/j.ibmb.2006.02.002
   Hsu JuChun, 2000, Chinese Journal of Entomology, V20, P109
   Jin T, 2010, PESTIC BIOCHEM PHYS, V96, P1, DOI 10.1016/j.pestbp.2009.07.013
   Kitthawee S., 2004, SCIASIA, V30, P391
   Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056
   Ladbury JE, 2007, ACTA CRYSTALLOGR D, V63, P26, DOI 10.1107/S09074449060
   Lao C, 2009, MOD AGR SCI TECH, V16, P118
   Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838
   Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118
   Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104
   Liang HY, 2008, TREE GENET GENOMES, V4, P419, DOI 10.1007/s11295-007-0120-2
   Liu SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048156
   Maier D, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-74
   Mayer BJ, 2001, J CELL SCI, V114, P1253
   McCart C, 2008, PEST MANAG SCI, V64, P639, DOI 10.1002/ps.1567
   McNeil GP, 2001, GENETICS, V159, P229
   MEYER JA, 1991, ENVIRON ENTOMOL, V20, P915, DOI 10.1093/ee/20.3.915
   Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708
   Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226
   Noguchi H, 2003, INSECT BIOCHEM MOLEC, V33, P209, DOI 10.1016/S0965-1748(02)00192-3
   Ogura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008030
   Pannebakker BA, 2008, ENTOMOL EXP APPL, V127, P48, DOI 10.1111/j.1570-7458.2008.00666.x
   Perez-Maluf R, 2008, PHYSIOL ENTOMOL, V33, P226, DOI 10.1111/j.1365-3032.2008.00636.x
   Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034
   Punta M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI 10.1093/nar/gkr1065
   Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x
   Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100
   SCHMIDT C D, 1978, Southwestern Entomologist, V3, P69
   Schurmann D, 2009, NATURWISSENSCHAFTEN, V96, P383, DOI 10.1007/s00114-008-0490-9
   SEGER R, 1995, FASEB J, V9, P726
   Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5
   Stanewsky R, 1996, GENETICS, V143, P259
   Sutherland LC, 2005, J CELL BIOCHEM, V94, P5, DOI 10.1002/jcb.20204
   Tang KS, 2003, STRUCTURE, V11, P67, DOI 10.1016/S0969-2126(02)00929-2
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596
   Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0
   Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6
   Wang JPZ, 2004, BIOINFORMATICS, V20, P2973, DOI 10.1093/bioinformatics/bth342
   Wee SL, 2007, CHEMOECOLOGY, V17, P81, DOI 10.1007/s00049-006-0363-7
   White IM, 1992, FRUIT FLIES EC SIGNI
   Wu WY, 2007, J INSECT PHYSIOL, V53, P509, DOI 10.1016/j.jinsphys.2007.02.003
   Xue R., 1989, Chinese Journal of Biological Control, V5, P52
   Yu XJ, 2006, GENOMICS, V88, P745, DOI 10.1016/j.ygeno.2006.05.008
   [詹予忠 ZHAN Yuzhong], 2007, [郑州大学学报. 工学版, Journal of Zhengzhou University. Engineering Science], V28, P20
   Zhang B, 2000, J MOL BIOL, V299, P1121, DOI 10.1006/jmbi.2000.3803
   Zhang Yu-ping, 2009, Yingyong Shengtai Xuebao, V20, P381
   Zhang YuPing, 2008, Journal of Huazhong Agricultural University, V27, P456
NR 68
TC 9
Z9 13
U1 0
U2 37
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 5
PY 2014
VL 9
IS 2
AR e87800
DI 10.1371/journal.pone.0087800
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AA1AT
UT WOS:000330829200073
PM 24505315
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Girona, J
   Rosales, R
   Plana, N
   Saavedra, P
   Masana, L
   Vallve, JC
AF Girona, Josefa
   Rosales, Roser
   Plana, Nuria
   Saavedra, Paula
   Masana, Lluis
   Vallve, Joan-Carles
TI FABP4 Induces Vascular Smooth Muscle Cell Proliferation and Migration
   through a MAPK-Dependent Pathway
SO PLOS ONE
LA English
DT Article
ID ACID-BINDING PROTEIN; ADIPOSE-TISSUE DEPOTS; METABOLIC SYNDROME; PLASMA
   FATTY-ACID-BINDING-PROTEIN-4; CAROTID ATHEROSCLEROSIS;
   ENDOTHELIAL-CELLS; HEART-DISEASE; IN-VITRO; EXPRESSION; PATHOGENESIS
AB Purpose: The migration and proliferation of vascular smooth muscle cells play crucial roles in the development of atherosclerotic lesions. This study examined the effects of fatty acid binding protein 4 (FABP4), an adipokine that is associated with cardiovascular risk, endothelial dysfunction and proinflammatory effects, on the migration and proliferation of human coronary artery smooth muscle cells (HCASMCs).
   Methods and Results: A DNA 5-bromo-2'-deoxy-uridine (BrdU) incorporation assay indicated that FABP4 significantly induced the dose-dependent proliferation of HCASMCs with a maximum stimulatory effect at 120 ng/ml (13% vs. unstimulated cells, p<0.05). An anti-FABP4 antibody (40 ng/ml) significantly inhibited the induced cell proliferation, demonstrating the specificity of the FABP4 proliferative effect. FABP4 significantly induced HCASMC migration in a dose-dependent manner with an initial effect at 60 ng/ml (12% vs. unstimulated cells, p<0.05). Time-course studies demonstrated that FABP4 significantly increased cell migration compared with unstimulated cells from 4 h (23% vs. 17%, p<0.05) to 12 h (74% vs. 59%, p<0.05). Pretreatment with LY-294002 (5 mu M) and PD98059 (10 mu M) blocked the FABP4-induced proliferation and migration of HCASMCs, suggesting the activation of a kinase pathway. On a molecular level, we observed an up-regulation of the MAPK pathway without activation of Akt. We found that FABP4 induced the active forms of the nuclear transcription factors c-jun and c-myc, which are regulated by MAPK cascades, and increased the expression of the downstream genes cyclin D1 and MMP2, CCL2, and fibulin 4 and 5, which are involved in cell cycle regulation and cell migration.
   Conclusions: These findings indicate a direct effect of FABP4 on the migration and proliferation of HCASMCs, suggesting a role for this adipokine in vascular remodelling. Taken together, these results demonstrate that the FABP4-induced DNA synthesis and cell migration are mediated primarily through a MAPK-dependent pathway that activates the transcription factors c-jun and c-myc in HCASMCs.
C1 [Girona, Josefa; Rosales, Roser; Plana, Nuria; Saavedra, Paula; Masana, Lluis; Vallve, Joan-Carles] Univ Rovira & Virgili, Sant Joan Univ Hosp, IISPV,Res Unit Lipids & Atherosclerosis, Spanish Biomed Res Ctr Diabet & Associated Metab, E-43201 Reus, Spain.
RP Vallve, JC (reprint author), Univ Rovira & Virgili, Sant Joan Univ Hosp, IISPV,Res Unit Lipids & Atherosclerosis, Spanish Biomed Res Ctr Diabet & Associated Metab, C St Llorenc 21, E-43201 Reus, Spain.
EM jc.vallve@urv.cat
RI Girona, Josefa/U-3489-2018; MASANA, LUIS/M-7002-2019
OI Girona, Josefa/0000-0002-6267-8779; MASANA, LUIS/0000-0002-0789-4954;
   Saavedra, Paula/0000-0002-9907-475X; Plana, Nuria/0000-0002-4231-7618;
   Vallve, Joan-Carles/0000-0001-8711-9618
FU ISCIII, Madrid, Spain [PI 10/02547]; CIBER in Diabetes and Associated
   Metabolic Disorders (ISCIII, Ministerio de Ciencia e Innovacion), Spain
FX This work was supported by grants from the ISCIII, Madrid, Spain (PI
   10/02547) and CIBER in Diabetes and Associated Metabolic Disorders
   (ISCIII, Ministerio de Ciencia e Innovacion), Spain. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Agardh HE, 2011, J INTERN MED, V269, P200, DOI 10.1111/j.1365-2796.2010.02304.x
   Aragones G, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-72
   Aragones G, 2012, EUR J CLIN INVEST, V42, P34, DOI 10.1111/j.1365-2362.2011.02553.x
   Aragones G, 2010, ATHEROSCLEROSIS, V213, P329, DOI 10.1016/j.atherosclerosis.2010.07.026
   Boord JB, 2002, ARTERIOSCL THROM VAS, V22, P1686, DOI 10.1161/01.ATV.0000033090.81345.E66
   Boord JB, 2002, CURR OPIN LIPIDOL, V13, P141, DOI 10.1097/00041433-200204000-00005
   Cabre A, 2007, Atherosclerosis, V195, pe150
   Cabre A, 2008, J LIPID RES, V49, P1746, DOI 10.1194/jlr.M800102-JLR200
   Cabre A, 2008, CLIN CHEM, V54, P181, DOI 10.1373/clinchem.2007.094672
   Cabre A, 2010, J LIPID RES, V51, P1173, DOI 10.1194/jlr.M900066
   Coll B, 2008, ATHEROSCLEROSIS, V199, P147, DOI 10.1016/j.atherosclerosis.2007.09.032
   Doi M, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-44
   Duan C, 2000, CIRC RES, V86, P15, DOI 10.1161/01.RES.86.1.15
   Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249
   Elmasri H, 2012, ANGIOGENESIS, V15, P457, DOI 10.1007/s10456-012-9274-0
   Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882
   Fischer H, 2006, BIOCHEM BIOPH RES CO, V346, P125, DOI 10.1016/j.bbrc.2006.05.083
   Fisher RM, 2002, MOL CELL BIOCHEM, V239, P95, DOI 10.1023/A:1020532823751
   Fisher RM, 2001, DIABETOLOGIA, V44, P1268, DOI 10.1007/s001250100643
   Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844
   Holm S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028785
   Kralisch S, 2013, DIABETOLOGIA, V56, P10, DOI 10.1007/s00125-012-2737-4
   Lamounier-Zepter V, 2009, CIRC RES, V105, P326, DOI 10.1161/CIRCRESAHA.109.200501
   Lee K, 2013, ATHEROSCLEROSIS, V226, P74, DOI 10.1016/j.atherosclerosis.2012.09.037
   Lee MYK, 2011, BRIT J PHARMACOL, V162, P1564, DOI 10.1111/j.1476-5381.2010.01158.x
   Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30
   Lu L, 2013, ARTERIOSCL THROM VAS, V33, P572, DOI 10.1161/ATVBAHA.112.301016
   Peeters W, 2011, EUR HEART J, V32, P1758, DOI 10.1093/eurheartj/ehq387
   ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0
   SEGER R, 1995, FASEB J, V9, P726
   Stabile E, 2003, CIRC RES, V93, P1059, DOI 10.1161/01.RES.0000105086.31909.1B
   Stejskal D, 2006, EUR J CLIN INVEST, V36, P621, DOI 10.1111/j.1365-2362.2006.01696.x
   von Eynatten M, 2012, ARTERIOSCL THROM VAS, V32, P2327, DOI 10.1161/ATVBAHA.112.248609
   Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503
   Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463
   Yeung DCY, 2007, ARTERIOSCL THROM VAS, V27, P1796, DOI 10.1161/ATVBAHA.107.146274
   Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y
NR 37
TC 32
Z9 33
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 29
PY 2013
VL 8
IS 11
AR e81914
DI 10.1371/journal.pone.0081914
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 261MX
UT WOS:000327670300057
PM 24312381
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Vanderheyden, WM
   Vanderheyden, M
   Tanenhaus, A
   Yin, JC
   Shaw, PJ
AF Vanderheyden, William M.
   Gerstner, Jason R.
   Tanenhaus, Anne
   Yin, Jerry C.
   Shaw, Paul J.
TI ERK Phosphorylation Regulates Sleep and Plasticity in Drosophila
SO PLOS ONE
LA English
DT Article
ID ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION PATHWAY; LONG-TERM
   POTENTIATION; SYNAPTIC PLASTICITY; MUSHROOM BODIES; MAP KINASES; MEMORY;
   CASCADE; DEPRIVATION; HOMEOSTASIS
AB Given the relationship between sleep and plasticity, we examined the role of Extracellular signal-regulated kinase (ERK) in regulating baseline sleep, and modulating the response to waking experience. Both sleep deprivation and social enrichment increase ERK phosphorylation in wild-type flies. The effects of both sleep deprivation and social enrichment on structural plasticity in the LNvs can be recapitulated by expressing an active version of ERK (UAS-ERKSEM) pan-neuronally in the adult fly using GeneSwitch (Gsw) Gsw-elav-GAL4. Conversely, disrupting ERK reduces sleep and prevents both the behavioral and structural plasticity normally induced by social enrichment. Finally, using transgenic flies carrying a cAMP response Element (CRE)-luciferase reporter we show that activating ERK enhances CRE-Luc activity while disrupting ERK reduces it. These data suggest that ERK phosphorylation is an important mediator in transducing waking experience into sleep.
C1 [Vanderheyden, William M.] Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI 48109 USA.
   [Vanderheyden, William M.; Shaw, Paul J.] Washington Univ, Sch Med, Dept Anat, St Louis, MO USA.
   [Gerstner, Jason R.] Univ Penn, Perelman Sch Med, Ctr Sleep & Circadian Neurobiol, Translat Res Labs, Philadelphia, PA 19104 USA.
   [Tanenhaus, Anne; Yin, Jerry C.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.
   [Tanenhaus, Anne; Yin, Jerry C.] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA.
RP Vanderheyden, WM (reprint author), Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI 48109 USA.
EM wmvander@med.umich.edu
RI Gerstner, Jason/J-3778-2013
OI Gerstner, Jason/0000-0003-3113-6974
FU National Institutes of Health (NIH) [2 R01 NS051305-06]; NIH
   Neuroscience Blueprint Core Grant [NS057105]
FX This study was funded in part by National Institutes of Health (NIH)
   grant 2 R01 NS051305-06, and NIH Neuroscience Blueprint Core Grant
   NS057105. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Adams JP, 2000, ACTA NEUROBIOL EXP, V60, P377
   Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1
   Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836
   Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9
   BIGGS WH, 1994, EMBO J, V13, P1628, DOI 10.1002/j.1460-2075.1994.tb06426.x
   Blum S, 1999, J NEUROSCI, V19, P3535
   Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839
   Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p
   Donlea JM, 2011, SCIENCE, V332, P1571, DOI 10.1126/science.1202249
   Donlea JM, 2009, ADV GENET, V68, P57, DOI 10.1016/S0065-2660(09)68003-2
   Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657
   Eddison M, 2011, NEURON, V70, P979, DOI 10.1016/j.neuron.2011.03.030
   English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103
   Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957
   Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408
   Gelinas JN, 2007, J BIOL CHEM, V282, P27527, DOI 10.1074/jbc.M701077200
   Gerdjikov TV, 2004, BEHAV NEUROSCI, V118, P740, DOI 10.1037/0735-7044.118.4.740
   Gerstner Jason R, 2011, Commun Integr Biol, V4, P623, DOI 10.4161/cib.4.5.16927
   Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673
   Giovannini MG, 2006, REV NEUROSCIENCE, V17, P619
   Goldin M, 2003, EUR J NEUROSCI, V17, P2529, DOI 10.1046/j.1460-9568.2003.02694.x
   Graves L, 2001, TRENDS NEUROSCI, V24, P237, DOI 10.1016/S0166-2236(00)01744-6
   Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6
   Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743
   Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628
   Iijima-Andot K, 2005, P NATL ACAD SCI USA, V102, P10261, DOI 10.1073/pnas.0503937102
   Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811
   Keene AC, 2010, CURR BIOL, V20, P1209, DOI 10.1016/j.cub.2010.05.029
   Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1
   Kim MJ, 2006, EMBO J, V25, P3056, DOI 10.1038/sj.emboj.7601180
   Koh YH, 2002, J NEUROSCI, V22, P2496, DOI 10.1523/JNEUROSCI.22-07-02496.2002
   Li XJ, 2009, SLEEP, V32, P1417, DOI 10.1093/sleep/32.11.1417
   Lim YM, 1999, GENETICS, V153, P763
   Maret S, 2011, NAT NEUROSCI, V14, P1418, DOI 10.1038/nn.2934
   Morgan TH, 1925, GENETICS DROSOPHILA, P1
   Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298
   Panja D, 2009, J BIOL CHEM, V284, P31498, DOI 10.1074/jbc.M109.056077
   Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042
   Peng S, 2010, INT J MOL SCI, V11, P222, DOI 10.3390/ijms11010222
   Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739
   Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x
   SEGER R, 1995, FASEB J, V9, P726
   Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478
   Seugnet L, 2008, CURR BIOL, V18, P1110, DOI 10.1016/j.cub.2008.07.028
   Seugnet L, 2011, SLEEP, V34, P137, DOI 10.1093/sleep/34.2.137
   Seugnet L, 2009, SLEEP, V32, P984, DOI 10.1093/sleep/32.8.984
   Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834
   Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a
   Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033
   Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001
   Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x
   Tessier CR, 2008, DEVELOPMENT, V135, P1547, DOI 10.1242/dev.015867
   Thiels E, 2001, REV NEUROSCIENCE, V12, P327
   Thimgan MS, 2010, PLOS BIOL, V8
   Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002
   Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004
   Wairkar YP, 2009, J NEUROSCI, V29, P517, DOI 10.1523/JNEUROSCI.3848-08.2009
NR 57
TC 15
Z9 15
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 14
PY 2013
VL 8
IS 11
AR e81554
DI 10.1371/journal.pone.0081554
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 254DJ
UT WOS:000327143800183
PM 24244744
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Rockey, DC
   Weymouth, N
   Shi, ZD
AF Rockey, Don C.
   Weymouth, Nate
   Shi, Zengdun
TI Smooth Muscle alpha Actin (Acta2) and Myofibroblast Function during
   Hepatic Wound Healing
SO PLOS ONE
LA English
DT Article
ID FOCAL ADHESION KINASE; AMINO-ACID SEQUENCE; FAT-STORING CELLS;
   SKELETAL-MUSCLE; STELLATE CELLS; EXTRACELLULAR-MATRIX;
   GRANULATION-TISSUE; LIVER-INJURY; GAMMA-ACTIN; IN-VIVO
AB Smooth muscle alpha actin (Acta2) expression is largely restricted to smooth muscle cells, pericytes and specialized fibroblasts, known as myofibroblasts. Liver injury, associated with cirrhosis, induces transformation of resident hepatic stellate cells into liver specific myofibroblasts, also known as activated cells. Here, we have used in vitro and in vivo wound healing models to explore the functional role of Acta2 in this transformation. Acta2 was abundant in activated cells isolated from injured livers but was undetectable in quiescent cells isolated from normal livers. Both cellular motility and contraction were dramatically increased in injured liver cells, paralleled by an increase in Acta2 expression, when compared with quiescent cells. Inhibition of Acta2 using several different techniques had no effect on cytoplasmic actin isoform expression, but led to reduced cellular motility and contraction. Additionally, Acta2 knockdown was associated with a significant reduction in Erk1/2 phosphorylation compared to control cells. The data indicate that Acta2 is important specifically in myofibroblast cell motility and contraction and raise the possibility that the Acta2 cytoskeleton, beyond its structural importance in the cell, could be important in regulating signaling processes during wound healing in vivo.
C1 [Rockey, Don C.; Shi, Zengdun] Med Univ S Carolina, Dept Internal Med, Charleston, SC 29425 USA.
   [Weymouth, Nate] Univ Texas SW Med Ctr Dallas, Div Digest & Liver Dis, Dallas, TX 75390 USA.
RP Rockey, DC (reprint author), Med Univ S Carolina, Dept Internal Med, Charleston, SC 29425 USA.
EM rockey@musc.edu
FU National Institutes of Health [DK 02124, DK 50574, DK 57830]
FX This work was supported by the National Institutes of Health (grants DK
   02124, DK 50574, and DK 57830 to DCR). We thank Shmuel Tuvia for
   assistance with immunohistochemical studies and confocal imaging and
   John Chung for development of antisense oligonucleotides. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Amin E, 2013, BIOL CHEM IN PRESS
   ARORA PD, 1994, J CELL PHYSIOL, V159, P161, DOI 10.1002/jcp.1041590120
   Bartman T, 2004, PLOS BIOL, V2, P673, DOI 10.1371/journal.pbio.0020129
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0
   Crawford K, 2002, MOL CELL BIOL, V22, P5887, DOI 10.1128/MCB.22.16.5887-5896.2002
   DARBY I, 1990, LAB INVEST, V63, P21
   Davis BH, 1996, CLIN LAB MED, V16, P361, DOI 10.1016/S0272-2712(18)30274-9
   DELEEUW AM, 1984, HEPATOLOGY, V4, P392
   DESMOULIERE A, 1995, EXP NEPHROL, V3, P134
   FRIEDMAN SL, 1989, J CLIN INVEST, V84, P1780, DOI 10.1172/JCI114362
   GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594
   Gabbiani G, 1981, Prog Clin Biol Res, V54, P183
   GABBIANI G, 1972, J EXP MED, V135, P719, DOI 10.1084/jem.135.4.719
   GAILIT J, 1994, CURR OPIN CELL BIOL, V6, P717, DOI 10.1016/0955-0674(94)90099-X
   GARRELS JI, 1976, CELL, V9, P793, DOI 10.1016/0092-8674(76)90142-2
   GATES RE, 1994, CELL GROWTH DIFFER, V5, P891
   GRESSNER AM, 1995, J HEPATOL, V22, P28
   GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401
   Herman IM, 1993, CURR OPIN CELL BIOL, V5, P48, DOI 10.1016/S0955-0674(05)80007-9
   Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049
   Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481
   JOHNSON RJ, 1991, J CLIN INVEST, V87, P847, DOI 10.1172/JCI115089
   Kapanci Y, 1997, MODERN PATHOL, V10, P1134
   Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344
   KatoMinoura T, 1997, J CELL BIOL, V137, P649, DOI 10.1083/jcb.137.3.649
   Khimji AK, 2008, AM J PATHOL, V173, P716, DOI 10.2353/ajpath.2008.071121
   KISLAUSKIS EH, 1993, J CELL BIOL, V123, P165, DOI 10.1083/jcb.123.1.165
   Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481
   KOUNTOURAS J, 1984, BRIT J EXP PATHOL, V65, P305
   KUHN C, 1991, AM J PATHOL, V138, P1257
   Kumar A, 1997, P NATL ACAD SCI USA, V94, P4406, DOI 10.1073/pnas.94.9.4406
   Liu ZA, 2010, BRIT J PHARMACOL, V159, P304, DOI 10.1111/j.1476-5381.2009.00477.x
   MAHER JJ, 1990, J CLIN INVEST, V86, P1641, DOI 10.1172/JCI114886
   Mayer DCG, 1997, J CELL BIOL, V139, P1477, DOI 10.1083/jcb.139.6.1477
   McClain SA, 1996, AM J PATHOL, V149, P1257
   MCHUGH KM, 1991, DEV BIOL, V148, P442, DOI 10.1016/0012-1606(91)90263-3
   MITCHELL J, 1989, LAB INVEST, V60, P643
   Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549
   MIWA T, 1991, MOL CELL BIOL, V11, P3296, DOI 10.1128/MCB.11.6.3296
   Nowak KJ, 2009, J CELL BIOL, V185, P903, DOI 10.1083/jcb.200812132
   Okayama T, 2008, BBA-MOL BASIS DIS, V1782, P542, DOI 10.1016/j.bbadis.2008.06.006
   Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890
   Paradis V, 2010, AM J PATHOL, V177, P1791, DOI 10.2353/ajpath.2010.100166
   Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X
   PROCTOR E, 1982, GASTROENTEROLOGY, V83, P1183
   RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858
   ROCHE WR, 1990, J PATHOL, V161, P281, DOI 10.1002/path.1711610402
   ROCKEY DC, 1992, J SUBMICR CYTOL PATH, V24, P193
   RonnovJessen L, 1996, J CELL BIOL, V134, P67, DOI 10.1083/jcb.134.1.67
   RUBENSTEIN PA, 1990, BIOESSAYS, V12, P309, DOI 10.1002/bies.950120702
   Santos MF, 1997, J CLIN INVEST, V100, P216, DOI 10.1172/JCI119515
   Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com
   SCHMITTGRAFF A, 1994, VIRCHOWS ARCH, V425, P3, DOI 10.1007/BF00193944
   Schurch W, 1998, AM J SURG PATHOL, V22, P141, DOI 10.1097/00000478-199802000-00001
   SEGER R, 1995, FASEB J, V9, P726
   Shafiei MS, 2012, LAB INVEST, V92, P305, DOI 10.1038/labinvest.2011.155
   Sonnemann KJ, 2006, DEV CELL, V11, P387, DOI 10.1016/j.devcel.2006.07.001
   Svegliati-Baroni G, 2003, J HEPATOL, V39, P528, DOI 10.1016/S0168-8278(03)00291-5
   TANAKA Y, 1991, J PATHOL, V164, P273, DOI 10.1002/path.1711640314
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7
   VANDEKERCKHOVE J, 1979, DIFFERENTIATION, V14, P123, DOI 10.1111/j.1432-0436.1979.tb01021.x
   Weymouth N, 2012, DEV BIOL, V363, P1, DOI 10.1016/j.ydbio.2011.11.002
   Yata Y, 2002, HEPATOLOGY, V35, P1022, DOI 10.1053/jhep.2002.32673
NR 67
TC 38
Z9 38
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 29
PY 2013
VL 8
IS 10
AR e77166
DI 10.1371/journal.pone.0077166
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 242VF
UT WOS:000326270700020
PM 24204762
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU El Andalousi, J
   Li, Y
   Anand-Srivastava, MB
AF El Andalousi, Jasmine
   Li, Yuan
   Anand-Srivastava, Madhu B.
TI Natriuretic Peptide Receptor-C Agonist Attenuates the Expression of Cell
   Cycle Proteins and Proliferation of Vascular Smooth Muscle Cells from
   Spontaneously Hypertensive Rats: Role of Gi Proteins and
   MAPkinase/PI3kinase Signaling
SO PLOS ONE
LA English
DT Article
ID ADENYLATE-CYCLASE; ENHANCED EXPRESSION; CLEARANCE RECEPTOR; CYTOPLASMIC
   DOMAIN; ATRIAL; GROWTH; INHIBITION; MECHANISMS; 3-KINASE; KINASE
AB Vascular smooth muscle cells (VSMC) from spontaneously hypertensive rats (SHR) exhibit hyperproliferation and overexpression of cell cycle proteins. We earlier showed that small peptide fragments of cytoplasmic domain of natriuretic receptor-C (NPR-C) attenuate vasoactive peptide-induced hyperproliferation of VSMC. The present study investigated if C-ANP(4-23), a specific agonist of NPR-C, could attanuate the hyperproliferation of VSMC from SHR by inhibiting the overexpression of cell cycle proteins and examine the underlying signaling pathways contributing to this inhibition. The proliferation of VSMC was determined by [H-3] thymidine incorporation and the expression of proteins was determined by Western blotting. The hyperproliferation of VSMC from SHR and overexpression of cyclin D1, cyclin A, cyclin E, cyclin-dependent kinase 2 (cdk2), phosphorylated retinoblastoma protein (pRb), Gi alpha proteins and enhanced phosphorylation of ERK1/2 and AKT exhibited by VSMC from SHR were attenuated by C-ANP(4-23) to control levels. In addition, in vivo treatment of SHR with C-ANP(4-23) also attenuated the enhanced proliferation of VSMC. Furthemore, PD98059, wortmannin and pertussis toxin, the inhibitors of MAP kinase, PI3kinase and Gi alpha proteins respectively, also attenuated the hyperproliferation of VSMC from SHR and overexpression of cell cycle proteins to control levels. These results indicate that NPR-C activation by C-ANP(4-23) attenuates the enhanced levels of cell cycle proteins through the inhibition of enhanced expression of Gi alpha proteins and enhanced activation of MAPkinase/PI3kinase and results in the attenuation of hyperproliferation of VSMC from SHR. It may be suggested that C-ANP(4-23) could be used as a therapeutic agent in the treatment of vascular complications associated with hypertension, atherosclerosis and restenosis.
C1 [El Andalousi, Jasmine; Li, Yuan; Anand-Srivastava, Madhu B.] Univ Montreal, Dept Physiol, Quebec City, PQ, Canada.
RP Anand-Srivastava, MB (reprint author), Univ Montreal, Dept Physiol, Quebec City, PQ, Canada.
EM madhu.anand-srivastava@umontreal.ca
FU Canadian Institutes of Health Research [MOP 86569]
FX The work was supported by a grant from Canadian Institutes of Health
   Research (MOP 86569). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ANANDSRIVASTAVA MB, 1986, AM J PHYSIOL, V251, pF417
   ANANDSRIVASTAVA MB, 1990, J BIOL CHEM, V265, P8566
   ANANDSRIVASTAVA MB, 1986, BIOCHEM BIOPH RES CO, V138, P427, DOI 10.1016/0006-291X(86)90299-8
   ANANDSRIVASTAVA MB, 1984, BIOCHEM BIOPH RES CO, V121, P855, DOI 10.1016/0006-291X(84)90756-3
   ANANDSRIVASTAVA MB, 1985, LIFE SCI, V36, P1873, DOI 10.1016/0024-3205(85)90161-4
   ANANDSRIVASTAVA MB, 1987, J BIOL CHEM, V262, P4931
   ANANDSRIVASTAVA MB, 1985, FEBS LETT, V181, P199, DOI 10.1016/0014-5793(85)80259-3
   ANANDSRIVASTAVA MB, 1982, BIOCHEM BIOPH RES CO, V108, P213, DOI 10.1016/0006-291X(82)91853-8
   ANANDSRIVASTAVA MB, 1993, PHARMACOL REV, V45, P455
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRENNER BM, 1990, PHYSIOL REV, V70, P665
   Cardus A, 2006, KIDNEY INT, V69, P1377, DOI 10.1038/sj.ki.5000304
   FULLER F, 1988, J BIOL CHEM, V263, P9395
   HAMET P, 1984, BIOCHEM BIOPH RES CO, V123, P515, DOI 10.1016/0006-291X(84)90260-2
   Hashim S, 2006, AM J PHYSIOL-HEART C, V291, pH3144, DOI 10.1152/ajpheart.00327.2006
   Hayashi S, 2000, HYPERTENSION, V35, P237, DOI 10.1161/01.HYP.35.1.237
   HIRATA M, 1989, BIOCHIM BIOPHYS ACTA, V1010, P346, DOI 10.1016/0167-4889(89)90060-8
   Kubo A, 2000, AM J HYPERTENS, V13, P1117, DOI 10.1016/S0895-7061(00)00298-3
   Kubo A, 1996, J CARDIOVASC PHARM, V27, P58, DOI 10.1097/00005344-199601000-00010
   Lappas G, 2005, J HYPERTENS, V23, P2251, DOI 10.1097/01.hjh.0000191905.26853.f1
   Lee SJ, 2009, INT IMMUNOPHARMACOL, V9, P837, DOI 10.1016/j.intimp.2009.03.010
   Levin ER, 1998, NEW ENGL J MED, V339, P321
   Li Y, 2005, CAN J CARDIOL, V21, p155C
   LIAU G, 1989, J BIOL CHEM, V264, P10315
   Liu J, 2013, HYPERTENSION, V62
   MOLLOY CJ, 1993, J BIOL CHEM, V268, P7338
   Mouawad R, 2004, MOL PHARMACOL, V65, P917, DOI 10.1124/mol.65.4.917
   Pagano M, 2001, J BIOL CHEM, V276, P22064, DOI 10.1074/jbc.M101587200
   Pedram A, 1998, J BIOL CHEM, V273, P13966, DOI 10.1074/jbc.273.22.13966
   Prins BA, 1996, J BIOL CHEM, V271, P14156, DOI 10.1074/jbc.271.24.14156
   Sandoval YHG, 2011, CELL SIGNAL, V23, P354, DOI 10.1016/j.cellsig.2010.10.005
   Sandoval YHG, 2009, CAN J PHYSIOL PHARM, V87, P1037, DOI 10.1139/Y09-089
   Saward L, 1997, CIRC RES, V81, P249, DOI 10.1161/01.RES.81.2.249
   Schmidt CM, 1999, EUR J GASTROEN HEPAT, V11, P1393, DOI 10.1097/00042737-199912000-00009
   SEGER R, 1995, FASEB J, V9, P726
   SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K
   SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0
   Tanner FC, 2003, HYPERTENSION, V42, P184, DOI 10.1161/01.HYP.0000082360.65547.7C
   Touyz RM, 2005, EXP PHYSIOL, V90, P449, DOI 10.1113/expphysiol.2005.030080
   VARTICOVSKI L, 1994, BBA-MOL BASIS DIS, V1226, P1, DOI 10.1016/0925-4439(94)90051-5
   WINQUIST RJ, 1984, P NATL ACAD SCI-BIOL, V81, P7661, DOI 10.1073/pnas.81.23.7661
NR 41
TC 12
Z9 12
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 14
PY 2013
VL 8
IS 10
AR e76183
DI 10.1371/journal.pone.0076183
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 237RD
UT WOS:000325887300028
PM 24155894
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Jesan, T
   Sarma, U
   Halder, S
   Saha, B
   Sinha, S
AF Jesan, Tharmaraj
   Sarma, Uddipan
   Halder, Subhadra
   Saha, Bhaskar
   Sinha, Sitabhra
TI Branched Motifs Enable Long-Range Interactions in Signaling Networks
   through Retrograde Propagation
SO PLOS ONE
LA English
DT Article
ID ACTIVATED PROTEIN-KINASE; LEISHMANIA-MAJOR INFECTION; CELL ANTIGEN
   RECEPTOR; KAPPA-B KINASE; MEK KINASE; INSULIN-RESISTANCE;
   NEGATIVE-FEEDBACK; MAPK PATHWAY; P38; JNK
AB Branched structures arise in the intra-cellular signaling network when a molecule is involved in multiple enzyme-substrate reaction cascades. Such branched motifs are involved in key biological processes, e. g., immune response activated by T-cell and B-cell receptors. In this paper, we demonstrate long-range communication through retrograde propagation between branches of signaling pathways whose molecules do not directly interact. Our numerical simulations and experiments on a system comprising branches with JNK and p38MAPK as terminal molecules respectively that share a common MAP3K enzyme MEKK3/4 show that perturbing an enzyme in one branch can result in a series of changes in the activity levels of molecules "upstream" to the enzyme that eventually reaches the branch-point and affects other branches. In the absence of any evidence for explicit feedback regulation between the functionally distinct JNK and p38MAPK pathways, the experimentally observed modulation of phosphorylation amplitudes in the two pathways when a terminal kinase is inhibited implies the existence of long-range coordination through retrograde information propagation previously demonstrated in single linear reaction pathways. An important aspect of retrograde propagation in branched pathways that is distinct from previous work on retroactivity focusing exclusively on single chains is that varying the type of perturbation, e. g., between pharmaceutical agent mediated inhibition of phosphorylation or suppression of protein expression, can result in opposing responses in the other branches. This can have potential significance in designing drugs targeting key molecules which regulate multiple pathways implicated in systems-level diseases such as cancer and diabetes.
C1 [Jesan, Tharmaraj; Sinha, Sitabhra] Inst Math Sci, Chennai 600113, Tamil Nadu, India.
   [Jesan, Tharmaraj] Bhabha Atom Res Ctr, Div Hlth Phys, Kalpakkam, Tamil Nadu, India.
   [Sarma, Uddipan; Halder, Subhadra; Saha, Bhaskar] Natl Ctr Cell Sci, Pune, Maharashtra, India.
RP Sinha, S (reprint author), Inst Math Sci, Chennai 600113, Tamil Nadu, India.
EM sitabhra@imsc.res.in
FU Department of Bio-Technology (DBT), Government of India
   [BT/PR7521/BRB/10/482/2006]; IMSc Complex Systems Project (XI Plan)
FX This study was supported by the Department of Bio-Technology (DBT),
   Government of India (BT/PR7521/BRB/10/482/2006) and IMSc Complex Systems
   Project (XI Plan). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abell AN, 2007, J BIOL CHEM, V282, P30476, DOI 10.1074/jbc.M705783200
   Alon U, 1999, NATURE, V397, P168
   Bennett BL, 2003, CURR OPIN PHARMACOL, V3, P420, DOI 10.1016/S1471-4892(03)00068-7
   Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465
   Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x
   Chowdhury TA, 2010, QJM-INT J MED, V103, P905, DOI 10.1093/qjmed/hcq149
   Cloutier M, 2011, INTEGR BIOL-UK, V3, P724, DOI 10.1039/c0ib00145g
   Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008
   de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200
   Deacon K, 1999, J BIOL CHEM, V274, P16604, DOI 10.1074/jbc.274.23.16604
   Deacon K, 1997, J BIOL CHEM, V272, P14489, DOI 10.1074/jbc.272.22.14489
   Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138
   Fanger GR, 1998, J BIOL CHEM, V273, P3476, DOI 10.1074/jbc.273.6.3476
   Fritsche-Guenther R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.27
   Gantke T, 2012, IMMUNOL REV, V246, P168, DOI 10.1111/j.1600-065X.2012.01104.x
   Hagemann D, 1999, ONCOGENE, V18, P1391, DOI 10.1038/sj.onc.1202431
   Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540
   Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078
   Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033
   Huse M, 2009, J CELL SCI, V122, P1269, DOI 10.1242/jcs.042762
   Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90
   Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009
   Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126
   Kolch W, 2000, BIOCHEM J, V351, P289, DOI 10.1042/0264-6021:3510289
   KOMAROVA NL, 2005, MOL SYS BIOL, V1
   LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802
   Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37
   Lewin B., 2007, CELLS
   Lu XH, 1997, J BIOL CHEM, V272, P24751, DOI 10.1074/jbc.272.40.24751
   Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060
   Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045
   Millat T, 2007, MATH BIOSCI, V207, P40, DOI 10.1016/j.mbs.2006.08.012
   Olson JM, 2004, TRENDS MOL MED, V10, P125, DOI 10.1016/j.molmed.2004.01.007
   Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908
   Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184
   Rub A, 2009, NAT IMMUNOL, V10, P273, DOI 10.1038/ni.1705
   Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443
   SEGER R, 1995, FASEB J, V9, P726
   Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319
   Soyer OS, 2006, J THEOR BIOL, V238, P416, DOI 10.1016/j.jtbi.2005.05.030
   Srivastava N, 2011, J IMMUNOL, V186, P5863, DOI 10.4049/jimmunol.1003957
   Sudan R, 2012, J IMMUNOL, V188, P2328, DOI 10.4049/jimmunol.1101678
   Sutherland CL, 1996, J IMMUNOL, V157, P3381
   Ventura AC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000041
   Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694
   Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92
   Widmann C, 1999, PHYSIOL REV, V79, P143
   YAN MH, 1994, NATURE, V372, P798
   Zama T, 2002, J BIOL CHEM, V277, P23919, DOI 10.1074/jbc.M200838200
NR 49
TC 5
Z9 5
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 31
PY 2013
VL 8
IS 5
AR UNSP e64409
DI 10.1371/journal.pone.0064409
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 156DC
UT WOS:000319799900039
PM 23741327
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Testa, ND
   Ghosh, SM
   Shingleton, AW
AF Testa, Nicholas D.
   Ghosh, Shampa M.
   Shingleton, Alexander W.
TI Sex-Specific Weight Loss Mediates Sexual Size Dimorphism in Drosophila
   melanogaster
SO PLOS ONE
LA English
DT Article
ID BODY-SIZE; STATIC ALLOMETRY; GROWTH; EVOLUTION; CELL; METAMORPHOSIS;
   PERSPECTIVE; GENETICS; INSECTS
AB The selective pressures leading to the evolution of Sexual Size Dimorphism (SSD) have been well studied in many organisms, yet, the underlying developmental mechanisms are poorly understood. By generating a complete growth profile by sex in Drosophila melanogaster, we describe the sex-specific pattern of growth responsible for SSD. Growth rate and critical size for pupariation significantly contributed to adult SSD, whereas duration of growth did not. Surprisingly, SSD at peak larval mass was twice that of the uneclosed adult SSD with weight loss between peak larval mass and pupariation playing an important role in generating the final SSD. Our finding that weight loss is an important regulator of SSD adds additional complexity to our understanding of how body size is regulated in different sexes. Collectively, these data allow for the elucidation of the molecular-genetic mechanisms that generate SSD, an important component of understanding how SSD evolves.
C1 [Testa, Nicholas D.; Ghosh, Shampa M.; Shingleton, Alexander W.] Michigan State Univ, Dept Zool & Ecol & Evolutionary Biol & Behav, E Lansing, MI 48824 USA.
RP Testa, ND (reprint author), Michigan State Univ, Dept Zool & Ecol & Evolutionary Biol & Behav, E Lansing, MI 48824 USA.
EM testanick@gmail.com
OI Shingleton, Alexander/0000-0001-9862-9947
FU National Science Foundation [IOS-0919855, IOS-0845847]; Michigan State
   University
FX This research was supported by National Science Foundation grants
   IOS-0919855 and IOS-0845847 to AWS, and fellowship support from Michigan
   State University to NDT. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7
   Bininda-Emonds ORP, 2000, EVOLUTION, V54, P1011
   Blanckenhorn WU, 2007, AM NAT, V169, P245, DOI 10.1086/510597
   Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0
   Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X
   Caldwell PE, 2005, CURR BIOL, V15, P2175, DOI 10.1016/j.cub.2005.11.041
   Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846
   D'Amico LJ, 2001, P ROY SOC B-BIOL SCI, V268, P1589, DOI 10.1098/rspb.2001.1698
   Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x
   De Jong G, 2003, J GENET, V82, P207, DOI 10.1007/BF02715819
   Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989
   Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286
   Esperk T, 2007, ECOL ENTOMOL, V32, P243, DOI 10.1111/j.1365-2311.2007.00872.x
   Fabian DK, 2012, MOL ECOL, V21, P4748, DOI 10.1111/j.1365-294X.2012.05731.x
   Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659
   Fischer K, 2001, ENTOMOL EXP APPL, V100, P325, DOI 10.1023/A:1019297222922
   Freeman M, 1997, DEVELOPMENT, V124, P261
   GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9
   Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6
   Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010
   LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269
   Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017
   Molleman F, 2011, J INSECT PHYSIOL, V57, P712, DOI 10.1016/j.jinsphys.2011.02.009
   Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8
   Nijhout H F, 2006, J Biol, V5, P16, DOI 10.1186/jbiol43
   NIJHOUT HF, 1974, J EXP BIOL, V61, P481
   NIJHOUT HF, 1981, AM ZOOL, V21, P631
   Norman MD, 2002, NEW ZEAL J MAR FRESH, V36, P733, DOI 10.1080/00288330.2002.9517126
   Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008
   SEGER R, 1995, FASEB J, V9, P726
   Shingleton AW, 2008, P ROY SOC B-BIOL SCI, V275, P1875, DOI 10.1098/rspb.2008.0227
   Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584
   Shingleton AW, 2005, CURR BIOL, V15, pR825, DOI 10.1016/j.cub.2005.10.006
   Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289
   Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009
   Smith RJ, 1999, J HUM EVOL, V36, P423, DOI 10.1006/jhev.1998.0281
   Stieper BC, 2008, DEV BIOL, V321, P18, DOI 10.1016/j.ydbio.2008.05.556
   Stillwell RC, 2010, P ROY SOC B-BIOL SCI, V277, P2069, DOI 10.1098/rspb.2009.2277
   Stillwell RC, 2010, ANNU REV ENTOMOL, V55, P227, DOI 10.1146/annurev-ento-112408-085500
   Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
NR 41
TC 31
Z9 32
U1 0
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 28
PY 2013
VL 8
IS 3
AR e58936
DI 10.1371/journal.pone.0058936
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 121RP
UT WOS:000317262200008
PM 23555608
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Mai, ZX
   Liu, HY
AF Mai, Zhongxing
   Liu, Haiyan
TI Random Parameter Sampling of a Generic Three-Tier MAPK Cascade Model
   Reveals Major Factors Affecting Its Versatile Dynamics
SO PLOS ONE
LA English
DT Article
ID PROTEIN-KINASE CASCADES; KINETIC-MODELS; REGULATORY NETWORKS; NEGATIVE
   FEEDBACK; SIGNALING CASCADE; CELL FATE; BISTABILITY; ULTRASENSITIVITY;
   PHOSPHORYLATION; IDENTIFICATION
AB The mitogen-activated protein kinase (MAPK) pathway is considered to be a central block in many biological signaling networks. Despite the common core cascade structure, the activation of MAPK in different biological systems can exhibit different types of dynamic behaviors. Computer modeling may help to reveal the mechanisms underlying such variations. However, so far most computational models of the MAPK cascade have been system-specific, or to reflect a particular type among the wide spectrum of possible dynamics. To obtain a general and integrated view of the relationship between the dynamics of MAPK activation and the structures and parameters of the MAPK cascade, we constructed a generic model by comparing previous models covering different specific biological systems. We assumed that reliable qualitative results could be predicted through a qualitative model with pseudo parameters. We used randomly sampled parameters instead of a specific set of "best-fit" parameters to avoid biases towards any particular systems. A range of dynamics behaviors for MAPK activation, including ultrasensitivity, bistability, transient activation and oscillation, were successfully predicted by the generic model. The results indicated that the steady state dynamics (ultrasensitivity and bistability) was jointly determined by the three-tiered structure of the MAPK cascade and the competitive substrate binding in the dual-phosphorylation processes of the central components, while the temporal dynamics (transient activation and oscillation) was mainly affected by the upstream signaling pathway and feedbacks. Moreover, MAPK kinase (MAPKK) played more important roles than the other two components in determining the dynamics of MAPK activation. We hypothesize that this is an important and advantageous property for the regulation and for the functional diversity of MAPK pathways in real cells. Finally, to assist developing generic models for signaling motifs through model comparisons, we proposed a reaction-based database to make the model data more flexible and interoperable.
C1 [Liu, Haiyan] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China.
   Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.
RP Liu, HY (reprint author), Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China.
EM hyliu@ustc.edu.cn
RI Liu, Haiyan/O-9637-2014
FU Chinese Ministry of Science and Technology [2011CBA00801]
FX This work is financially supported by the Chinese Ministry of Science
   and Technology (grant number 2011CBA00801). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x
   Beal MJ, 2005, BIOINFORMATICS, V21, P349, DOI 10.1093/bioinformatics/bti014
   Campagne Fabien, 2004, Sci STKE, V2004, ppl11
   Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007
   Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9
   Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894
   Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895
   HarshaRani GV, 2005, J BIOCHEM, V137, P653, DOI 10.1093/jb/mvi083
   Hilioti Z, 2008, CURR BIOL, V18, P1700, DOI 10.1016/j.cub.2008.09.027
   Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078
   Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044
   Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015
   Keshet Y, 2010, METHODS MOL BIOL, V661, P3, DOI 10.1007/978-1-60761-795-2_1
   Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x
   Kuida K, 2004, J BIOCHEM, V135, P653, DOI 10.1093/jb/mvh078
   Kurata H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001103
   Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092
   Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818
   Lue HQ, 2006, CELL SIGNAL, V18, P688, DOI 10.1016/j.cellsig.2005.06.013
   Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060
   Nakakuki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001782
   Nikolaev EV, 2007, J THEOR BIOL, V247, P442, DOI 10.1016/j.jtbi.2007.02.013
   Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184
   Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543
   Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233
   Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370
   SEGER R, 1995, FASEB J, V9, P726
   Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005
   Sivakumaran S, 2003, BIOINFORMATICS, V19, P408, DOI 10.1093/bioinformatics/btf860
   Torii S, 2004, J BIOCHEM, V136, P557, DOI 10.1093/jb/mvh159
   van Riel NAW, 2006, BRIEF BIOINFORM, V7, P364, DOI 10.1093/bib/bbl040
   Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498
   Yoon J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004560
   Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218
NR 34
TC 4
Z9 4
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 24
PY 2013
VL 8
IS 1
AR e54441
DI 10.1371/journal.pone.0054441
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 077JK
UT WOS:000314023600055
PM 23365667
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Chou, MF
   Prisic, S
   Lubner, JM
   Church, GM
   Husson, RN
   Schwartz, D
AF Chou, Michael F.
   Prisic, Sladjana
   Lubner, Joshua M.
   Church, George M.
   Husson, Robert N.
   Schwartz, Daniel
TI Using Bacteria to Determine Protein Kinase Specificity and Predict
   Target Substrates
SO PLOS ONE
LA English
DT Article
ID TOPOISOMERASE-II-ALPHA; CASEIN KINASE; MASS-SPECTROMETRY; IN-VITRO;
   PHOSPHORYLATED INVITRO; ESCHERICHIA-COLI; MOTIFS; IDENTIFICATION;
   CHANNEL; PHOSPHOPROTEOME
AB The identification of protein kinase targets remains a significant bottleneck for our understanding of signal transduction in normal and diseased cellular states. Kinases recognize their substrates in part through sequence motifs on substrate proteins, which, to date, have most effectively been elucidated using combinatorial peptide library approaches. Here, we present and demonstrate the ProPeL method for easy and accurate discovery of kinase specificity motifs through the use of native bacterial proteomes that serve as in vivo libraries for thousands of simultaneous phosphorylation reactions. Using recombinant kinases expressed in E. coli followed by mass spectrometry, the approach accurately recapitulated the well-established motif preferences of human basophilic (Protein Kinase A) and acidophilic (Casein Kinase II) kinases. These motifs, derived for PKA and CK II using only bacterial sequence data, were then further validated by utilizing them in conjunction with the scan-x software program to computationally predict known human phosphorylation sites with high confidence.
C1 [Chou, Michael F.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA.
   [Prisic, Sladjana; Husson, Robert N.] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA.
   [Lubner, Joshua M.; Schwartz, Daniel] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA.
RP Schwartz, D (reprint author), Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA.
EM daniel.schwartz@uconn.edu
OI church, george/0000-0001-6232-9969; Lubner, Joshua/0000-0003-1506-0949;
   Prisic, Sladjana/0000-0003-3137-4358
FU University of Connecticut Research Foundation; Genomes to Life grant
   from US Department of Energy
FX This study was funded in part by grants from the University of
   Connecticut Research Foundation (http://uconn.edu/)(DS) and the Genomes
   to Life grant from US Department of Energy
   (http://genomicscience.energy.gov/)(GMC). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1
   Brunati AM, 2000, FEBS LETT, V471, P151, DOI 10.1016/S0014-5793(00)01378-8
   Chambers SP, 2004, PROTEIN EXPRES PURIF, V36, P40, DOI 10.1016/j.pep.2004.03.003
   Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022
   Chemnitz J, 2009, EUR J IMMUNOL, V39, P267, DOI 10.1002/eji.200838619
   Chiang CWK, 2008, GENETICS, V180, P2277, DOI 10.1534/genetics.108.096537
   Chou Michael F, 2011, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1316s36
   Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127
   Cui J, 2000, CURR BIOL, V10, P671, DOI 10.1016/S0960-9822(00)00516-9
   Douglass J, 2012, AM J PHYSIOL-CELL PH, V303, pC715, DOI 10.1152/ajpcell.00166.2012
   Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019
   ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2
   Escargueil AE, 2000, J BIOL CHEM, V275, P34710, DOI 10.1074/jbc.M005179200
   Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001
   Gonzalez-Santos JM, 2008, HUM MOL GENET, V17, P225, DOI 10.1093/hmg/ddm300
   Guo ZK, 2006, BIOCHEM BIOPH RES CO, V347, P867, DOI 10.1016/j.bbrc.2006.06.178
   Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122
   Huang SY, 2007, J PROTEOME RES, V6, P2674, DOI 10.1021/pr070134c
   Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708
   Kettenbach AN, 2012, CHEM BIOL, V19, P608, DOI 10.1016/j.chembiol.2012.04.011
   Knight JDR, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-5
   Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449
   LEESMILLER SP, 1989, J BIOL CHEM, V264, P2431
   Li DX, 1996, J BIOL CHEM, V271, P15662, DOI 10.1074/jbc.271.26.15662
   Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200
   Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200
   Mant A, 2011, J BIOL CHEM, V286, P14110, DOI 10.1074/jbc.M110.190702
   Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433
   Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200
   NAIRN AC, 1994, SEMIN CANCER BIOL, V5, P295
   O'Donnell M RM, 2011, FASEB J
   Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584
   Ozlu N, 2010, WIRES SYST BIOL MED, V2, P255, DOI 10.1002/wsbm.41
   Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107
   Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261
   Saad FA, 2005, BIOCHEM BIOPH RES CO, V333, P443, DOI 10.1016/j.bbrc.2005.05.124
   Sarno S, 1996, J BIOL CHEM, V271, P10595, DOI 10.1074/jbc.271.18.10595
   Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146
   Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200
   SEGER R, 1995, FASEB J, V9, P726
   SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027, DOI 10.1073/pnas.89.6.2027
   SUGIMOTO K, 1992, BIOSCI BIOTECH BIOCH, V56, P1174, DOI 10.1271/bbb.56.1174
   Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200
   Vergarajauregui S, 2008, BIOCHEM J, V410, P417, DOI 10.1042/BJ20070713
   Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150
   Wang DJ, 2009, CANCER RES, V69, P8200, DOI 10.1158/0008-5472.CAN-09-1976
   WELLS NJ, 1994, J BIOL CHEM, V269, P29746
   Zhang MY, 2011, PROTEOMICS, V11, P4632, DOI 10.1002/pmic.201100339
   ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9
NR 49
TC 15
Z9 15
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 26
PY 2012
VL 7
IS 12
AR e52747
DI 10.1371/journal.pone.0052747
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 071TV
UT WOS:000313618800136
PM 23300758
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Kapfhamer, D
   King, I
   Zou, ME
   Lim, JP
   Heberlein, U
   Wolf, FW
AF Kapfhamer, David
   King, Ian
   Zou, Mimi E.
   Lim, Jana P.
   Heberlein, Ulrike
   Wolf, Fred W.
TI JNK Pathway Activation Is Controlled by Tao/TAOK3 to Modulate Ethanol
   Sensitivity
SO PLOS ONE
LA English
DT Article
ID N-TERMINAL-KINASE; INDUCED CELL-DEATH; DUAL-SPECIFICITY PHOSPHATASES;
   INDUCED OXIDATIVE STRESS; JUN NH2-TERMINAL KINASE; PROTEIN-KINASE;
   KNOCKOUT MICE; INFLAMMATORY MEDIATORS; SIGNALING PATHWAYS; STE20-LIKE
   KINASE
AB Neuronal signal transduction by the JNK MAP kinase pathway is altered by a broad array of stimuli including exposure to the widely abused drug ethanol, but the behavioral relevance and the regulation of JNK signaling is unclear. Here we demonstrate that JNK signaling functions downstream of the Sterile20 kinase family gene tao/Taok3 to regulate the behavioral effects of acute ethanol exposure in both the fruit fly Drosophila and mice. In flies tao is required in neurons to promote sensitivity to the locomotor stimulant effects of acute ethanol exposure and to establish specific brain structures. Reduced expression of key JNK pathway genes substantially rescued the structural and behavioral phenotypes of tao mutants. Decreasing and increasing JNK pathway activity resulted in increased and decreased sensitivity to the locomotor stimulant properties of acute ethanol exposure, respectively. Further, JNK expression in a limited pattern of neurons that included brain regions implicated in ethanol responses was sufficient to restore normal behavior. Mice heterozygous for a disrupted allele of the homologous Taok3 gene (Taok3Gt) were resistant to the acute sedative effects of ethanol. JNK activity was constitutively increased in brains of Taok3Gt/+ mice, and acute induction of phospho-JNK in brain tissue by ethanol was occluded in Taok3Gt/+ mice. Finally, acute administration of a JNK inhibitor conferred resistance to the sedative effects of ethanol in wild-type but not Taok3Gt/+ mice. Taken together, these data support a role of a TAO/TAOK3-JNK neuronal signaling pathway in regulating sensitivity to acute ethanol exposure in flies and in mice.
C1 [Kapfhamer, David; Zou, Mimi E.; Lim, Jana P.; Heberlein, Ulrike; Wolf, Fred W.] Univ Calif San Francisco, Ernest Gallo Clin, Emeryville, CA USA.
   [Kapfhamer, David; Zou, Mimi E.; Lim, Jana P.; Heberlein, Ulrike; Wolf, Fred W.] Univ Calif San Francisco, Res Ctr, Emeryville, CA USA.
   [King, Ian; Heberlein, Ulrike] Univ Calif San Francisco, Dept Anat, Program Neurosci, San Francisco, CA 94143 USA.
RP Kapfhamer, D (reprint author), Univ Calif San Francisco, Ernest Gallo Clin, Emeryville, CA USA.
EM dkapfhamer@gallo.ucsf.edu; fwolf@ucmerced.edu
OI King, Ian/0000-0003-3405-9767
FU National Institutes of Health/National Institute on Alcohol Abuse and
   Alcoholism Grant [P50 AA017072]
FX This work was supported by National Institutes of Health/National
   Institute on Alcohol Abuse and Alcoholism Grant P50 AA017072 (FWW, UH).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aroor AR, 2010, ALCOHOL CLIN EXP RES, V34, P1543, DOI 10.1111/j.1530-0277.2010.01239.x
   Aroor AR, 2004, LIFE SCI, V74, P2339, DOI 10.1016/S0024-3205(03)01196-2
   Bakal C, 2008, SCIENCE, V322, P453, DOI 10.1126/science.1158739
   Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298
   Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02.03.0046
   Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893
   Boyce-Rustay JM, 2006, ALCOHOL CLIN EXP RES, V30, P1957, DOI 10.1111/j.1530-0277.2006.00241.x
   Chen Z, 2001, J BIOL CHEM, V276, P16070, DOI 10.1074/jbc.M100681200
   Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026
   Corl AB, 2005, NAT NEUROSCI, V8, P18, DOI 10.1038/nn1363
   Corl AB, 2009, CELL, V137, P949, DOI 10.1016/j.cell.2009.03.020
   Crabbe JC, 1996, NAT GENET, V14, P98, DOI 10.1038/ng0996-98
   Cui SZ, 2011, ACTA PHARMACOL SIN, V32, P175, DOI 10.1038/aps.2010.199
   Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8
   Das SK, 2007, LIFE SCI, V81, P177, DOI 10.1016/j.lfs.2007.05.005
   Davies DL, 2013, ALCOHOL CLIN EXP RES, V37, P8, DOI 10.1111/j.1530-0277.2012.01846.x
   de la Monte SM, 2000, ALCOHOL CLIN EXP RES, V24, P716, DOI 10.1097/00000374-200005000-00017
   Downing C, 2003, GENES BRAIN BEHAV, V2, P140, DOI 10.1034/j.1601-183X.2003.00022.x
   Eddison M, 2011, NEURON, V70, P979, DOI 10.1016/j.neuron.2011.03.030
   Faccidomo S, 2009, PSYCHOPHARMACOLOGY, V204, P135, DOI 10.1007/s00213-008-1444-9
   Fadda F, 1998, PROG NEUROBIOL, V56, P385, DOI 10.1016/S0301-0082(98)00032-X
   Fee JR, 2004, ALCOHOL CLIN EXP RES, V28, P1459, DOI 10.1097/01.ALC.0000141809.53115.71
   French RL, 2009, P NATL ACAD SCI USA, V106, P20924, DOI 10.1073/pnas.0910813106
   Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549
   Gao YQ, 2005, J CEREBR BLOOD F MET, V25, P694, DOI 10.1038/sj.jcbfm.9600062
   Gibson GE, 2002, NEUROCHEM INT, V40, P493, DOI 10.1016/S0197-0186(01)00120-6
   Glise B, 1997, GENE DEV, V11, P1738, DOI 10.1101/gad.11.13.1738
   Goodrich LV, 2008, NEURON, V60, P9, DOI 10.1016/j.neuron.2008.09.003
   Han JY, 2008, J NEUROSCI RES, V86, P3221, DOI 10.1002/jnr.21759
   Han JY, 2006, NEUROSCI LETT, V398, P113, DOI 10.1016/j.neulet.2005.12.065
   Hogan B., 1994, MANIPULATING MOUSE E
   Hutchison M, 1998, J BIOL CHEM, V273, P28625, DOI 10.1074/jbc.273.44.28625
   Insolera R, 2011, DEV NEUROBIOL, V71, P483, DOI 10.1002/dneu.20867
   Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289
   Johne C, 2008, MOL BIOL CELL, V19, P1391, DOI 10.1091/mbc.E07-07-0730
   Jung ME, 2010, NEUROBIOL AGING, V32, P2266
   Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev
   Kapfhamer D, 2008, GENES BRAIN BEHAV, V7, P669, DOI 10.1111/j.1601-183X.2008.00404.x
   Kapfhamer D., 2012, GENES BRAIN BEHAV
   King Ian, 2011, Commun Integr Biol, V4, P554, DOI 10.4161/cib.4.5.16051
   King I, 2011, J NEUROSCI, V31, P1139, DOI 10.1523/JNEUROSCI.4416-10.2011
   Kolch W, 2005, FEBS LETT, V579, P1891, DOI 10.1016/j.febslet.2005.02.002
   Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954
   Kong EC, 2010, ALCOHOL CLIN EXP RES, V34, P302, DOI 10.1111/j.1530-0277.2009.01093.x
   Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7
   Ku BM, 2007, NEUROSCI LETT, V419, P64, DOI 10.1016/j.neulet.2007.03.049
   Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497
   Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557
   McAlhany RE, 2000, DEV BRAIN RES, V119, P209, DOI 10.1016/S0165-3806(99)00171-6
   Milton VJ, 2012, DEV NEUROBIOL, V72, P100, DOI 10.1002/dneu.20957
   Milton VJ, 2011, P NATL ACAD SCI USA, V108, P17521, DOI 10.1073/pnas.1014511108
   Mitchell JM, 2012, PSYCHOPHARM BERL
   Mitsopoulos C, 2003, J BIOL CHEM, V278, P18085, DOI 10.1074/jbc.M213064200
   Mitsuyama K, 2006, CLIN EXP IMMUNOL, V143, P24, DOI 10.1111/j.1365-2249.2005.02959.x
   Moore TM, 2000, J BIOL CHEM, V275, P4311, DOI 10.1074/jbc.275.6.4311
   Morean ME, 2010, ALCOHOL CLIN EXP RES, V34, P385, DOI 10.1111/j.1530-0277.2009.01103.x
   Naassila M, 2004, NEUROPHARMACOLOGY, V46, P243, DOI 10.1016/j.neuropharm.2003.09.002
   Naassila M, 2002, J NEUROSCI, V22, P10487
   Nagata H, 2009, HEPATOLOGY, V49, P1944, DOI 10.1002/hep.22860
   Newton PM, 2007, BEHAV NEUROSCI, V121, P439, DOI 10.1037/0735-7044.121.2.439
   Ng J, 2012, DEVELOPMENT, V139, P165, DOI 10.1242/dev.068668
   Nutt DJ, 2010, LANCET, V376, P1558, DOI 10.1016/S0140-6736(10)61462-6
   Offenhauser N, 2006, CELL, V127, P213, DOI 10.1016/j.cell.2006.09.011
   Palmer AA, 2004, PSYCHOPHARMACOLOGY, V176, P386, DOI 10.1007/s00213-004-1896-5
   Pascual M, 2003, J NEUROCHEM, V87, P1535, DOI 10.1046/j.1471-4159.2003.02130.x
   Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234
   Peng JS, 2009, J NEUROSCI, V29, P8408, DOI 10.1523/JNEUROSCI.0714-09.2009
   Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917
   Radwanska K, 2008, NEUROPSYCHOPHARMACOL, V33, P1835, DOI 10.1038/sj.npp.1301567
   Rallis A, 2010, DEV BIOL, V339, P65, DOI 10.1016/j.ydbio.2009.12.016
   Ren J, 2009, TOXICOL LETT, V187, P149, DOI 10.1016/j.toxlet.2009.02.019
   RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759
   Sahara N, 2008, EUR J NEUROSCI, V27, P2897, DOI 10.1111/j.1460-9568.2008.06258.x
   Sanchez-Alvarez L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002257
   SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184
   SEGER R, 1995, FASEB J, V9, P726
   Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745
   Srahna M, 2006, PLOS BIOL, V4, P2076, DOI 10.1371/journal.pbio.0040348
   Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016
   Takahama K, 2012, BIOCHEM BIOPH RES CO, V417, P807, DOI 10.1016/j.bbrc.2011.12.040
   Takamura M, 2007, LIFE SCI, V80, P1335, DOI 10.1016/j.lfs.2006.12.034
   Tao H, 2011, AM J HUM GENET, V88, P138, DOI 10.1016/j.ajhg.2010.12.012
   Tassi E, 1999, J BIOL CHEM, V274, P33287, DOI 10.1074/jbc.274.47.33287
   Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447
   Valles SL, 2004, BRAIN PATHOL, V14, P365
   Villegas SN, 2006, BRAIN RES BULL, V71, P116, DOI 10.1016/j.brainresbull.2006.08.014
   Wagle M, 2011, J NEUROSCI, V31, P214, DOI 10.1523/JNEUROSCI.3339-10.2011
   Wang JW, 2007, J NEUROSCI, V27, P574, DOI 10.1523/JNEUROSCI.5094-06.2007
   Weber U, 2000, DEVELOPMENT, V127, P3619
   Wetzel MK, 2008, NEURON, V59, P708, DOI 10.1016/j.neuron.2008.07.021
   Wilkinson MB, 2011, J NEUROSCI, V31, P9084, DOI 10.1523/JNEUROSCI.0039-11.2011
   Wolf FW, 2002, J NEUROSCI, V22, P11035
   Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005
   Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020
   Young CL, 2008, NEUROBIOL DIS, V31, P355, DOI 10.1016/j.nbd.2008.05.009
   Yustein JT, 2003, ONCOGENE, V22, P6129, DOI 10.1038/sj.onc.1206605
   Zihni C, 2006, J BIOL CHEM, V281, P7317, DOI 10.1074/jbc.M513769200
NR 97
TC 12
Z9 14
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 5
PY 2012
VL 7
IS 12
AR e50594
DI 10.1371/journal.pone.0050594
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 057TZ
UT WOS:000312588200049
PM 23227189
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Sepulchre, JA
   Merajver, SD
   Ventura, AC
AF Sepulchre, Jacques-Alexandre
   Merajver, Sofia D.
   Ventura, Alejandra C.
TI Retroactive Signaling in Short Signaling Pathways
SO PLOS ONE
LA English
DT Article
ID MODULAR CELL BIOLOGY; COVALENT MODIFICATION; CASCADE; PROTEIN; KINASE;
   MODEL; ULTRASENSITIVITY; SYSTEMS; TARGET
AB In biochemical signaling pathways without explicit feedback connections, the core signal transduction is usually described as a one-way communication, going from upstream to downstream in a feedforward chain or network of covalent modification cycles. In this paper we explore the possibility of a new type of signaling called retroactive signaling, offered by the recently demonstrated property of retroactivity in signaling cascades. The possibility of retroactive signaling is analysed in the simplest case of the stationary states of a bicyclic cascade of signaling cycles. In this case, we work out the conditions for which variables of the upstream cycle are affected by a change of the total amount of protein in the downstream cycle, or by a variation of the phosphatase deactivating the same protein. Particularly, we predict the characteristic ranges of the downstream protein, or of the downstream phosphatase, for which a retroactive effect can be observed on the upstream cycle variables. Next, we extend the possibility of retroactive signaling in short but nonlinear signaling pathways involving a few covalent modification cycles.
C1 [Sepulchre, Jacques-Alexandre] Univ Nice Sophia Antipolis, CNRS, UMR 7335, Inst Non Lineaire Nice, Valbonne, France.
   [Merajver, Sofia D.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.
   [Merajver, Sofia D.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.
   [Ventura, Alejandra C.] Univ Buenos Aires, CONICET, Inst Fisiol Biol Mol & Neurociencias, Buenos Aires, DF, Argentina.
   [Ventura, Alejandra C.] Univ Buenos Aires, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina.
RP Sepulchre, JA (reprint author), Univ Nice Sophia Antipolis, CNRS, UMR 7335, Inst Non Lineaire Nice, Valbonne, France.
EM jacques-alexandre.sepulchre@inln.cnrs.fr
FU Department of Defense Breast Cancer Research Program; Center for
   Computational Medicine and Bioinformatics (University of Michigan);
   Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina);
   Breast Cancer Research Foundation; international program of scientific
   collaboration [PICS 05922]
FX ACV is a member of the Carrera del Investigador Cientifico (CONICET) and
   was supported by the Department of Defense Breast Cancer Research
   Program, the Center for Computational Medicine and Bioinformatics
   (University of Michigan), and the Agencia Nacional de Promocion
   Cientifica y Tecnologica (Argentina). SDM receives funding from the
   Breast Cancer Research Foundation. The international program of
   scientific collaboration PICS 05922 between CNRS (France) and CONICET
   (Argentina) supported this work. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alexander R.P., 2009, SCI SIGNAL, V2, ppe44
   Anderson J, 2011, AUTOMATICA, V47, P1165, DOI 10.1016/j.automatica.2011.03.010
   ANDRIANANTOANDR.E, 2006, MOL SYST BIOL, V2
   Callis J, 2000, CURR OPIN PLANT BIOL, V3, P381, DOI 10.1016/S1369-5266(00)00100-X
   Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204
   Elion EA, 2005, SCIENCE, V307, P687, DOI 10.1126/science.1109500
   Feliu E, 2012, B MATH BIOL, V74, P45, DOI 10.1007/s11538-011-9658-0
   Franco E, 2009, IEEE DECIS CONTR P, P4584, DOI 10.1109/CDC.2009.5400523
   GOLDBETER A, 1991, P NATL ACAD SCI USA, V88, P9107, DOI 10.1073/pnas.88.20.9107
   GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840
   Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540
   Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078
   Jiang P., 2011, SCI SIGNAL, V4
   Kim Y, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.121
   Kim Y, 2010, CURR BIOL, V20, P446, DOI 10.1016/j.cub.2010.01.019
   Kumar N, 2008, MOL PHARMACOL, V73, P1668, DOI 10.1124/mol.107.043794
   Nelson D.L., 2004, LEHNINGER PRINCIPLES
   Ossareh HR, 2011, BIOPHYS J, V100, P1617, DOI 10.1016/j.bpj.2011.02.014
   Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184
   SEGER R, 1995, FASEB J, V9, P726
   Soyer OS, 2009, FEBS J, V276, P3290, DOI 10.1111/j.1742-4658.2009.07054.x
   Ventura AC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000041
   Ventura AC, 2010, P NATL ACAD SCI USA, V107, P10032, DOI 10.1073/pnas.0913815107
   Wynn ML, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-156
   Zumsande M, 2010, J THEOR BIOL, V265, P481, DOI 10.1016/j.jtbi.2010.04.025
NR 25
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 26
PY 2012
VL 7
IS 7
AR e40806
DI 10.1371/journal.pone.0040806
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 012MO
UT WOS:000309240600010
PM 22848403
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Ma, J
   Cui, W
   He, SM
   Duan, YH
   Heng, LJ
   Wang, L
   Gao, GD
AF Ma, Jie
   Cui, Wei
   He, Shi-ming
   Duan, Yong-hong
   Heng, Li-jun
   Wang, Liang
   Gao, Guo-dong
TI Human U87 Astrocytoma Cell Invasion Induced by Interaction of beta ig-h3
   with Integrin alpha 5 beta 1 Involves Calpain-2
SO PLOS ONE
LA English
DT Article
ID INDUCIBLE GENE-H3 BETA-IG-H3; GROWTH-FACTOR-BETA; ALPHA(5)BETA(1)
   INTEGRIN; ALPHA-3-BETA-1 INTEGRIN; EXTRACELLULAR-MATRIX; IN-VITRO;
   TGF-BETA; ADHESION; GLIOMA; MIGRATION
AB It is known that beta ig-h3 is involved in the invasive process of many types of tumors, but its mechanism in glioma cells has not been fully clarified. Using immunofluorescent double-staining and confocal imaging analysis, and co-immunoprecipitation assays, we found that beta ig-h3 co-localized with integrin alpha 5 beta 1 in U87 cells. We sought to elucidate the function of this interaction by performing cell invasion assays and gelatin zymography experiments. We found that siRNA knockdowns of beta ig-h3 and calpain-2 impaired cell invasion and MMP secretion. Moreover, beta ig-h3, integrins and calpain-2 are known to be regulated by Ca2+, and they are also involved in tumor cell invasion. Therefore, we further investigated if calpain-2 was relevant to beta ig-h3-integrin alpha 5 beta 1 interaction to affect U87 cell invasion. Our data showed that beta ig-h3 co-localized with integrin alpha 5 beta 1 to enhance the invasion of U87 cells, and that calpain-2, is involved in this process, acting as a downstream molecule.
C1 [Ma, Jie; He, Shi-ming; Heng, Li-jun; Wang, Liang; Gao, Guo-dong] Forth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian, Peoples R China.
   [Cui, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol & Metab, Xian 710032, Peoples R China.
   [Duan, Yong-hong] Chinese Peoples Liberat Army, Hosp 451, Dept Orthopaed Surg, Xian, Peoples R China.
RP Ma, J (reprint author), Forth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian, Peoples R China.
EM neurogao@163.com
FU National Natural Science Foundation of China [31070940]
FX This work is supported by National Natural Science Foundation of China
   (31070940). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Bae JS, 2002, BIOCHEM BIOPH RES CO, V294, P940, DOI 10.1016/S0006-291X(02)00576-4
   Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6
   Carragher NO, 2002, INT J BIOCHEM CELL B, V34, P1539, DOI 10.1016/S1357-2725(02)00069-9
   Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028
   D'Abaco GM, 2007, J CLIN NEUROSCI, V14, P1041, DOI 10.1016/j.jocn.2007.06.019
   Dai JY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-337
   Delamarre E, 2009, AM J PATHOL, V175, P844, DOI 10.2353/ajpath.2009.080920
   Farber K, 2008, MOL CELL NEUROSCI, V39, P579, DOI 10.1016/j.mcn.2008.08.005
   Fan DG, 2009, CELL BIOL INT, V33, P1263, DOI 10.1016/j.cellbi.2009.08.014
   GAO JX, 1995, CELL IMMUNOL, V163, P178, DOI 10.1006/cimm.1995.1114
   Gibson RM, 2005, MOL CELL NEUROSCI, V28, P588, DOI 10.1016/j.mcn.2004.11.004
   Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002
   Guo YS, 2011, CELL BIOL INT, V35, P811, DOI 10.1042/CBI20100916
   Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481
   Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4
   Jang HS, 2010, NEUROCHEM RES, V35, P1796, DOI 10.1007/s11064-010-0246-8
   Kawataki T, 2007, EXP CELL RES, V313, P3819, DOI 10.1016/j.yexcr.2007.07.038
   Kim KW, 2009, NEUROCHEM RES, V34, P1479, DOI 10.1007/s11064-009-9935-6
   Kim MO, 2003, NEUROSCI LETT, V336, P93, DOI 10.1016/S0304-3940(02)01260-0
   Kita D, 2001, CANCER RES, V61, P7985
   Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008
   Martin S, 2009, BBA-MOL CELL RES, V1793, P354, DOI 10.1016/j.bbamcr.2008.09.019
   Meng XB, 2004, J PROTEOME RES, V3, P506, DOI 10.1021/pr0340983
   PACHTER JA, 1995, ANAL BIOCHEM, V230, P101, DOI 10.1006/abio.1995.1443
   Roumes H, 2010, EXP CELL RES, V316, P1587, DOI 10.1016/j.yexcr.2010.02.017
   Sawhney RS, 2006, J BIOL CHEM, V281, P8497, DOI 10.1074/jbc.M600787200
   SEGER R, 1995, FASEB J, V9, P726
   SKONIER J, 1992, DNA CELL BIOL, V11, P511, DOI 10.1089/dna.1992.11.511
   Tang J, 2008, CELL MOL LIFE SCI, V65, P2933, DOI 10.1007/s00018-008-8315-8
   Tang J, 2009, EXP BIOL MED, V234, P35, DOI 10.3181/0806-RM-187
   Thapa N, 2005, BONE, V36, P232, DOI 10.1016/j.bone.2004.08.007
   Thapa N, 2007, INT J BIOCHEM CELL B, V39, P2183, DOI 10.1016/j.biocel.2007.06.004
   Tsubokawa T, 2006, STROKE, V37, P1888, DOI 10.1161/01.STR.0000227259.15506.24
   Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069
   WAYNER EA, 1988, J CELL BIOL, V107, P1881, DOI 10.1083/jcb.107.5.1881
   Wu HY, 2007, ACTA MED OKAYAMA, V61, P123
   Yun SJ, 2002, MOL BRAIN RES, V107, P57, DOI 10.1016/S0169-328X(02)00447-3
   Zeng BX, 2007, J REPROD IMMUNOL, V73, P1, DOI 10.1016/j.jri.2006.05.007
NR 38
TC 15
Z9 15
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 21
PY 2012
VL 7
IS 5
AR e37297
DI 10.1371/journal.pone.0037297
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959VD
UT WOS:000305343100021
PM 22629380
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Liang, QH
   Jiang, Y
   Zhu, X
   Cui, RR
   Liu, GY
   Liu, Y
   Wu, SS
   Liao, XB
   Xie, H
   Zhou, HD
   Wu, XP
   Yuan, LQ
   Liao, EY
AF Liang, Qiu-Hua
   Jiang, Yi
   Zhu, Xiao
   Cui, Rong-Rong
   Liu, Guan-Ying
   Liu, Yuan
   Wu, Shan-Shan
   Liao, Xiao-Bo
   Xie, Hui
   Zhou, Hou-De
   Wu, Xian-Ping
   Yuan, Ling-Qing
   Liao, Er-Yuan
TI Ghrelin Attenuates the Osteoblastic Differentiation of Vascular Smooth
   Muscle Cells through the ERK Pathway
SO PLOS ONE
LA English
DT Article
ID IN-VITRO; ARTERIAL CALCIFICATION; ACYLATED PEPTIDE; HORMONE; MECHANISMS;
   VIVO; IDENTIFICATION; PROLIFERATION; EXPRESSION; PITUITARY
AB Vascular calcification results from osteoblastic differentiation of vascular smooth muscle cells (VSMCs) and is a major risk factor for cardiovascular events. Ghrelin is a newly discovered bioactive peptide that acts as a natural endogenous ligand of the growth hormone secretagog receptor (GHSR). Several studies have identified the protective effects of ghrelin on the cardiovascular system, however research on the effects and mechanisms of ghrelin on vascular calcification is still quite rare. In this study, we determined the effect of ghrelin on osteoblastic differentiation of VSMCs and investigated the mechanism involved using the two universally accepted calcifying models of calcifying vascular smooth muscle cells (CVSMCs) and beta-glycerophosphate (beta-GP)-induced VSMCs. Our data demonstrated that ghrelin inhibits osteoblastic differentiation and mineralization of VSMCs due to decreased alkaline phosphatase (ALP) activity, Runx2 expression, bone morphogenetic protein-2 (BMP-2) expression and calcium content. Further study demonstrated that ghrelin exerted this suppression effect via an extracellular signal-related kinase (ERK)-dependent pathway and that the suppression effect of ghrelin was time dependent and dose dependent. Furthermore, inhibition of the growth hormone secretagog receptor (GHSR), the ghrelin receptor, by siRNA significantly reversed the activation of ERK by ghrelin. In conclusion, our study suggests that ghrelin may inhibit osteoblastic differentiation of VSMCs through the GHSR/ERK pathway.
C1 [Liang, Qiu-Hua; Zhu, Xiao; Cui, Rong-Rong; Liu, Guan-Ying; Liu, Yuan; Wu, Shan-Shan; Xie, Hui; Zhou, Hou-De; Wu, Xian-Ping; Yuan, Ling-Qing; Liao, Er-Yuan] Cent S Univ, Xiang Ya Hosp 2, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China.
   [Jiang, Yi] Cent S Univ, Xiang Ya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China.
   [Cui, Rong-Rong] Cent S Univ, Xiang Ya Hosp 2, Dept Pediat, Changsha, Hunan, Peoples R China.
   [Liao, Xiao-Bo] Cent S Univ, Xiang Ya Hosp 2, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China.
RP Yuan, LQ (reprint author), Cent S Univ, Xiang Ya Hosp 2, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China.
EM allenylq@hotmail.com; eyliao007@yahoo.com.cn
OI Zhou, Hou-De/0000-0001-9131-4141
FU National Natural Science Foundation of China [30801174, 30900622,
   81070246, 81000313]; Ministry of Education of the People's Republic of
   China [078202042]; Central South University
FX This work was supported by funding from The National Natural Science
   Foundation of China (No. 30801174, 30900622, 81070246 and 81000313).
   Scholarship Award for Excellent Doctoral Student granted by Ministry of
   Education of the People's Republic of China (078202042); Excellent
   Doctoral Dissertation of training support program of Central South
   University. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42
   Alexander MY, 2005, ARTERIOSCL THROM VAS, V25, P1851, DOI 10.1161/01.ATV.0000175750.94742.46
   Bing HT, 2006, J CELL BIOCHEM, V99, P1343, DOI 10.1002/jcb.20999
   Bostrom K, 2001, AM J CARDIOL, V88, p20E
   Byon CH, 2011, ARTERIOSCL THROM VAS, V31, P1387, DOI 10.1161/ATVBAHA.110.222547
   Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255
   Doherty TM, 2002, FASEB J, V16, DOI 10.1096/fj.01-0898hyp
   Fukushima N, 2005, J BONE MINER RES, V20, P790, DOI 10.1359/JBMR.041237
   Granata R, 2010, J MOL ENDOCRINOL, V45, P107, DOI 10.1677/JME-10-0019
   Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974
   Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c
   Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21
   Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105
   Kim SW, 2009, J CELL BIOCHEM, V106, P626, DOI 10.1002/jcb.22042
   Kim SW, 2005, BONE, V37, P359, DOI 10.1016/j.bone.2005.04.020
   Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230
   Li GZ, 2005, REGUL PEPTIDES, V129, P167, DOI 10.1016/j.regpep.2005.02.015
   Liao XB, 2008, AMINO ACIDS, V34, P525, DOI 10.1007/s00726-007-0003-8
   Liao XB, 2010, AMINO ACIDS, V39, P375, DOI 10.1007/s00726-009-0448-z
   Liu HM, 2010, J CELL BIOCHEM, V111, P1556, DOI 10.1002/jcb.22887
   Luo XH, 2009, J BONE MINER RES, V24, P1461, DOI [10.1359/JBMR.090227, 10.1359/jbmr.090227]
   McKee KK, 1997, MOL ENDOCRINOL, V11, P415, DOI 10.1210/me.11.4.415
   Nakahara T, 2010, BIOCHEM BIOPH RES CO, V394, P243, DOI 10.1016/j.bbrc.2009.11.038
   Oikawa Y, 2011, CELL RES, V21, P1578, DOI 10.1038/cr.2011.90
   Papotti M, 2000, J CLIN ENDOCR METAB, V85, P3803, DOI 10.1210/jc.85.10.3803
   Radcliff K, 2005, CIRC RES, V96, P398, DOI 10.1161/01.RES.0000159671.47477.71
   SEGER R, 1995, FASEB J, V9, P726
   Shan PF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017938
   Shao JS, 2006, ARTERIOSCL THROM VAS, V26, P1423, DOI 10.1161/01.ATV.0000220441.42041.20
   Shi YL, 2009, J CELL BIOCHEM, V108, P1184, DOI 10.1002/jcb.22348
   Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070
   Tanaka T, 2008, MOL CELL BIOL, V28, P1147, DOI 10.1128/MCB.01771-07
   Xie H, 2011, CARDIOVASC RES
   Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017
   Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705
   Zhang GG, 2010, CURR CARDIOL REV, V6, P62, DOI 10.2174/157340310790231662
NR 36
TC 38
Z9 43
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 13
PY 2012
VL 7
IS 4
AR e33126
DI 10.1371/journal.pone.0033126
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959UT
UT WOS:000305341600008
PM 22514603
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Popic, J
   Pesic, V
   Milanovic, D
   Todorovic, S
   Kanazir, S
   Jevtovic-Todorovic, V
   Ruzdijic, S
AF Popic, Jelena
   Pesic, Vesna
   Milanovic, Desanka
   Todorovic, Smilja
   Kanazir, Selma
   Jevtovic-Todorovic, Vesna
   Ruzdijic, Sabera
TI Propofol-Induced Changes in Neurotrophic Signaling in the Developing
   Nervous System In Vivo
SO PLOS ONE
LA English
DT Article
ID PROTEIN-KINASE-B; DEVELOPING RAT-BRAIN; GABA(A) RECEPTOR; INDUCED
   DIFFERENTIATION; SYMPATHETIC NEURONS; CELL-DEATH; PHOSPHORYLATION;
   ACTIVATION; ERK; TRANSCRIPTION
AB Several studies have revealed a role for neurotrophins in anesthesia-induced neurotoxicity in the developing brain. In this study we monitored the spatial and temporal expression of neurotrophic signaling molecules in the brain of 14-day-old (PND14) Wistar rats after the application of a single propofol dose (25 mg/kg i.p). The structures of interest were the cortex and thalamus as the primary areas of anesthetic actions. Changes of the protein levels of the brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), their activated receptors tropomyosin-related kinase (TrkA and TrkB) and downstream kinases Akt and the extracellular signal regulated kinase (ERK) were assessed by Western immunoblot analysis at different time points during the first 24 h after the treatment, as well as the expression of cleaved caspase-3 fragment. Fluoro-Jade B staining was used to follow the appearance of degenerating neurons. The obtained results show that the treatment caused marked alterations in levels of the examined neurotrophins, their receptors and downstream effector kinases. However, these changes were not associated with increased neurodegeneration in either the cortex or the thalamus. These results indicate that in the brain of PND14 rats, the interaction between Akt/ERK signaling might be one of important part of endogenous defense mechanisms, which the developing brain utilizes to protect itself from potential anesthesia-induced damage. Elucidation of the underlying molecular mechanisms will improve our understanding of the age-dependent component of anesthesia-induced neurotoxicity.
C1 [Popic, Jelena; Pesic, Vesna; Milanovic, Desanka; Todorovic, Smilja; Kanazir, Selma; Ruzdijic, Sabera] Univ Belgrade, Inst Biol Res, Dept Neurobiol, Belgrade, Serbia.
   [Milanovic, Desanka; Jevtovic-Todorovic, Vesna] Univ Virginia Hlth Syst, Dept Anesthesiol, Charlottesville, VA USA.
RP Popic, J (reprint author), Univ Belgrade, Inst Biol Res, Dept Neurobiol, Belgrade, Serbia.
EM sabir@ibiss.bg.ac.rs
RI Kanazir, Selma/E-5495-2015
OI Kanazir, Selma/0000-0002-7229-5296; Pesic, Vesna/0000-0002-1415-5834;
   Popic, Jelena/0000-0002-0959-3856
FU Ministry of Education and Science of the Republic of Serbia [ON173056]
FX This work was suported by grant no. ON173056 from the Ministry of
   Education and Science of the Republic of Serbia. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x
   Altar CA, 1998, TRENDS NEUROSCI, V21, P433, DOI 10.1016/S0166-2236(98)01273-9
   BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107
   Ben-Ari Y, 2010, TRENDS NEUROSCI, V33, P485, DOI 10.1016/j.tins.2010.08.005
   Bjornstrom K, 2008, J PHYSIOL PHARMACOL, V59, P617
   Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004
   Briner A, 2010, ANESTHESIOLOGY, V112, P546, DOI 10.1097/ALN.0b013e3181cd7942
   Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318
   CHEUNG EC, 2004, SCI STKE, V251, pPE45
   CURTIS R, 1995, NEURON, V14, P1201, DOI 10.1016/0896-6273(95)90267-8
   DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7
   Dolcet X, 1999, J NEUROCHEM, V73, P521, DOI 10.1046/j.1471-4159.1999.0730521.x
   Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231
   Engelhard K, 2004, ANESTHESIOLOGY, V101, P912, DOI 10.1097/00000542-200410000-00016
   Fredriksson A, 2007, ANESTHESIOLOGY, V107, P427, DOI 10.1097/01.anes.0000278892.62305.9c
   Galetic I, 2003, J BIOL CHEM, V278, P4416, DOI 10.1074/jbc.M210578200
   Gilman CP, 2002, NEUROMOL MED, V2, P197, DOI 10.1385/NMM:2:2:197
   Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0
   Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887
   HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5
   Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677
   JENSEN AG, 1994, ANESTHESIOLOGY, V81, P1220, DOI 10.1097/00000542-199411000-00016
   Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1
   Kidambi Srivatsan, 2010, BMC Res Notes, V3, P201, DOI 10.1186/1756-0500-3-201
   Kozinn J, 2006, ANESTHESIOLOGY, V105, P1182, DOI 10.1097/00000542-200612000-00018
   Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371
   Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445
   Liao Y, 2010, AM J TRANSL RES, V2, P19
   Lu LX, 2006, APOPTOSIS, V11, P1603, DOI 10.1007/s10495-006-8762-3
   Lu S, 2011, TOXICOLOGY, V279, P189, DOI 10.1016/j.tox.2010.10.011
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   Marik PE, 2004, CURR PHARM DESIGN, V10, P3639, DOI 10.2174/1381612043382846
   Muller DL, 2004, J PHARMACOL EXP THER, V310, P774, DOI 10.1124/jpet.104.066548
   Nakao S, 2003, ACTA ANAESTH SCAND, V47, P284, DOI 10.1034/j.1399-6576.2003.00040.x
   Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6
   Oscarsson A, 2007, ACTA ANAESTH SCAND, V51, P1184, DOI 10.1111/j.1399-6576.2007.01388.x
   Pesic V, 2009, INT J DEV NEUROSCI, V27, P279, DOI 10.1016/j.ijdevneu.2008.12.005
   Ponten E, 2011, BEHAV BRAIN RES, V223, P75, DOI 10.1016/j.bbr.2011.04.019
   QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A
   Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004
   Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097
   Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6
   Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738
   SEGER R, 1995, FASEB J, V9, P726
   Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7
   Tsui-Pierchala BA, 1999, J NEUROSCI, V19, P8207
   Turina D, 2008, BRIT J ANAESTH, V101, P374, DOI 10.1093/bja/aen185
   Varju P, 2001, CELL TISSUE RES, V305, P239, DOI 10.1007/s004410100356
   Vutskits L, 2005, ANESTHESIOLOGY, V102, P970, DOI 10.1097/00000542-200505000-00016
   Wang C, 2002, DEV BRAIN RES, V139, P59, DOI 10.1016/S0165-3806(02)00536-9
   Watson FL, 1999, J NEUROSCI, V19, P7887
   Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6
   Yon JH, 2005, NEUROSCIENCE, V135, P815, DOI 10.1016/j.euroscience.2005.03.064
   Zhang YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027019
   Zhang YZ, 2000, J NEUROSCI, V20, P5671
NR 55
TC 38
Z9 39
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 4
PY 2012
VL 7
IS 4
AR e34396
DI 10.1371/journal.pone.0034396
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 953GO
UT WOS:000304855200046
PM 22496799
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Asano, E
   Maeda, M
   Hasegawa, H
   Ito, S
   Hyodo, T
   Yuan, H
   Takahashi, M
   Hamaguchi, M
   Senga, T
AF Asano, Eri
   Maeda, Masao
   Hasegawa, Hitoki
   Ito, Satoko
   Hyodo, Toshinori
   Yuan, Hong
   Takahashi, Masahide
   Hamaguchi, Michinari
   Senga, Takeshi
TI Role of Palladin Phosphorylation by Extracellular Signal-Regulated
   Kinase in Cell Migration
SO PLOS ONE
LA English
DT Article
ID EPIDERMAL-GROWTH-FACTOR; CROSS-LINKING PROTEIN; ACTIN ORGANIZATION;
   BINDING PARTNER; ALPHA-ACTININ; SH3 DOMAINS; V-SRC; ADHESION; MOTILITY;
   ERK
AB Phosphorylation of actin-binding proteins plays a pivotal role in the remodeling of the actin cytoskeleton to regulate cell migration. Palladin is an actin-binding protein that is phosphorylated by growth factor stimulation; however, the identity of the involved protein kinases remains elusive. In this study, we report that palladin is a novel substrate of extracellular signal-regulated kinase (ERK). Suppression of ERK activation by a chemical inhibitor reduced palladin phosphorylation, and expression of active MEK alone was sufficient for phosphorylation. In addition, an in vitro kinase assay demonstrated direct palladin phosphorylation by ERK. We found that Ser77 and Ser197 are essential residues for phosphorylation. Although the phosphorylation of these residues was not required for actin cytoskeletal organization, we found that expression of non-phosphorylated palladin enhanced cell migration. Finally, we show that phosphorylation inhibits the palladin association with Abl tyrosine kinase. Taken together, our results indicate that palladin phosphorylation by ERK has an anti-migratory function, possibly by modulating interactions with molecules that regulate cell migration.
C1 [Asano, Eri; Hasegawa, Hitoki; Ito, Satoko; Hyodo, Toshinori; Hamaguchi, Michinari; Senga, Takeshi] Nagoya Univ, Grad Sch Med, Div Canc Biol, Nagoya, Aichi 4648601, Japan.
   [Maeda, Masao] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi 4648601, Japan.
   [Yuan, Hong] Nagoya Univ, Grad Sch Med, Dept Obstet & Gynecol, Nagoya, Aichi 4648601, Japan.
   [Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Dept Pathol, Nagoya, Aichi 4648601, Japan.
RP Asano, E (reprint author), Nagoya Univ, Grad Sch Med, Div Canc Biol, Nagoya, Aichi 4648601, Japan.
EM tsenga@med.nagoya-u.ac.jp
RI TAKAHASHI, Masahide/I-7244-2014; MAEDA, Masao/P-2709-2015
OI Maeda, Masao/0000-0001-5936-5790
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
FX The work was supported by a grant from the Ministry of Education,
   Culture, Sports, Science and Technology of Japan. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript. No additional external funding was
   received for this study.
CR Boukhelifa M, 2006, FEBS J, V273, P26, DOI 10.1111/j.1742-4658.2005.05036.x
   Boukhelifa M, 2004, CELL MOTIL CYTOSKEL, V58, P17, DOI 10.1002/cm.10173
   Boukhelifa M, 2003, MOL CELL NEUROSCI, V23, P661, DOI 10.1016/S1044-7431(03)00127-1
   Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031
   Clarke DM, 2004, J CELL BIOL, V166, P901, DOI 10.1083/jcb.200404024
   Dixon RDS, 2008, J BIOL CHEM, V283, P6222, DOI 10.1074/jbc.M707694200
   Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911
   Goicoechea SM, 2009, ONCOGENE, V28, P587, DOI 10.1038/onc.2008.408
   Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076
   Goicoechea SM, 2008, EUR J CELL BIOL, V87, P517, DOI 10.1016/j.ejcb.2008.01.010
   Han MY, 2007, MOL CELL BIOL, V27, P8190, DOI 10.1128/MCB.00661-07
   Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481
   Hunger-Glaser I, 2003, J BIOL CHEM, V278, P22631, DOI 10.1074/jbc.M210876200
   Ito S, 2010, MOL BIOL CELL, V21, P4120, DOI 10.1091/mbc.E10-05-0459
   Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682
   Kurata H, 2000, EXP CELL RES, V254, P180, DOI 10.1006/excr.1999.4738
   Liu XS, 2007, J CELL BIOCHEM, V100, P1288, DOI 10.1002/jcb.21126
   Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200
   Luo HJ, 2005, MOL CELL NEUROSCI, V29, P507, DOI 10.1016/j.mcn.2004.12.002
   Maeda M, 2009, FEBS J, V276, P2775, DOI 10.1111/j.1742-4658.2009.07001.x
   Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288
   Mitsushima M, 2004, J BIOL CHEM, V279, P34570, DOI 10.1074/jbc.M402304200
   Mykkanen OM, 2001, MOL BIOL CELL, V12, P3060, DOI 10.1091/mbc.12.10.3060
   Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149
   Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584
   Otey CA, 2005, INT REV CYTOL, V246, P31, DOI 10.1016/S0074-7696(05)46002-7
   Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643
   PAWSON T, 1994, ADV CANCER RES, V64, P87, DOI 10.1016/S0065-230X(08)60835-0
   Porter AC, 1998, ONCOGENE, V17, P1343, DOI 10.1038/sj.onc.1202171
   Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825
   Ronty M, 2005, EXP CELL RES, V310, P88, DOI 10.1016/j.yexcr.2005.06.026
   Ronty M, 2004, FEBS LETT, V566, P30, DOI 10.1061/j.febslet.2004.04.006
   Ronty M, 2007, EXP CELL RES, V313, P2575, DOI 10.1016/j.yexcr.2007.04.030
   SEGER R, 1995, FASEB J, V9, P726
   Senga T, 2000, ONCOGENE, V19, P273, DOI 10.1038/sj.onc.1203296
   Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200
   Taieb D, 2008, CANCER RES, V68, P4588, DOI 10.1158/0008-5472.CAN-08-0958
   Yamasaki Y, 2007, BIOCHEM BIOPH RES CO, V361, P7, DOI 10.1016/j.bbrc.2007.06.159
   Zhang X, CELL MOL BIOL LETT, V16, P279
NR 39
TC 12
Z9 12
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 28
PY 2011
VL 6
IS 12
AR e29338
DI 10.1371/journal.pone.0029338
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 897SK
UT WOS:000300676300048
PM 22216253
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Kuo, MW
   Wang, CH
   Wu, HC
   Chang, SJ
   Chuang, YJ
AF Kuo, Meng-Wei
   Wang, Chian-Huei
   Wu, Hsiao-Chun
   Chang, Shing-Jyh
   Chuang, Yung-Jen
TI Soluble THSD7A Is an N-Glycoprotein That Promotes Endothelial Cell
   Migration and Tube Formation in Angiogenesis
SO PLOS ONE
LA English
DT Article
ID FOCAL ADHESION KINASE; P38 MAP KINASE; ACTIVATED PROTEIN-KINASE;
   LATENT-TGF-BETA; GROWTH-FACTOR; SIGNAL-TRANSDUCTION; TIP CELLS; VEGF-C;
   THROMBOSPONDIN; INTEGRINS
AB Background: Thrombospondin type I domain containing 7A (THSD7A) is a novel neural protein that is known to affect endothelial migration and vascular patterning during development. To further understand the role of THSD7A in angiogenesis, we investigated the post-translational modification scheme of THS7DA and to reveal the underlying mechanisms by which this protein regulates blood vessel growth.
   Methodology/Principal Findings: Full-length THSD7A was overexpressed in human embryonic kidney 293T (HEK293T) cells and was found to be membrane associated and N-glycosylated. The soluble form of THSD7A, which is released into the cultured medium, was harvested for further angiogenic assays. We found that soluble THSD7A promotes human umbilical vein endothelial cell (HUVEC) migration and tube formation. HUVEC sprouts and zebrafish subintestinal vessel (SIV) angiogenic assays further revealed that soluble THSD7A increases the number of branching points of new vessels. Interestingly, we found that soluble THSD7A increased the formation of filopodia in HUVEC. The distribution patterns of vinculin and phosphorylated focal adhesion kinase (FAK) were also affected, which implies a role for THSD7A in focal adhesion assembly. Moreover, soluble THSD7A increased FAK phosphorylation in HUVEC, suggesting that THSD7A is involved in regulating cytoskeleton reorganization.
   Conclusions/Significance: Taken together, our results indicate that THSD7A is a membrane-associated N-glycoprotein with a soluble form. Soluble THSD7A promotes endothelial cell migration during angiogenesis via a FAK-dependent mechanism and thus may be a novel neuroangiogenic factor.
C1 [Kuo, Meng-Wei; Wang, Chian-Huei; Wu, Hsiao-Chun; Chuang, Yung-Jen] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan.
   [Kuo, Meng-Wei; Wang, Chian-Huei; Wu, Hsiao-Chun; Chuang, Yung-Jen] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.
   [Chang, Shing-Jyh] Hsinchu Mackay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan.
RP Kuo, MW (reprint author), Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan.
EM yjchuang@life.nthu.edu.tw
RI Chuang, Yung-Jen/D-2362-2013; Xiao, Yang/B-5668-2012
OI Chuang, Yung-Jen/0000-0002-6022-0107
FU National Science Council, Taiwan [NSC 98-2311-B-007-012-MY3]; Taiwan
   Zebrafish Core Facility at NTHU; NHRI
FX This work was supported by the National Science Council, Taiwan (NSC
   98-2311-B-007-012-MY3 to YJC). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.; We thank the Taiwan Zebrafish Core Facility at NTHU and
   NHRI for providing critical experimental materials and instrumentation
   support for this study.
CR Adams JC, 2000, DEV DYNAM, V218, P280
   Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183
   Benest AV, 2008, CARDIOVASC RES, V78, P315, DOI 10.1093/cvr/cvm094
   Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184
   Davis GE, 2006, J INVEST DERM SYMP P, V11, P44, DOI 10.1038/sj.jidsymp.5650008
   De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165
   Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405
   Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904
   Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047
   GUO NH, 1992, P NATL ACAD SCI USA, V89, P3040, DOI 10.1073/pnas.89.7.3040
   Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211
   Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571
   Hodivala-Dilke KM, 2003, CELL TISSUE RES, V314, P131, DOI 10.1007/s00441-003-0774-5
   Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3
   Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727
   Horowitz A, 2008, CIRC RES, V103, P784, DOI 10.1161/CIRCRESAHA.108.181818
   Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481
   Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103
   Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898
   Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481
   Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e
   Lawrence DA, 2001, MOL CELL BIOCHEM, V219, P163, DOI 10.1023/A:1010819716023
   Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080
   Masson-Gadais B, 2003, CELL STRESS CHAPERON, V8, P37, DOI 10.1379/1466-1268(2003)8<37:IVRFVA>2.0.CO;2
   Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406
   McLaughlin MM, 1996, J BIOL CHEM, V271, P8488, DOI 10.1074/jbc.271.14.8488
   Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83
   Munoz-Chapuli R, 2004, CELL MOL LIFE SCI, V61, P2224, DOI 10.1007/s00018-004-4070-7
   Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5
   Nicoli S, 2009, J CELL MOL MED, V13, P2061, DOI 10.1111/j.1582-4934.2008.00432.x
   Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6
   Park JA, 2003, BIOCHEM BIOPH RES CO, V311, P247, DOI 10.1016/j.bbrc.2003.09.129
   Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877
   Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373
   Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0
   Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380
   Roy RS, 2010, P NATL ACAD SCI USA, V107, P13608, DOI 10.1073/pnas.1006007107
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   SEGER R, 1995, FASEB J, V9, P726
   Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052
   Sieg DJ, 2000, NAT CELL BIOL, V2, P249
   Silva R, 2008, ARTERIOSCL THROM VAS, V28, P1703, DOI 10.1161/ATVBAHA.108.172015
   SIPES JM, 1993, J CELL BIOL, V121, P469, DOI 10.1083/jcb.121.2.469
   Sipes JM, 1999, J BIOL CHEM, V274, P22755, DOI 10.1074/jbc.274.32.22755
   Somanath PR, 2009, ANGIOGENESIS, V12, P177, DOI 10.1007/s10456-009-9141-9
   Stratman AN, 2011, BLOOD, V117, P3709, DOI 10.1182/blood-2010-11-316752
   Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104
   Tangkijvanich P, 2002, J CELL PHYSIOL, V191, P351, DOI 10.1002/jcp.10112
   Vainionpaa N, 2006, AM J PHYSIOL-CELL PH, V290, pC764, DOI 10.1152/ajpcell.00285.2005
   Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8
   Wang CH, 2011, DEV DYNAM, V240, P1412, DOI 10.1002/dvdy.22641
   Wang CH, 2010, J CELL PHYSIOL, V222, P685, DOI 10.1002/jcp.21990
   Young GD, 2004, J BIOL CHEM, V279, P47633, DOI 10.1074/jbc.M404918200
NR 53
TC 26
Z9 30
U1 0
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 14
PY 2011
VL 6
IS 12
AR e29000
DI 10.1371/journal.pone.0029000
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 866GS
UT WOS:000298369100137
PM 22194972
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Lee, H
   Park, MT
   Choi, BH
   Oh, ET
   Song, MJ
   Lee, J
   Kim, C
   Lim, BU
   Park, HJ
AF Lee, Hyemi
   Park, Moon-Taek
   Choi, Bo-Hwa
   Oh, Eun-Taex
   Song, Min-Jeong
   Lee, Jeonghun
   Kim, Chulhee
   Lim, Byung Uk
   Park, Heon Joo
TI Endoplasmic Reticulum Stress-Induced JNK Activation Is a Critical Event
   Leading to Mitochondria-Mediated Cell Death Caused by beta-Lapachone
   Treatment
SO PLOS ONE
LA English
DT Article
ID UNFOLDED PROTEIN RESPONSE; BREAST-CANCER CELLS; INDUCED APOPTOSIS;
   IONIZING-RADIATION; CYTOCHROME-C; MAP KINASES; CLEAVAGE; BAX; BCL-2; ERK
AB Background: beta-lapachone (beta-lap) is a bioreductive agent that is activated by the two-electron reductase NAD(P)H quinone oxidoreductase 1 (NQO1). Although beta-lap has been reported to induce apoptosis in various cancer types in an NQO1-dependent manner, the signaling pathways by which beta-lap causes apoptosis are poorly understood.
   Methodology/Principal Findings: beta-lap-induced apoptosis and related molecular signaling pathways in NQO1-negative and NQO1-overexpressing MDA-MB-231 cells were investigated. Pharmacological inhibitors or siRNAs against factors involved in beta-lap-induced apoptosis were used to clarify the roles played by such factors in beta-lap-activated apoptotic signaling pathways. beta-lap leads to clonogenic cell death and apoptosis in an NQO1-dependent manner. Treatment of NQO1-overexpressing MDA-MB-231 cells with beta-lap causes rapid disruption of mitochondrial membrane potential, nuclear translocation of AIF and Endo G from mitochondria, and subsequent caspase-independent apoptotic cell death. siRNAs targeting AIF and Endo G effectively attenuate beta-lap-induced clonogenic and apoptotic cell death. Moreover, beta-lap induces cleavage of Bax, which accumulates in mitochondria, coinciding with the observed changes in mitochondria membrane potential. Pretreatment with Salubrinal (Sal), an endoplasmic reticulum (ER) stress inhibitor, efficiently attenuates JNK activation caused by beta-lap, and subsequent mitochondria-mediated cell death. In addition, beta-lap-induced generation and mitochondrial translocation of cleaved Bax are efficiently blocked by JNK inhibition.
   Conclusions/Significance: Our results indicate that b-lap triggers induction of endoplasmic reticulum (ER) stress, thereby leading to JNK activation and mitochondria-mediated apoptosis. The signaling pathways that we revealed in this study may significantly contribute to an improvement of NQO1-directed tumor therapies.
C1 [Lee, Hyemi; Park, Moon-Taek; Choi, Bo-Hwa; Oh, Eun-Taex; Song, Min-Jeong; Lim, Byung Uk; Park, Heon Joo] Inha Univ, Ctr Adv Med Educ Project BK21, Coll Med, Dept Microbiol, Inchon, South Korea.
   [Lee, Jeonghun; Kim, Chulhee] Inha Univ, Dept Polymer Sci & Engn, Inchon, South Korea.
RP Lee, H (reprint author), Inha Univ, Ctr Adv Med Educ Project BK21, Coll Med, Dept Microbiol, Inchon, South Korea.
EM park001@inha.ac.kr
FU Korea Health 21 RD Project [A062254]; KOSEF [2009-0093747]
FX This work was supported by grants from the Korea Health 21 R&D Project
   (A062254), and the Nuclear R&D Program of KOSEF (2009-0093747). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aarti I, 2010, APOPTOSIS, V15, P679, DOI 10.1007/s10495-010-0474-z
   Ariyama H, 2006, J CELL BIOCHEM, V97, P724, DOI 10.1002/jcb.20678
   Belgardt BF, 2010, AGING-US, V2, P621, DOI 10.18632/aging.100192
   Bey EA, 2007, P NATL ACAD SCI USA, V104, P11832, DOI 10.1073/pnas.0702176104
   Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465
   BOOTHMAN DA, 1989, CANCER RES, V49, P605
   Cao XF, 2003, BLOOD, V102, P2605, DOI 10.1182/blood-2003-01-0211
   Choi HJ, 2009, EXP MOL MED, V41, P94, DOI 10.3858/emm.2009.41.2.012
   Dadakhujaev S, 2009, AUTOPHAGY, V5, P103, DOI 10.4161/auto.5.1.7276
   Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2
   DEMARIA M, 2010, AGING ALBANY NY, V11, P823
   DONG Y, 2011, CLIN CANCER RES, V15, P131
   Dudekula S, 2010, AGING-US, V2, P1023, DOI 10.18632/aging.100263
   GUIRAUD P, 1994, PLANTA MED, V60, P373, DOI 10.1055/s-2006-959504
   Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8
   Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2
   Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682
   Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004
   Kadowaki H, 2004, J CHEM NEUROANAT, V28, P93, DOI 10.1016/j.jchemneu.2004.05.004
   Katagiri C, 2005, J BIOL CHEM, V280, P14716, DOI 10.1074/jbc.M500200200
   Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838
   Klekotka PA, 2001, J BIOL CHEM, V276, P32353, DOI 10.1074/jbc.M101921200
   Lai CC, 1998, HISTOL HISTOPATHOL, V13, P89, DOI 10.14670/HH-13.89
   Lee J. I., 2006, Experimental Oncology, V28, P30
   Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1
   Lien YC, 2008, HISTOL HISTOPATHOL, V23, P1299, DOI 10.14670/HH-23.1299
   Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003
   Masuda K, 2003, J BIOL CHEM, V278, P32448, DOI 10.1074/jbc.M213254200
   Pardee AB, 2002, CURR CANCER DRUG TAR, V2, P227, DOI 10.2174/1568009023333854
   Park HJ, 2005, INT J RADIAT ONCOL, V61, P212, DOI 10.1016/j.ijrobp.2004.09.018
   Park MT, 2005, BLOOD, V105, P1724, DOI 10.1182/blood-2004-07-2938
   Park MT, 2003, J BIOL CHEM, V278, P50624, DOI 10.1074/jbc.M309011200
   Paumelle R, 2000, MOL BIOL CELL, V11, P3751, DOI 10.1091/mbc.11.11.3751
   Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416
   Pink JJ, 2000, EXP CELL RES, V255, P144, DOI 10.1006/excr.1999.4790
   Planchon SM, 1999, ONCOL REP, V6, P485
   Preston TJ, 2001, ADV DRUG DELIVER REV, V49, P45, DOI 10.1016/S0169-409X(01)00127-2
   Pu YS, 2004, PROSTATE, V60, P120, DOI 10.1002/pros.20057
   Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199
   Sakahira H, 1998, NATURE, V391, P96
   SEGER R, 1995, FASEB J, V9, P726
   Shiah SG, 1999, CANCER RES, V59, P391
   Su LT, 2010, J MOL BIOL, V396, P858, DOI 10.1016/j.jmb.2010.01.014
   Sun XG, 2006, CELL CYCLE, V5, P2029, DOI 10.4161/cc.5.17.3312
   Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779
   Tagliarino C, 2001, J BIOL CHEM, V276, P19150, DOI 10.1074/jbc.M100730200
   Theruvath TP, 2008, TRANSPLANTATION, V85, P1500, DOI 10.1097/TP.0b013e31816fefb5
   Toyota H, 2003, CANCER LETT, V189, P221, DOI 10.1016/S0304-3835(02)00552-9
   Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556
   Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619
   Wuerzberger SM, 1998, CANCER RES, V58, P1876
   XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326
   Yanase N, 2000, J INTERF CYTOK RES, V20, P1121, DOI 10.1089/107999000750053799
   Yeo JK, 2002, CANCER LETT, V182, P83, DOI 10.1016/S0304-3835(02)00075-7
NR 54
TC 31
Z9 32
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 29
PY 2011
VL 6
IS 6
AR e21533
DI 10.1371/journal.pone.0021533
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 786FZ
UT WOS:000292290100032
PM 21738692
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Villalta, JI
   Galli, S
   Iacaruso, MF
   Arciuch, VGA
   Poderoso, JJ
   Jares-Erijman, EA
   Pietrasanta, LI
AF Ignacio Villalta, Jorge
   Galli, Soledad
   Florencia Iacaruso, Maria
   Antico Arciuch, Valeria Gabriela
   Jose Poderoso, Juan
   Andrea Jares-Erijman, Elizabeth
   Isabel Pietrasanta, Lia
TI New Algorithm to Determine True Colocalization in Combination with Image
   Restoration and Time-Lapse Confocal Microscopy to Map Kinases in
   Mitochondria
SO PLOS ONE
LA English
DT Article
ID FLUORESCENCE MICROSCOPY; NUCLEAR TRANSLOCATION; PROTEIN; SIGNAL; CELLS;
   MEK1
AB The subcellular localization and physiological functions of biomolecules are closely related and thus it is crucial to precisely determine the distribution of different molecules inside the intracellular structures. This is frequently accomplished by fluorescence microscopy with well-characterized markers and posterior evaluation of the signal colocalization. Rigorous study of colocalization requires statistical analysis of the data, albeit yet no single technique has been established as a standard method. Indeed, the few methods currently available are only accurate in images with particular characteristics. Here, we introduce a new algorithm to automatically obtain the true colocalization between images that is suitable for a wide variety of biological situations. To proceed, the algorithm contemplates the individual contribution of each pixel's fluorescence intensity in a pair of images to the overall Pearsons correlation and Manders' overlap coefficients. The accuracy and reliability of the algorithm was validated on both simulated and real images that reflected the characteristics of a range of biological samples. We used this algorithm in combination with image restoration by deconvolution and time-lapse confocal microscopy to address the localization of MEK1 in the mitochondria of different cell lines. Appraising the previously described behavior of Akt1 corroborated the reliability of the combined use of these techniques. Together, the present work provides a novel statistical approach to accurately and reliably determine the colocalization in a variety of biological images.
C1 [Ignacio Villalta, Jorge; Florencia Iacaruso, Maria; Isabel Pietrasanta, Lia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Ctr Microscopias Avanzadas, Buenos Aires, DF, Argentina.
   [Galli, Soledad; Andrea Jares-Erijman, Elizabeth] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Organ, CIHIDECAR,CONICET, RA-1428 Buenos Aires, DF, Argentina.
   [Antico Arciuch, Valeria Gabriela; Jose Poderoso, Juan] Univ Buenos Aires, Fac Med, Lab Oxygen Metab, Univ Hosp Jose de San Martin, Buenos Aires, DF, Argentina.
RP Villalta, JI (reprint author), Univ Buenos Aires, Fac Med, Dept Fisiol, RA-1425 Buenos Aires, DF, Argentina.
EM eli@qo.fcen.uba.ar; lia@df.uba.ar
OI PIETRASANTA, LIA/0000-0002-2714-3162
FU Universidad de Buenos Aires; Consejo Nacional de Investigaciones
   Cientificas y Tecnicas (CONICET); Agencia Nacional de Promocion
   Cientifica y Tecnologica (ANPCyT); Max Planck Society
FX This work was supported by the Universidad de Buenos Aires, the Consejo
   Nacional de Investigaciones Cientificas y Tecnicas (CONICET), the
   Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) and the
   Max Planck Society. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x
   Antico Arciuch Valeria Gabriela, 2009, PLoS One, V4, pe7523, DOI 10.1371/journal.pone.0007523
   Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X
   Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x
   Bronfman FC, 2003, J NEUROSCI, V23, P3209
   Comeau JWD, 2006, BIOPHYS J, V91, P4611, DOI 10.1529/biophysj.106.089441
   Costes SV, 2004, BIOPHYS J, V86, P3993, DOI 10.1529/biophysi.103.038422
   Craig EA, 2008, DEV DYNAM, V237, P3102, DOI 10.1002/dvdy.21750
   Fletcher PA, 2010, BIOPHYS J, V99, P1996, DOI 10.1016/j.bpj.2010.07.006
   Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024
   Galli S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007541
   Galli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002379
   Galmiche A, 2008, J BIOL CHEM, V283, P14857, DOI 10.1074/jbc.M709098200
   Horgan AM, 2003, EXP CELL RES, V285, P208, DOI 10.1016/S0014-4827(03)00037-5
   Jaaro H, 1997, P NATL ACAD SCI USA, V94, P3742, DOI 10.1073/pnas.94.8.3742
   Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004
   Lidke DS, 2009, J BIOL CHEM, V285, P3092
   MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x
   MANDERS EMM, 1992, J CELL SCI, V103, P857
   Monick MM, 2008, J IMMUNOL, V180, P7485, DOI 10.4049/jimmunol.180.11.7485
   Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153
   Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443
   Ramay HR, 2009, BIOPHYS J, V97, P443, DOI 10.1016/j.bpj.2009.04.062
   Ramirez O, 2010, J MICROSC-OXFORD, V239, P173, DOI 10.1111/j.1365-2818.2010.03369.x
   Sedarat F, 2004, J APPL PHYSIOL, V97, P1098, DOI 10.1152/japplphysiol.00089.2004
   SEGER R, 1995, FASEB J, V9, P726
   SEGER R, 1992, J BIOL CHEM, V267, P14373
   Yao Z, 2001, ONCOGENE, V20, P7588, DOI 10.1038/sj.onc.1204963
   ZHENG CF, 1993, J BIOL CHEM, V268, P23933
   Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002
NR 30
TC 18
Z9 18
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 29
PY 2011
VL 6
IS 4
AR e19031
DI 10.1371/journal.pone.0019031
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 756OZ
UT WOS:000290024700054
PM 21559502
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Shan, PF
   Lu, Y
   Cui, RR
   Jiang, Y
   Yuan, LQ
   Liao, EY
AF Shan, Peng-Fei
   Lu, Ying
   Cui, Rong-Rong
   Jiang, Yi
   Yuan, Ling-Qing
   Liao, Er-Yuan
TI Apelin Attenuates the Osteoblastic Differentiation of Vascular Smooth
   Muscle Cells
SO PLOS ONE
LA English
DT Article
ID ENDOGENOUS LIGAND APELIN; ENDOTHELIAL-CELLS; PEPTIDE APELIN; APJ
   RECEPTOR; IN-VIVO; IMMUNOCYTOCHEMICAL LOCALIZATION;
   BETA-GLYCEROPHOSPHATE; CARDIAC CONTRACTILITY; TISSUE DISTRIBUTION;
   OXIDATIVE STRESS
AB Vascular calcification, which results from a process osteoblastic differentiation of vascular smooth muscle cells (VSMCs), is a major risk factor for cardiovascular morbidity and mortality. Apelin is a recently discovered peptide that is the endogenous ligand for the orphan G-protein-coupled receptor, APJ. Several studies have identified the protective effects of apelin on the cardiovascular system. However, the effects and mechanisms of apelin on the osteoblastic differentiation of VSMCs have not been elucidated. Using a culture of calcifying vascular smooth muscle cells (CVMSCs) as a model for the study of vascular calcification, the relationship between apelin and the osteoblastic differentiation of VSMCs and the signal pathway involved were investigated. Alkaline phosphatase (ALP) activity and osteocalcin secretion were examined in CVSMCs. The involved signal pathway was studied using the extracellular signal-regulated kinase (ERK) inhibitor, PD98059, the phosphatidylinositol 3-kinase (PI3-K) inhibitor, LY294002, and APJ siRNA. The results showed that apelin inhibited ALP activity, osteocalcin secretion, and the formation of mineralized nodules. APJ protein was detected in CVSMCs, and apelin activated ERK and AKT (a downstream effector of PI3-K). Suppression of APJ with siRNA abolished the apelin-induced activation of ERK and Akt. Furthermore, inhibition of APJ expression, and the activation of ERK or PI3-K, reversed the effects of apelin on ALP activity. These results showed that apelin inhibited the osteoblastic differentiation of CVSMCs through the APJ/ERK and APJ/PI3-K/AKT signaling pathway. Apelin appears to play a protective role against arterial calcification.
C1 [Shan, Peng-Fei] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Endocrinol & Metab, Hangzhou 310003, Zhejiang, Peoples R China.
   [Lu, Ying] Peoples Hosp Zhongshan City, Dept Endocrinol & Metab, Zhongshan, Guangdong, Peoples R China.
   [Shan, Peng-Fei; Lu, Ying; Cui, Rong-Rong; Yuan, Ling-Qing; Liao, Er-Yuan] Cent S Univ, Xiang Ya Hosp 2, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China.
   [Cui, Rong-Rong] Cent S Univ, Xiang Ya Hosp 2, Dept Pediat, Changsha, Hunan, Peoples R China.
   [Jiang, Yi] Cent S Univ, Xiang Ya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China.
RP Yuan, LQ (reprint author), Cent S Univ, Xiang Ya Hosp 2, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China.
EM allenylq@hotmail.com
OI Shan, Peng-Fei/0000-0002-6684-9395
FU Health Department of Zhejiang Province [2009QN012]; National Natural
   Science Foundation of China [30801203]; Ph. D. Programs Foundation of
   Ministry of Education of China [200805331017]; China Postdoctoral
   Science Foundation [20100471240]
FX This work was supported by funding from the Health Department of
   Zhejiang Province (2009QN012), the National Natural Science Foundation
   of China (30801203), the Ph. D. Programs Foundation of Ministry of
   Education of China (No. 200805331017) and China Postdoctoral Science
   Foundation (20100471240). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42
   Alexander MY, 2005, ARTERIOSCL THROM VAS, V25, P1851, DOI 10.1161/01.ATV.0000175750.94742.46
   Ashley EA, 2005, CARDIOVASC RES, V65, P73, DOI 10.1016/j.cardiores.2004.08.018
   Bear M, 2008, J CELL BIOCHEM, V105, P185, DOI 10.1002/jcb.21812
   Bing HT, 2006, J CELL BIOCHEM, V99, P1343, DOI 10.1002/jcb.20999
   Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427
   Cai Y, 2010, ACTA PHARMACOL SIN, V31, P1359, DOI 10.1038/aps.2010.89
   Collett GDM, 2007, CIRC RES, V100, P502, DOI 10.1161/01.RES.0000258854.03388.02
   Cui RR, 2010, AMINO ACIDS, V39, P1193, DOI 10.1007/s00726-010-0555-x
   Dray C, 2010, AM J PHYSIOL-ENDOC M, V298, pE1161, DOI 10.1152/ajpendo.00598.2009
   Farkasfalvi K, 2007, BIOCHEM BIOPH RES CO, V357, P889, DOI 10.1016/j.bbrc.2007.04.017
   Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.00001.45894.57533.C4
   Hashimoto T, 2007, AM J PATHOL, V171, P1705, DOI 10.2353/ajpath.2007.070471
   Hashimoto T, 2006, ARTERIOSCL THROM VAS, V26, P1267, DOI 10.1161/01.ATV.0000218841.39828.91
   Hosoya M, 2000, J BIOL CHEM, V275, P21061, DOI 10.1074/jbc.M908417199
   Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200
   Japp AG, 2010, CIRCULATION, V121, P1818, DOI 10.1161/CIRCULATIONAHA.109.911339
   Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21
   Kanazawa I, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-51
   Kanno Y, 2008, CARDIOVASC RES, V77, P221, DOI 10.1093/cvr/cvm049
   Kasai A, 2010, ARTERIOSCL THROM VAS, V30, P2182, DOI 10.1161/ATVBAHA.110.209775
   Katugampola SD, 2001, BRIT J PHARMACOL, V132, P1255, DOI 10.1038/sj.bjp.0703939
   Kawamata Y, 2001, BBA-MOL CELL RES, V1538, P162, DOI 10.1016/S0167-4889(00)00143-9
   Kleinz MJ, 2005, REGUL PEPTIDES, V126, P233, DOI 10.1016/j.regpep.2004.10.019
   Kleinz MJ, 2004, REGUL PEPTIDES, V118, P119, DOI 10.1016/j.regpep.2003.11.002
   Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031
   Kume S, 2005, J BONE MINER RES, V20, P1647, DOI 10.1359/JBMR.050514
   Lee DK, 2000, J NEUROCHEM, V74, P34, DOI 10.1046/j.1471-4159.2000.0740034.x
   Lee HL, 2010, EXP MOL MED, V42, P437, DOI 10.3858/emm.2010.42.6.045
   Lee HL, 2010, BIOCHEM BIOPH RES CO, V391, P1087, DOI 10.1016/j.bbrc.2009.12.027
   Lee HW, 2009, STEM CELLS, V27, P2254, DOI 10.1002/stem.144
   Lee SK, 2009, BIOL PHARM BULL, V32, P1328, DOI 10.1248/bpb.32.1328
   Liao XB, 2008, AMINO ACIDS, V34, P525, DOI 10.1007/s00726-007-0003-8
   Liao XB, 2010, AMINO ACIDS, V39, P375, DOI 10.1007/s00726-009-0448-z
   Lin IC, 2008, PLAST RECONSTR SURG, V121, P1554, DOI 10.1097/PRS.0b013e31816c3bd7
   Liu CH, 2010, ACTA BIOCH BIOPH SIN, V42, P396, DOI 10.1093/abbs/gmq035
   Luo XH, 2009, J BONE MINER RES, V24, P1461, DOI [10.1359/JBMR.090227, 10.1359/jbmr.090227]
   Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9
   Masri B, 2005, CELL SIGNAL, V17, P415, DOI 10.1016/j.cellsig.2004.09.018
   Masri B, 2004, FASEB J, V18, P1909, DOI 10.1096/fj.04-1930fje
   Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x
   Nishiwaki-Yasuda K, 2007, ENDOCR J, V54, P103, DOI 10.1507/endocrj.K06-093
   ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O
   Peltonen T, 2009, J HEART VALVE DIS, V18, P644
   Persy V, 2009, TRENDS MOL MED, V15, P405, DOI 10.1016/j.molmed.2009.07.001
   Radcliff K, 2005, CIRC RES, V96, P398, DOI 10.1161/01.RES.0000159671.47477.71
   SEGER R, 1995, FASEB J, V9, P726
   Shao JS, 2006, ARTERIOSCL THROM VAS, V26, P1423, DOI 10.1161/01.ATV.0000220441.42041.20
   Shi YL, 2009, J CELL BIOCHEM, V108, P1184, DOI 10.1002/jcb.22348
   Shi Y, 2009, BIOMETALS, V22, P317, DOI 10.1007/s10534-008-9168-1
   SHIOI A, 1995, ARTERIOSCL THROM VAS, V15, P2003, DOI 10.1161/01.ATV.15.11.2003
   Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053
   Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69
   Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1
   Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489
   WATSON KE, 1994, J CLIN INVEST, V93, P2106, DOI 10.1172/JCI117205
   Xie H, 2006, REGUL PEPTIDES, V134, P118, DOI 10.1016/j.regpep.2006.02.004
   You HZ, 2009, RENAL FAILURE, V31, P313, DOI 10.1080/08860220902875182
NR 58
TC 36
Z9 40
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 18
PY 2011
VL 6
IS 3
AR e17938
DI 10.1371/journal.pone.0017938
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 737CD
UT WOS:000288545100046
PM 21437254
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Giagulli, C
   Marsico, S
   Magiera, AK
   Bruno, R
   Caccuri, F
   Barone, I
   Fiorentini, S
   Ando, S
   Caruso, A
AF Giagulli, Cinzia
   Marsico, Stefania
   Magiera, Anna K.
   Bruno, Rosalinda
   Caccuri, Francesca
   Barone, Ines
   Fiorentini, Simona
   Ando, Sebastiano
   Caruso, Arnaldo
TI Opposite Effects of HIV-1 p17 Variants on PTEN Activation and Cell
   Growth in B Cells
SO PLOS ONE
LA English
DT Article
ID MATRIX PROTEIN P17; TUMOR-SUPPRESSOR PTEN; PROINFLAMMATORY CYTOKINES;
   VIRUS; PHOSPHORYLATION; PATHWAY; CANCER; BINDING; STABILITY; KINASES
AB The HIV-1 matrix protein p17 is a structural protein that can act in the extracellular environment to deregulate several functions of immune cells, through the interaction of its NH(2)-terminal region with a cellular surface receptor (p17R). The intracellular events triggered by p17/p17R interaction have been not completely characterized yet. In this study we analyze the signal transduction pathways induced by p17/p17R interaction and show that in Raji cells, a human B cell line stably expressing p17R on its surface, p17 induces a transient activation of the transcriptional factor AP-1. Moreover, it was found to upregulate pERK1/2 and downregulate pAkt, which are the major intracellular signalling components involved in AP-1 activation. These effects are mediated by the COOH-terminal region of p17, which displays the capability of keeping PTEN, a phosphatase that regulates the PI3K/Akt pathway, in an active state through the serin/threonin (Ser/Thr) kinase ROCK. Indeed, the COOH-terminal truncated form of p17 (p17 Delta 36) induced activation of the PI3K/Akt pathway by maintaining PTEN in an inactive phosphorylated form. Interestingly, we show that among different p17s, a variant derived from a Ugandan HIV-1 strain, named S75X, triggers an activation of PI3K/Akt signalling pathway, and leads to an increased B cell proliferation and malignant transformation. In summary, this study shows the role of the COOH-terminal region in modulating the p17 signalling pathways so highlighting the complexity of p17 binding to and signalling through its receptor(s). Moreover, it provides the first evidence on the presence of a p17 natural variant mimicking the p17 Delta 36-induced signalling in B cells and displaying the capacity of promoting B cell growth and tumorigenesis.
C1 [Giagulli, Cinzia; Caccuri, Francesca; Fiorentini, Simona; Caruso, Arnaldo] Univ Brescia, Dept Expt & Appl Med, Brescia, Italy.
   [Marsico, Stefania; Bruno, Rosalinda] Univ Calabria, Dept Pharmaco Biol, I-87036 Cosenza, Italy.
   [Barone, Ines; Ando, Sebastiano] Univ Calabria, Dept Cell Biol, I-87036 Cosenza, Italy.
   [Magiera, Anna K.] Medestea Res, Turin, Italy.
RP Giagulli, C (reprint author), Univ Brescia, Dept Expt & Appl Med, Brescia, Italy.
EM caruso@med.unibs.it
RI MARSICO, Stefania/J-9938-2019
OI MARSICO, Stefania/0000-0003-1598-0526; FIORENTINI,
   SIMONA/0000-0002-1866-314X; Caccuri, Francesca/0000-0002-1923-9033;
   BARONE, Ines/0000-0002-9769-1615
FU Italian Ministry of University and Scientific Research; Istituto
   Superiore di Sanita [40G.16]; Bonino-Pulejo Foundation (Messina, Italy)
FX This work was supported by the Italian Ministry of University and
   Scientific Research (Programmi di Ricerca di Rilevante Interesse
   Nazionale projects) and Istituto Superiore di Sanita (AIDS Grant
   40G.16). This work was also supported in part by the Bonino-Pulejo
   Foundation (Messina, Italy). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adey NB, 2000, CANCER RES, V60, P35
   ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9
   Backman SA, 2002, CURR OPIN NEUROBIOL, V12, P516, DOI 10.1016/S0959-4388(02)00354-9
   BUDKA H, 1990, ACTA NEUROPATHOL, V79, P611, DOI 10.1007/BF00294238
   Bukrinskaya AG, 1996, P NATL ACAD SCI USA, V93, P367, DOI 10.1073/pnas.93.1.367
   Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240
   Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659
   Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100
   De Francesco MA, 1998, AIDS, V12, P245, DOI 10.1097/00002030-199803000-00001
   De Francesco MA, 2002, P NATL ACAD SCI USA, V99, P9972, DOI 10.1073/pnas.142274699
   Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023
   Ehrlich LS, 1996, BIOCHEMISTRY-US, V35, P3933, DOI 10.1021/bi952337x
   Fiorentini S, 2006, NEW MICROBIOL, V29, P1
   Fiorentini S, 2008, VACCINE, V26, P4758, DOI 10.1016/j.vaccine.2008.06.082
   Fiorentini S, 2008, P NATL ACAD SCI USA, V105, P3867, DOI 10.1073/pnas.0800370105
   Fiorentini S, 2010, PHARMACOL THERAPEUT, V128, P433, DOI 10.1016/j.pharmthera.2010.08.005
   FREED EO, 1994, J VIROL, V68, P5311
   Gericke A, 2006, GENE, V374, P1, DOI 10.1016/j.gene.2006.02.024
   Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.183143100
   Gucalp A, 2009, CURR OPIN HEMATOL, V17, P362
   Haffar O, 2005, J VIROL, V79, P13028, DOI 10.1128/JVI.79.20.13028-13036.2005
   Haffar OK, 2000, J MOL BIOL, V299, P359, DOI 10.1006/jmbi.2000.3768
   Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099
   Ishizaki T, 2000, MOL PHARMACOL, V57, P976
   Jiang BH, 2008, BBA-PROTEINS PROTEOM, V1784, P150, DOI 10.1016/j.bbapap.2007.09.008
   Kozikowski AP, 2003, J AM CHEM SOC, V125, P1144, DOI 10.1021/ja0285159
   Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243
   Li L, 2005, PROSTATE CANCER P D, V8, P108, DOI 10.1038/sj.pcan.4500776
   Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236
   Marini E, 2008, CELL MICROBIOL, V10, P655, DOI 10.1111/j.1462-5822.2007.01073.x
   Massiah MA, 1996, PROTEIN SCI, V5, P2391, DOI 10.1002/pro.5560051202
   MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719
   Tiberio GAM, 2007, HEPATO-GASTROENTEROL, V54, P878
   McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004
   Meili R, 2005, NAT CELL BIOL, V7, P334, DOI 10.1038/ncb0405-334
   Miller SJ, 2002, FEBS LETT, V528, P145, DOI 10.1016/S0014-5793(02)03274-X
   Narumiya S, 2000, METHOD ENZYMOL, V325, P273
   Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x
   PAPSIDERO LD, 1989, J VIROL, V63, P267
   Popovic M, 2005, P NATL ACAD SCI USA, V102, P14807, DOI 10.1073/pnas.0506857102
   RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0
   Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093
   Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128
   Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102
   Schuurbiers OCJ, 2009, J THORAC ONCOL, V4, P761, DOI 10.1097/JTO.0b013e3181a1084f
   SEGER R, 1995, FASEB J, V9, P726
   Shin S, 2009, MOL CANCER RES, V7, P745, DOI 10.1158/1541-7786.MCR-08-0462
   Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8
   Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7
   Tiberio L, 2006, CYTOKINE, V34, P131, DOI 10.1016/j.cyto.2006.04.009
   Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200
   Vandergeeten C, 2007, BIOCHEM PHARMACOL, V73, P1738, DOI 10.1016/j.bcp.2007.02.011
   Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000
   Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1067/jbc.C100556200
   Verli H, 2007, J MOL GRAPH MODEL, V26, P62, DOI 10.1016/j.jmgm.2006.09.009
   Vitale M, 2003, BRIT J HAEMATOL, V120, P337, DOI 10.1046/j.1365-2141.2003.04053.x
   Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/mrc839
   Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587
NR 58
TC 44
Z9 44
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 14
PY 2011
VL 6
IS 3
AR e17831
DI 10.1371/journal.pone.0017831
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 736RS
UT WOS:000288512400032
PM 21423810
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Peddinti, D
   Memili, E
   Burgess, SC
AF Peddinti, Divyaswetha
   Memili, Erdogan
   Burgess, Shane C.
TI Proteomics-Based Systems Biology Modeling of Bovine Germinal Vesicle
   Stage Oocyte and Cumulus Cell Interaction
SO PLOS ONE
LA English
DT Article
ID IN-VITRO MATURATION; TANDEM MASS-SPECTROMETRY; COMPANION
   GRANULOSA-CELLS; MESSENGER-RNA EXPRESSION; PROTEIN EXPRESSION; METABOLIC
   COOPERATIVITY; PORCINE OOCYTES; MOUSE OOCYTES; INTERCELLULAR
   COMMUNICATION; EMBRYO DEVELOPMENT
AB Background: Oocytes are the female gametes which establish the program of life after fertilization. Interactions between oocyte and the surrounding cumulus cells at germinal vesicle (GV) stage are considered essential for proper maturation or 'programming' of oocytes, which is crucial for normal fertilization and embryonic development. However, despite its importance, little is known about the molecular events and pathways involved in this bidirectional communication.
   Methodology/Principal Findings: We used differential detergent fractionation multidimensional protein identification technology (DDF-Mud PIT) on bovine GV oocyte and cumulus cells and identified 811 and 1247 proteins in GV oocyte and cumulus cells, respectively; 371 proteins were significantly differentially expressed between each cell type. Systems biology modeling, which included Gene Ontology (GO) and canonical genetic pathway analysis, showed that cumulus cells have higher expression of proteins involved in cell communication, generation of precursor metabolites and energy, as well as transport than GV oocytes. Our data also suggests a hypothesis that oocytes may depend on the presence of cumulus cells to generate specific cellular signals to coordinate their growth and maturation.
   Conclusions/Significance: Systems biology modeling of bovine oocytes and cumulus cells in the context of GO and protein interaction networks identified the signaling pathways associated with the proteins involved in cell-to-cell signaling biological process that may have implications in oocyte competence and maturation. This first comprehensive systems biology modeling of bovine oocytes and cumulus cell proteomes not only provides a foundation for signaling and cell physiology at the GV stage of oocyte development, but are also valuable for comparative studies of other stages of oocyte development at the molecular level.
C1 [Peddinti, Divyaswetha; Burgess, Shane C.] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA.
   [Memili, Erdogan] Mississippi State Univ, Dept Anim & Dairy Sci, Mississippi State, MS 39762 USA.
   [Peddinti, Divyaswetha; Memili, Erdogan; Burgess, Shane C.] Mississippi State Univ, Inst Digital Biol, Mississippi State, MS 39762 USA.
   [Burgess, Shane C.] Mississippi State Univ, Life Sci & Biotechnol Inst, Mississippi State, MS 39762 USA.
   [Burgess, Shane C.] Mississippi State Univ, Mississippi Agr & Forestry Expt Stn, Mississippi State, MS 39762 USA.
RP Peddinti, D (reprint author), Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA.
EM dpeddinti@cvm.msstate.edu
FU Life Sciences and Biology Institute; Mississippi Agricultural and
   Forestry Experiment Station, Mississippi State University
FX This study was funded by the Life Sciences and Biology Institute and
   Mississippi Agricultural and Forestry Experiment Station, Mississippi
   State University. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Amano T, 2005, THERIOGENOLOGY, V64, P261, DOI 10.1016/j.theriogenology.2004.12.001
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   ASSIDI M, 2008, BIOL REPROD
   BETTEGOWDA A, 2008, BIOL REPROD
   Bhojwani M, 2006, CLONING STEM CELLS, V8, P259, DOI 10.1089/clo.2006.8.259
   BIGGERS JD, 1967, P NATL ACAD SCI USA, V58, P560, DOI 10.1073/pnas.58.2.560
   BRIDGES SM, 2007, BMC BIOINFORMATICS, V8
   BUCCIONE R, 1990, BIOL REPROD, V43, P543, DOI 10.1095/biolreprod43.4.543
   Buza TJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1167
   Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200
   Coonrod SA, 2002, J REPROD IMMUNOL, V53, P55, DOI 10.1016/S0165-0378(01)00102-4
   Cox B, 2005, METHODS, V35, P303, DOI 10.1016/j.ymeth.2004.08.021
   Dalbies-Tran R, 2005, MOL REPROD DEV, V71, P414, DOI 10.1002/mrd.20298
   deMatos DG, 1997, BIOL REPROD, V57, P1420, DOI 10.1095/biolreprod57.6.1420
   DONAHUE RP, 1968, J REPROD FERTIL, V17, P395
   Elias JE, 2004, NAT BIOTECHNOL, V22, P214, DOI 10.1038/nbt930
   Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019
   Ellederova Z, 2004, BIOL REPROD, V71, P1533, DOI 10.1095/biolreprod.104.030304
   EPPIG JJ, 1993, DEV BIOL, V158, P400, DOI 10.1006/dbio.1993.1198
   EPPIG JJ, 1991, BIOESSAYS, V13, P569, DOI 10.1002/bies.950131105
   Fair T, 2007, THERIOGENOLOGY, V68, pS91, DOI 10.1016/j.theriogenology.2007.04.018
   Fatehi AN, 2002, THERIOGENOLOGY, V57, P1347, DOI 10.1016/S0093-691X(01)00717-8
   Gerling IC, 2006, MOL CELL PROTEOMICS, V5, P293, DOI 10.1074/mcp.M500197-MCP200
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gilchrist RB, 2004, ANIM REPROD SCI, V82-3, P431, DOI 10.1016/j.anireprosci.2004.05.017
   GrazulBilska AT, 1997, BIOL REPROD, V57, P947, DOI 10.1095/biolreprod57.5.947
   Gygi SP, 1999, MOL CELL BIOL, V19, P1720
   Hamamah S, 2006, REPROD BIOMED ONLINE, V13, P807, DOI 10.1016/S1472-6483(10)61028-0
   Huang Y, 2006, PHYSIOL GENOMICS, V24, P144, DOI 10.1152/physiolgenomics.00258.2005
   KIM H, 1991, CELL TISSUE RES, V265, P105, DOI 10.1007/BF00318144
   LEESE HJ, 1985, J EXP ZOOL, V234, P231, DOI 10.1002/jez.1402340208
   Leyens G, 2004, BIOL REPROD, V71, P1646, DOI 10.1095/biolreprod.104.030155
   Lubec G, 2005, PROG NEUROBIOL, V77, P90, DOI 10.1016/j.pneurobio.2005.10.001
   Ma MY, 2008, J PROTEOME RES, V7, P4821, DOI 10.1021/pr800392s
   MacCoss MJ, 2002, ANAL CHEM, V74, P5593, DOI 10.1021/ac025826t
   Martens L, 2005, PROTEOMICS, V5, P3537, DOI 10.1002/pmic.200401303
   Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965
   McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229
   McCarthy FM, 2007, NUCLEIC ACIDS RES, V35, pD599, DOI 10.1093/nar/gkl936
   McCarthy FM, 2006, PROTEOMICS, V6, P2759, DOI 10.1002/pmic.200500648
   Memili E, 2007, REPRODUCTION, V133, P1107, DOI 10.1530/REP-06-0149
   Memili E, 1999, BIOL REPROD, V61, P1198, DOI 10.1095/biolreprod61.5.1198
   Meng Y, 2007, BBA-PROTEINS PROTEOM, V1774, P1477, DOI 10.1016/j.bbapap.2007.08.026
   Monniaux D, 2006, SEMIN REPROD MED, V24, P251, DOI 10.1055/s-2006-948554
   Mori T, 2000, BIOL REPROD, V62, P913, DOI 10.1095/biolreprod62.4.913
   Nanduri B, 2005, PROTEOMICS, V5, P4852, DOI 10.1002/pmic.200500112
   Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261
   Nie L, 2007, CRIT REV BIOTECHNOL, V27, P63, DOI 10.1080/07388550701334212
   Orchard Sandra, 2007, Proteomics, V7, P1006, DOI 10.1002/pmic.200700014
   Park GW, 2006, PROTEOMICS, V6, P1121, DOI 10.1002/pmic.200500318
   Peddinti D, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-19
   Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v
   Pennetier S, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X/6/26
   Pfeffer PL, 2007, THERIOGENOLOGY, V68, pS84, DOI 10.1016/j.theriogenology.2007.03.016
   PRUITT KD, 2007, NUCLEIC ACIDS RES, V35, P61
   Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638
   Racedo SE, 2009, REPROD FERT DEVELOP, V21, P738, DOI 10.1071/RD09039
   RICHTER JD, 1991, BIOESSAYS, V13, P179, DOI 10.1002/bies.950130406
   Sagirkaya H, 2006, REPRODUCTION, V131, P895, DOI 10.1530/rep.1.01021
   SEGER R, 1995, FASEB J, V9, P726
   Snow AJ, 2008, BIOL REPROD, V79, P337, DOI 10.1095/biolreprod.108.069328
   Su YQ, 2008, DEVELOPMENT, V135, P111, DOI 10.1242/dev.009068
   Su YQ, 2002, ENDOCRINOLOGY, V143, P2221, DOI 10.1210/en.143.6.2221
   Sugiura K, 2005, REPROD FERT DEVELOP, V17, P667, DOI 10.1071/RD05071
   Sugiura K, 2005, DEV BIOL, V279, P20, DOI 10.1016/j.ydbio.2004.11.027
   Sugiura K, 2007, DEVELOPMENT, V134, P2593, DOI 10.1242/dev.006882
   Sutton ML, 2003, REPRODUCTION, V126, P27, DOI 10.1530/rep.0.1260027
   Tanghe S, 2002, MOL REPROD DEV, V61, P414, DOI 10.1002/mrd.10102
   Thelie A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-125
   Veselska R, 2001, SCRIPTA MED, V74, P265
   Vozzi C, 2001, REPRODUCTION, V122, P619, DOI 10.1530/rep.0.1220619
   Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6
   Wongsrikeao P, 2005, REPROD DOMEST ANIM, V40, P166, DOI 10.1111/j.1439-0531.2005.00576.x
   ZHANG L, 1995, MOL REPROD DEV, V40, P338, DOI 10.1002/mrd.1080400310
NR 74
TC 18
Z9 23
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 21
PY 2010
VL 5
IS 6
AR e11240
DI 10.1371/journal.pone.0011240
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 614KV
UT WOS:000279058300024
PM 20574525
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Mihardja, SS
   Gao, DW
   Sievers, RE
   Fang, QZ
   Feng, JJ
   Wang, JM
   Vanbrocklin, HF
   Larrick, JW
   Huang, M
   Dae, M
   Lee, RJ
AF Mihardja, Shirley S.
   Gao, Dongwei
   Sievers, Richard E.
   Fang, Qizhi
   Feng, Jinjin
   Wang, Jianming
   Vanbrocklin, Henry F.
   Larrick, James W.
   Huang, Manley
   Dae, Michael
   Lee, Randall J.
TI Targeted In Vivo Extracellular Matrix Formation Promotes
   Neovascularization in a Rodent Model of Myocardial Infarction
SO PLOS ONE
LA English
DT Article
ID ENDOTHELIAL-CELL PROLIFERATION; LEFT-VENTRICULAR GEOMETRY; IV-COLLAGEN;
   SYNTHETIC PEPTIDE; ALPHA(V)BETA(3) INTEGRIN; GROWTH-FACTOR;
   ANGIOGENESIS; ADHESION; FIBRONECTIN; MIGRATION
AB Background: The extracellular matrix plays an important role in tissue regeneration. We investigated whether extracellular matrix protein fragments could be targeted with antibodies to ischemically injured myocardium to promote angiogenesis and myocardial repair.
   Methodology/Principal Findings: Four peptides, 2 derived from fibronectin and 2 derived from Type IV Collagen, were assessed for in vitro and in vivo tendencies for angiogenesis. Three of the four peptides-Hep I, Hep III, RGD-were identified and shown to increase endothelial cell attachment, proliferation, migration and cell activation in vitro. By chemically conjugating these peptides to an anti-myosin heavy chain antibody, the peptides could be administered intravenously and specifically targeted to the site of the myocardial infarction. When administered into Sprague-Dawley rats that underwent ischemia-reperfusion myocardial infarction, these peptides produced statistically significantly higher levels of angiogenesis and arteriogenesis 6 weeks post treatment.
   Conclusions/Significance: We demonstrated that antibody-targeted ECM-derived peptides alone can be used to sufficiently alter the extracellular matrix microenvironment to induce a dramatic angiogenic response in the myocardial infarct area. Our results indicate a potentially new non-invasive strategy for repairing damaged tissue, as well as a novel tool for investigating in vivo cell biology.
C1 [Mihardja, Shirley S.; Gao, Dongwei; Fang, Qizhi; Dae, Michael; Lee, Randall J.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.
   [Sievers, Richard E.; Lee, Randall J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
   [Lee, Randall J.] Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94143 USA.
   [Gao, Dongwei; Feng, Jinjin; Vanbrocklin, Henry F.; Dae, Michael] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA.
   [Lee, Randall J.] Univ Calif Berkeley, UCSF, Joint Bioengn Grad Grp, Berkeley, CA 94720 USA.
   [Wang, Jianming; Larrick, James W.; Huang, Manley] Panorama Res Inst, Sunnyvale, CA USA.
RP Mihardja, SS (reprint author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.
EM lee@medicine.ucsf.edu
FU NIH [R21 HL084121]; California Institute of Regenerative Medicine
   [RC1-00124-1]; American Heart Association; Margoes Foundation
FX This work was funded by NIH R21 HL084121 and by the California Institute
   of Regenerative Medicine (RC1-00124-1). SSM was supported by the
   American Heart Association Postdoctoral Fellowship and by the Margoes
   Foundation. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6
   Azarnoush K, 2005, J THORAC CARDIOV SUR, V130, P173, DOI 10.1016/j.jtcvs.2004.11.044
   Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962
   Bonanno E, 2000, IN VITRO CELL DEV-AN, V36, P336
   BOUCHENTOUF M, 2007, GENE THER, V15, P404
   CAMERON JD, 1991, INVEST OPHTH VIS SCI, V32, P2766
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Corda S, 2000, Heart Fail Rev, V5, P119, DOI 10.1023/A:1009806403194
   Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3
   FORM DM, 1986, LAB INVEST, V55, P521
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Heiss C, 2008, J CELL PHYSIOL, V215, P366, DOI 10.1002/jcp.21313
   Huang NF, 2006, NAT PROTOC, V1, P1596, DOI 10.1038/nprot.2006.188
   Kellar RS, 2001, CIRCULATION, V104, P2063, DOI 10.1161/hc4201.097192
   LITWIN SE, 1994, CIRCULATION, V89, P345, DOI 10.1161/01.CIR.89.1.345
   Liu YQ, 2004, FASEB J, V18, P457, DOI 10.1096/fj.03-0948com
   MALDONADO BA, 1995, INVEST OPHTH VIS SCI, V36, P364
   Manohar A, 2004, J CELL SCI, V117, P4043, DOI 10.1242/jcs.01277
   MOORADIAN DL, 1993, INVEST OPHTH VIS SCI, V34, P153
   Nam JO, 2003, J BIOL CHEM, V278, P25902, DOI 10.1074/jbc.M300358200
   NICOSIA RF, 1987, AM J PATHOL, V128, P78
   Nisato Riccardo E., 2003, Angiogenesis, V6, P105, DOI 10.1023/B:AGEN.0000011801.98187.f2
   Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040
   Patel S, 2007, J BIOMED MATER RES A, V83A, P423, DOI 10.1002/jbm.a.31320
   PIERSCHBACHER M, 1983, P NATL ACAD SCI-BIOL, V80, P1224, DOI 10.1073/pnas.80.5.1224
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y
   SEGER R, 1995, FASEB J, V9, P726
   Senger DR, 1996, AM J PATHOL, V149, P293
   Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5
   Setty S, 1998, J BIOL CHEM, V273, P12244, DOI 10.1074/jbc.273.20.12244
   SIMMONS M, 2004, MOL CELL BIOCHEM, V264, P99
   Springer ML, 2000, MOL THER, V1, P82, DOI 10.1006/mthe.1999.0006
   Springer ML, 2003, MOL THER, V7, P441, DOI 10.1016/S1525-0016(03)00010-8
   Strauer BE, 2003, CIRCULATION, V107, P929, DOI 10.1161/01.CIR.0000057525.13182.24
   SUDA T, 1981, CURRENT EYE RES, V1
   Thiagarajan P, 1996, BIOCHEMISTRY-US, V35, P4169, DOI 10.1021/bi952532b
   TSILIBARY EC, 1990, J CELL BIOL, V111, P1583, DOI 10.1083/jcb.111.4.1583
   Vailhe B, 2001, LAB INVEST, V81, P439, DOI 10.1038/labinvest.3780252
   Vinals F, 1999, MOL CELL BIOL, V19, P2763
   Virag JI, 2003, AM J PATHOL, V163, P2433, DOI 10.1016/S0002-9440(10)63598-5
   Vogel V, 2003, ANNU REV BIOMED ENG, V5, P441, DOI 10.1146/annurev.bioeng.5.040202.121615
   WOODS A, 1993, MOL BIOL CELL, V4, P605
   Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036
NR 44
TC 13
Z9 13
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 28
PY 2010
VL 5
IS 4
AR e10384
DI 10.1371/journal.pone.0010384
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 589MV
UT WOS:000277154200020
PM 20442783
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

PT J
AU Marchi, M
   D'Antoni, A
   Formentini, I
   Parra, R
   Brambilla, R
   Ratto, GM
   Costa, M
AF Marchi, Matilde
   D'Antoni, Angela
   Formentini, Ivan
   Parra, Riccardo
   Brambilla, Riccardo
   Ratto, Gian Michele
   Costa, Mario
TI The N-Terminal Domain of ERK1 Accounts for the Functional Differences
   with ERK2
SO PLOS ONE
LA English
DT Article
AB The Extracellular Regulated Kinase 1 and 2 transduce a variety of extracellular stimuli regulating processes as diverse as proliferation, differentiation and synaptic plasticity. Once activated in the cytoplasm, ERK1 and ERK2 translocate into the nucleus and interact with nuclear substrates to induce specific programs of gene expression. ERK1/2 share 85% of aminoacid identity and all known functional domains and thence they have been considered functionally equivalent until recent studies found that the ablation of either ERK1 or ERK2 causes dramatically different phenotypes. To search a molecular justification of this dichotomy we investigated whether the different functions of ERK1 and 2 might depend on the properties of their cytoplasmic-nuclear trafficking. Since in the nucleus ERK1/2 is predominantly inactivated, the maintenance of a constant level of nuclear activity requires continuous shuttling of activated protein from the cytoplasm. For this reason, different nuclear-cytoplasmic trafficking of ERK1 and 2 would cause a differential signalling capability. We have characterised the trafficking of fluorescently tagged ERK1 and ERK2 by means of time-lapse imaging in living cells. Surprisingly, we found that ERK1 shuttles between the nucleus and cytoplasm at a much slower rate than ERK2. This difference is caused by a domain of ERK1 located at its N-terminus since the progressive deletion of these residues converted the shuttling features of ERK1 into those of ERK2. Conversely, the fusion of this ERK1 sequence at the N-terminus of ERK2 slowed down its shuttling to a similar value found for ERK1. Finally, computational, biochemical and cellular studies indicated that the reduced nuclear shuttling of ERK1 causes a strong reduction of its nuclear phosphorylation compared to ERK2, leading to a reduced capability of ERK1 to carry proliferative signals to the nucleus. This mechanism significantly contributes to the differential ability of ERK1 and 2 to generate an overall signalling output.
C1 [Ratto, Gian Michele] Scuola Normale Superiore, NEST INFM, I-56100 Pisa, Italy.
   [Ratto, Gian Michele; Costa, Mario] CNR, Inst Neurosci, Pisa, Italy.
   [D'Antoni, Angela; Formentini, Ivan; Brambilla, Riccardo] San Raffele Sci Inst, Milan, Italy.
   [Parra, Riccardo] Scuola Normale Superiore, Pisa, Italy.
   [Marchi, Matilde] Italian Inst Technol IIT, Pisa, Italy.
   [D'Antoni, Angela] Univ Stud Milano, Milan, Italy.
RP Marchi, M (reprint author), Scuola Normale Superiore, NEST INFM, I-56100 Pisa, Italy.
EM gimmi@in.cnr.it; costa@in.cnr.it
RI Brambilla, Riccardo/A-6082-2010
OI Brambilla, Riccardo/0000-0003-3569-5706; Parra,
   Riccardo/0000-0003-1421-2832
FU International Foundation for Paraplegia [239]; Italian Ministry of
   Health
FX The study has been supported by a grant of the International Foundation
   for Paraplegia (grant 239) to GMR, and by a grant from the Italian
   Ministry of Health to RB.
CR Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849
   Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506
   Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1
   Bessard A, 2008, ONCOGENE, V27, P5315, DOI 10.1038/onc.2008.163
   BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J
   Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664
   Brunet A, 1996, SCIENCE, V272, P1652, DOI 10.1126/science.272.5268.1652
   Cancedda L, 2003, J NEUROSCI, V23, P7012, DOI 10.1523/JNEUROSCI.23-18-07012.2003
   Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200
   CHAMBARD JC, 2006, BIOCH BIOPHYS ACTA
   CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915
   Chuderland D, 2008, MOL CELL, V31, P850, DOI 10.1016/j.molcel.2008.08.007
   Chuderland D, 2008, J BIOL CHEM, V283, P11176, DOI 10.1074/jbc.M709030200
   Costa M, 2006, J CELL SCI, V119, P4952, DOI 10.1242/jcs.03272
   COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3
   Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426
   Di Cristo G, 2001, SCIENCE, V292, P2337
   Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969
   Fremin C, 2007, HEPATOLOGY, V45, P1035, DOI 10.1002/hep.21551
   Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200
   Fukuda M, 1997, J BIOL CHEM, V272, P32642, DOI 10.1074/jbc.272.51.32642
   Guha A, 1997, ONCOGENE, V15, P2755, DOI 10.1038/sj.onc.1201455
   KIM K, 2000, J BIOL CHEM, V275, P20685
   Kondoh K, 2005, CHROMOSOMA, V114, P86, DOI 10.1007/s00412-005-0341-9
   Kopito RB, 2007, P NATL ACAD SCI USA, V104, P12743, DOI 10.1073/pnas.0702690104
   Lenormand P, 1998, J CELL BIOL, V142, P625, DOI 10.1083/jcb.142.3.625
   Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097
   Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005
   Matsubayashi Y, 2001, J BIOL CHEM, V276, P41755, DOI 10.1074/jbc.M106012200
   Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X
   Mercer KE, 2003, BBA-REV CANCER, V1653, P25, DOI 10.1016/S0304-419X(03)00016-7
   Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412
   Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374
   Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153
   Pizzorusso T, 2000, J NEUROSCI, V20, P2809
   Ranganathan A, 2006, J BIOL CHEM, V281, P15645, DOI 10.1074/jbc.M513866200
   Robinson FL, 2002, J BIOL CHEM, V277, P14844, DOI 10.1074/jbc.M107776200
   Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X
   Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233
   Satoh Y, 2007, J NEUROSCI, V27, P10765, DOI 10.1523/JNEUROSCI.0117-07.2007
   SEGER R, 1995, FASEB J, V9, P726
   Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x
   Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065
   Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38
   Volmat V, 2001, J CELL SCI, V114, P3433
   Whitehurst AW, 2002, P NATL ACAD SCI USA, V99, P7496, DOI 10.1073/pnas.112495999
   Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331
   Yazicioglu MN, 2007, J BIOL CHEM, V282, P28759, DOI 10.1074/jbc.M703460200
   Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218
   ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0
   ZHENG CF, 1994, J BIOL CHEM, V269, P19947
NR 51
TC 31
Z9 32
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 4
PY 2008
VL 3
IS 12
AR e3873
DI 10.1371/journal.pone.0003873
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 436YO
UT WOS:000265452200014
PM 19052640
OA DOAJ Gold, Green Published
DA 2019-07-19
ER

EF